Section 72

EurekaMag PDF full texts Chapter 71,626


Chang, K.T.; Min, K-Tai. 2005: Drosophila melanogaster homolog of Down syndrome critical region 1 is critical for mitochondrial function. Nature Neuroscience 8(11): 1577-1585
de Bruijn, M.H. 1983: Drosophila melanogaster mitochondrial DNA, a novel organization and genetic code. Nature 304(5923): 234-241
Walker, J.A.; Bernards, Aé. 2007: Drosophila melanogaster neurofibromatosis-1: ROS, not Ras?. Nature Genetics 39(4): 443-445
Sakai, K.; Tsutsui, K.; Yamashita, T.; Iwabe, N.; Takahashi, K.; Wada, A.; Shichida, Y. 2017: Drosophila melanogaster rhodopsin Rh7 is a UV-to-visible light sensor with an extraordinarily broad absorption spectrum. Scientific Reports 7(1): 7349
Gonzalez, C. 2013: Drosophila melanogaster: a model and a tool to investigate malignancy and identify new therapeutics. Nature Reviews. Cancer 13(3): 172-183
Hamilton, P.J.; Campbell, N.G.; Sharma, S.; Erreger, K.; Hansen, F.H.; Saunders, C.; Belovich, A.N.; Sahai, M.A.; Cook, E.H.; Gether, U.; McHaourab, H.S.; Matthies, H.J.G.; Sutcliffe, J.S.; Galli, A. 2013: Drosophila melanogaster: a novel animal model for the behavioral characterization of autism-associated mutations in the dopamine transporter gene. Molecular Psychiatry 18(12): 1235
Ghosh, S.; Ghosh, S.; Mandal, L. 2020: Drosophila metamorphosis involves hemocyte mediated macroendocytosis and efferocytosis. International Journal of Developmental Biology 64(4-5): 319-329
Kitatani, Y.; Tezuka, A.; Hasegawa, E.; Yanagi, S.; Togashi, K.; Tsuji, M.; Kondo, S.; Parrish, J.Z.; Emoto, K. 2020: Drosophila miR-87 promotes dendrite regeneration by targeting the transcriptional repressor Tramtrack69. Plos Genetics 16(8): E1008942
de Navascués, Jín.; Perdigoto, C.N.; Bian, Y.; Schneider, M.H.; Bardin, A.J.; Martínez-Arias, A.; Simons, B.D. 2012: Drosophila midgut homeostasis involves neutral competition between symmetrically dividing intestinal stem cells. EMBO Journal 31(11): 2473-2485
Chan, H.Y.; Bonini, N.M. 2000: Drosophila models of human neurodegenerative disease. Cell Death and Differentiation 7(11): 1075-1080
Yusuff, T.; Jensen, M.; Yennawar, S.; Pizzo, L.; Karthikeyan, S.; Gould, D.J.; Sarker, A.; Gedvilaite, E.; Matsui, Y.; Iyer, J.; Lai, Z.-C.; Girirajan, S. 2020: Drosophila models of pathogenic copy-number variant genes show global and non-neuronal defects during development. Plos Genetics 16(6): E1008792
Yamaguchi, M.; Lee, I.-S.; Jantrapirom, S.; Suda, K.; Yoshida, H. 2021: Drosophila models to study causative genes for human rare intractable neurological diseases. Experimental Cell Research 403(1): 112584
Lawal, H.O.; Terrell, A.; Lam, H.A.; Djapri, C.; Jang, J.; Hadi, R.; Roberts, L.; Shahi, V.; Chou, M-T.; Biedermann, T.; Huang, B.; Lawless, G.M.; Maidment, N.T.; Krantz, D.E. 2014: Drosophila modifier screens to identify novel neuropsychiatric drugs including aminergic agents for the possible treatment of Parkinson's disease and depression. Molecular Psychiatry 19(2): 235-242
Bernstein, S.I.; Mogami, K.; Donady, J.J.; Emerson, C.P. 1983: Drosophila muscle myosin heavy chain encoded by a single gene in a cluster of muscle mutations. Nature 302(5907): 393-397
Yang, H.; Hultmark, D. 2017: Drosophila muscles regulate the immune response against wasp infection via carbohydrate metabolism. Scientific Reports 7(1): 15713
Salkoff, L. 1983: Drosophila mutants reveal two components of fast outward current. Nature 302(5905): 249-251
Yanai, H.; Yoshioka, Y.; Yoshida, H.; Nakao, Y.; Plessis, A.; Yamaguchi, M. 2014: Drosophila myeloid leukemia factor acts with DREF to activate the JNK signaling pathway. Oncogenesis 3: E98
Guo, Y.; Kronert, W.A.; Hsu, K.H.; Huang, A.; Sarsoza, F.; Bell, K.M.; Suggs, J.A.; Swank, D.M.; Bernstein, S.I. 2020: Drosophila myosin mutants model the disparate severity of type 1 and type 2B distal arthrogryposis and indicate an enhanced actin affinity mechanism. Skeletal Muscle 10(1): 24
Januschke, J.; Llamazares, S.; Reina, J.; Gonzalez, C. 2011: Drosophila neuroblasts retain the daughter centrosome. Nature Communications 2: 243
Büschges, A. 2021: Drosophila neuroscience: Unravelling the circuits of sensory-motor control in the fly. Current Biology: Cb 31(8): R394-R396
Wicher, D.; Schäfer, R.; Bauernfeind, Ré.; Stensmyr, M.C.; Heller, R.; Heinemann, S.H.; Hansson, B.S. 2008: Drosophila odorant receptors are both ligand-gated and cyclic-nucleotide-activated cation channels. Nature 452(7190): 1007-1011
Keene, A.C.; Waddell, S. 2007: Drosophila olfactory memory: single genes to complex neural circuits. Nature Reviews. Neuroscience 8(5): 341-354
Godt, D.; Tepass, U. 1998: Drosophila oocyte localization is mediated by differential cadherin-based adhesion. Nature 395(6700): 387-391
McDonough-Goldstein, C.E.; Pitnick, S.; Dorus, S. 2021: Drosophila oocyte proteome composition covaries with female mating status. Scientific Reports 11(1): 3142
Ryan, S.M.; Almassey, M.; Burch, A.M.; Ngo, G.; Martin, J.M.; Myers, D.; Compton, D.; Archie, S.; Cross, M.; Naeger, L.; Salzman, A.; Virola-Iarussi, A.; Barbee, S.A.; Mortimer, N.T.; Sanyal, S.; Vrailas-Mortimer, A.D. 2021: Drosophila p38 MAPK interacts with BAG-3/starvin to regulate age-dependent protein homeostasis. Aging Cell 20(11): E13481
Dichtel-Danjoy, M-L.; Ma, D.; Dourlen, P.; Chatelain, G.; Napoletano, F.; Robin, M.; Corbet, M.; Levet, C.; Hafsi, H.; Hainaut, P.; Ryoo, H.D.; Bourdon, J-C.; Mollereau, B. 2013: Drosophila p53 isoforms differentially regulate apoptosis and apoptosis-induced proliferation. Cell Death and Differentiation 20(1): 108-116
Dare, S.S.; Merlo, E.; Rodriguez Curt, J.; Ekanem, P.E.; Hu, N.; Berni, J. 2020: Drosophila para bss Flies as a Screening Model for Traditional Medicine: Anticonvulsant Effects of Annona senegalensis. Frontiers in Neurology 11: 606919
Terriente-Felix, A.; Wilson, E.L.; Whitworth, A.J. 2020: Drosophila phosphatidylinositol-4 kinase fwd promotes mitochondrial fission and can suppress Pink1/parkin phenotypes. Plos Genetics 16(10): E1008844
Clark, I.E.; Dodson, M.W.; Jiang, C.; Cao, J.H.; Huh, J.R.; Seol, J.Hong.; Yoo, S.Ji.; Hay, B.A.; Guo, M. 2006: Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441(7097): 1162-1166
Montigny, A.; Tavormina, P.; Duboe, C.; San Clémente, H.él.èn.; Aguilar, M.; Valenti, P.; Lauressergues, D.; Combier, J.-P.; Plaza, S. 2021: Drosophila primary microRNA-8 encodes a microRNA-encoded peptide acting in parallel of miR-8. Genome Biology 22(1): 118
Kretova, O.V.; Fedoseeva, D.M.; Slovohotov, I.Y.; Klushevskaya, E.S.; Kravatsky, Y.V.; Tchurikov, N.A. 2020: Drosophila rDNA Genes Shape the Stable Contacts with the Tlk Gene at the Expression Area of Small RNAs and Affect on Looped Domains inside the Gene. Molekuliarnaia Biologiia 54(3): 445-449
Behbahani, A.H.; Palmer, E.H.; Corfas, R.án.A.; Dickinson, M.H. 2021: Drosophila re-zero their path integrator at the center of a fictive food patch. Current Biology: Cb 31(20): 4534-4546.E5
de Castro, I.P.; Costa, A.C.; Celardo, I.; Tufi, R.; Dinsdale, D.; Loh, S.H.Y.; Martins, L.M. 2013: Drosophila ref(2)P is required for the parkin-mediated suppression of mitochondrial dysfunction in pink1 mutants. Cell Death and Disease 4: E873
Botas, J. 2007: Drosophila researchers focus on human disease. Nature Genetics 39(5): 589-591
Boeynaems, S.; Bogaert, E.; Michiels, E.; Gijselinck, I.; Sieben, A.; Jovičić, A.; De Baets, G.; Scheveneels, W.; Steyaert, J.; Cuijt, I.; Verstrepen, K.J.; Callaerts, P.; Rousseau, F.; Schymkowitz, J.; Cruts, M.; Van Broeckhoven, C.; Van Damme, P.; Gitler, A.D.; Robberecht, W.; Van Den Bosch, L. 2016: Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD. Scientific Reports 6: 20877
Dickson, D. 1998: Drosophila set for fast-track sequencing. Nature 393(6683): 296
Ruel, L.; Bourouis, M.; Heitzler, P.; Pantesco, V.; Simpson, P. 1993: Drosophila shaggy kinase and rat glycogen synthase kinase-3 have conserved activities and act downstream of Notch. Nature 362(6420): 557-560
Lee, K-Sun.; Kwon, O-Yu.; Lee, J.H.; Kwon, K.; Min, K-Jin.; Jung, S-Ah.; Kim, A-Kyeong.; You, K-Hee.; Tatar, M.; Yu, K. 2008: Drosophila short neuropeptide F signalling regulates growth by ERK-mediated insulin signalling. Nature Cell Biology 10(4): 468-475
Falkenburg, P.E.; Haass, C.; Kloetzel, P.M.; Niedel, B.; Kopp, F.; Kuehn, L.; Dahlmann, B. 1988: Drosophila small cytoplasmic 19S ribonucleoprotein is homologous to the rat multicatalytic proteinase. Nature 331(6152): 190-192
Wang, X.; Shaw, W.Robert.; Tsang, H.T.H.; Reid, E.; O'Kane, C.J. 2007: Drosophila spichthyin inhibits BMP signaling and regulates synaptic growth and axonal microtubules. Nature Neuroscience 10(2): 177-185
Schulz, J.G.; Ceulemans, H.; Caussinus, E.; Baietti, M.F.; Affolter, M.; Hassan, B.A.; David, G. 2011: Drosophila syndecan regulates tracheal cell migration by stabilizing Robo levels. Embo Reports 12(10): 1039-1046
Grimes, L.; Griffiths, J.; Pasqualetto, G.; Brancale, A.; Kemp, P.J.; Young, M.T.; van der Goes van Naters, W. 2020: Drosophila taste neurons as an agonist-screening platform for P2X receptors. Scientific Reports 10(1): 8292
On, K.; Crevel, G.; Cotterill, S.; Itoh, M.; Kato, Y. 2021: Drosophila telomere capping protein HOAP interacts with DSB sensor proteins Mre11 and Nbs. Genes to Cells: Devoted to Molecular and Cellular Mechanisms 26(4): 219-229
Xie, J.; Chen, S.; Bopassa, J.C.; Banerjee, S. 2021: Drosophila tubulin polymerization promoting protein mutants reveal pathological correlates relevant to human Parkinson's disease. Scientific Reports 11(1): 13614
Restrepo, S.; Basler, K. 2016: Drosophila wing imaginal discs respond to mechanical injury via slow InsP3R-mediated intercellular calcium waves. Nature Communications 7: 12450
Dougan, S.; DiNardo, S. 1992: Drosophila wingless generates cell type diversity among engrailed expressing cells. Nature 360(6402): 347-350
Van de Leemput, J.; Han, Z. 2021: Drosophila, a powerful model to study virus-host interactions and pathogenicity in the fight against SARS-CoV-2. Cell and Bioscience 11(1): 110
Noselli, Séphane. 2002: Drosophila, actin and videotape -- new insights in wound healing. Nature Cell Biology 4(11): E251-E253
Bier, E. 2005: Drosophila, the golden bug, emerges as a tool for human genetics. Nature Reviews. Genetics 6(1): 9-23
Tan, B.H.; Modlin, R.L. 2000: Drosophila, the savvy exterminator. Nature Immunology 1(5): 361
Luning, K.G. 1966: Drosophila-tests in pharmacology. Nature 209(5018): 84-86
Auerbach, C. 1966: Drosophila-tests in pharmacology. Nature 210(5031): 104
Knauf, F.; Preisig, P.A. 2011: Drosophila: a fruitful model for calcium oxalate nephrolithiasis?. Kidney International 80(4): 327-329
Sokolowski, M.B. 2001: Drosophila: genetics meets behaviour. Nature Reviews. Genetics 2(11): 879-890
Bryant, P.J.; Sang, J.H. 1968: Drosophila: lethal derangements of metamorphosis and modifications of gene expression caused by juvenile hormone mimics. Nature 220(5165): 393-394
Paton, D.M. 2020: Drospirenone: a novel progestogen used as an oral contraceptive without an estrogen component. Drugs of Today 56(5): 321-328
Wu, S.; Guo, C.; Zhao, H.; Sun, M.; Chen, J.; Han, C.; Peng, Q.; Qiao, H.; Peng, P.; Liu, Y.; Luo, S.D.; Pan, Y. 2019: Drosulfakinin signaling in fruitless circuitry antagonizes P1 neurons to regulate sexual arousal in Drosophila. Nature Communications 10(1): 4770
Kanbur, A.S.; Agarwal, A.; Rokade, M.L. 2021: Drotaverine-induced priapism. Indian Journal of Urology: Iju: Journal of the Urological Society of India 37(1): 90-91
LaRosa, S.P. 2006: Drotrecogin alfa (activated) in severe sepsis. New England Journal of Medicine 354(1): 94
Baillie, J.K.; Murray, G. 2006: Drotrecogin alfa (activated) in severe sepsis. New England Journal of Medicine 354(1): 94
Russo, G.; La Spina, M.; Disma, N.; Astuto, M. 2006: Drotrecogin alfa activated as a treatment for severe sepsis in pediatric cancer. Bone Marrow Transplantation 38(8): 575-576
Labbos, J.; Bradsher, J.; Kirkpatrick, P. 2003: Drotrecogin alpha (activated). Nature Reviews. Drug Discovery 2(1): 13-14
Kuswanto, H.; Puspa, A.W.; Ahmad, I.S.; Hibatullah, F. 2021: Drought Analysis in East Nusa Tenggara (Indonesia) Using Regional Frequency Analysis. Thescientificworldjournal 2021: 6626102
Prasad, J.K.; Pandey, P.; Anand, R.; Raghuwanshi, R. 2021: Drought Exposed Burkholderia seminalis JRBHU6 Exhibits Antimicrobial Potential Through Pyrazine-1,4-Dione Derivatives Targeting Multiple Bacterial and Fungal Proteins. Frontiers in Microbiology 12: 633036
Henderson, J.C.; Davies, F.T. 1990: Drought acclimation and the morphology of mycorrhizal Rosa hybrida L. cv. 'Ferdy' is independent of leaf elemental content. New Phytologist 115(3): 503-510
Vandegeer, R.; Miller, R.E.; Bain, M.; Gleadow, R.M.; Cavagnaro, T.R. 2013: Drought adversely affects tuber development and nutritional quality of the staple crop cassava (Manihot esculenta Crantz). Functional Plant Biology: Fpb 40(2): 195-200
Gómez-Gener, Lís.; Lupon, A.; Laudon, H.; Sponseller, R.A. 2020: Drought alters the biogeochemistry of boreal stream networks. Nature Communications 11(1): 1795
Dikici, M. 2020: Drought analysis with different indices for the Asi Basin (Turkey). Scientific Reports 10(1): 20739
Bellizzi, S.; Panu Napodano, C.M.; Fiamma, M.; Ali Maher, O. 2020: Drought and COVID-19 in the Eastern Mediterranean Region of the WHO. Public Health 183: 46-47
Xiang, L.-S.; Miao, L.-F.; Yang, F. 2021: Drought and Nitrogen Application Modulate the Morphological and Physiological Responses of Dalbergia odorifera to Different Niche Neighbors. Frontiers in Plant Science 12: 664122
Ma, Y.; Dias, M.C.; Freitas, H. 2020: Drought and Salinity Stress Responses and Microbe-Induced Tolerance in Plants. Frontiers in Plant Science 11: 591911
Delbiso, T.Darge.; Altare, C.; Rodriguez-Llanes, J.Manuel.; Doocy, S.; Guha-Sapir, D. 2017: Drought and child mortality: a meta-analysis of small-scale surveys from Ethiopia. Scientific Reports 7(1): 2212
Byers, E.A.; Coxon, G.; Freer, J.; Hall, J.W. 2020: Drought and climate change impacts on cooling water shortages and electricity prices in Great Britain. Nature Communications 11(1): 2239
Phillips, K.; Ludidi, N. 2017: Drought and exogenous abscisic acid alter hydrogen peroxide accumulation and differentially regulate the expression of two maize RD22-like genes. Scientific Reports 7(1): 8821
Di Francescantonio, D.éb.; Villagra, M.; Goldstein, G.; Campanello, P.I. 2020: Drought and frost resistance vary between evergreen and deciduous Atlantic Forest canopy trees. Functional Plant Biology: Fpb 47(9): 779-791
El-Madany, T.S.; Carrara, A.; Martín, M.P.; Moreno, G.; Kolle, O.; Pacheco-Labrador, J.; Weber, U.; Wutzler, T.; Reichstein, M.; Migliavacca, M. 2020: Drought and heatwave impacts on semi-arid ecosystems' carbon fluxes along a precipitation gradient. Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 375(1810): 20190519
Feng, W.; Lu, H.; Yao, T.; Yu, Q. 2020: Drought characteristics and its elevation dependence in the Qinghai-Tibet plateau during the last half-century. Scientific Reports 10(1): 14323
Xie, T.; Shan, L.; Su, P. 2020: Drought conditions alter litter decomposition and nutrient release of litter types in an agroforestry system of China. Ecology and Evolution 10(15): 8018-8029
Dyosi, M.; Kalumba, A.M.; Magagula, H.B.; Zhou, L.; Orimoloye, I.R. 2021: Drought conditions appraisal using geoinformatics and multi-influencing factors. Environmental Monitoring and Assessment 193(6): 365
Orimoloye, I.R.; Belle, J.A.; Ololade, O.O. 2021: Drought disaster monitoring using MODIS derived index for drought years: A space-based information for ecosystems and environmental conservation. Journal of Environmental Management 284: 112028
Mahmud, T.; Sifa, S.F.; Islam, N.N.; Rafsan, M.A.; Kamal, A.S.M.M.; Hossain, M.S.; Rahman, M.Z.; Chakraborty, T.R. 2021: Drought dynamics of Northwestern Teesta Floodplain of Bangladesh: a remote sensing approach to ascertain the cause and effect. Environmental Monitoring and Assessment 193(4): 218
Svensk, M.; Coste, S.; Gérard, B.; Gril, E.; Julien, F.éd.ér.; Maillard, P.; Stahl, C.ém.; Leroy, C.él. 2020: Drought effects on resource partition and conservation among leaf ontogenetic stages in epiphytic tank bromeliads. Physiologia Plantarum 170(4): 488-507
Salvador, C.; Nieto, R.; Linares, C.; Díaz, J.; Alves, C.A.; Gimeno, L. 2021: Drought effects on specific-cause mortality in Lisbon from 1983 to 2016: Risks assessment by gender and age groups. Science of the Total Environment 751: 142332
Leybourne, D.J.; Preedy, K.F.; Valentine, T.A.; Bos, J.I.B.; Karley, A.J. 2021: Drought has negative consequences on aphid fitness and plant vigor: Insights from a meta-analysis. Ecology and Evolution 11(17): 11915-11929
Doughty, C.E.; Metcalfe, D.B.; Girardin, C.A.J.; Amézquita, F.Farfán.; Cabrera, D.Galiano.; Huasco, W.Huaraca.; Silva-Espejo, J.E.; Araujo-Murakami, A.; da Costa, M.C.; Rocha, W.; Feldpausch, T.R.; Mendoza, A.L.M.; da Costa, A.C.L.; Meir, P.; Phillips, O.L.; Malhi, Y. 2015: Drought impact on forest carbon dynamics and fluxes in Amazonia. Nature 519(7541): 78-82
Smith, L.T.; Aragão, L.E.O.C.; Sabel, C.E.; Nakaya, T. 2014: Drought impacts on children's respiratory health in the Brazilian Amazon. Scientific Reports 4: 3726
Mahlalela, P.T.; Blamey, R.C.; Hart, N.C.G.; Reason, C.J.C. 2020: Drought in the Eastern Cape region of South Africa and trends in rainfall characteristics. Climate Dynamics 55(9-10): 2743-2759
Malik, A.; Kumar, A.; Salih, S.Q.; Kim, S.; Kim, N.W.; Yaseen, Z.M.; Singh, V.P. 2020: Drought index prediction using advanced fuzzy logic model: Regional case study over Kumaon in India. Plos one 15(5): E0233280
Castillioni, K.; Wilcox, K.; Jiang, L.; Luo, Y.; Jung, C.G.; Souza, L. 2020: Drought mildly reduces plant dominance in a temperate prairie ecosystem across years. Ecology and Evolution 10(13): 6702-6713
Li, X.; Zuo, X.; Yue, P.; Zhao, X.; Hu, Y.; Guo, X.; Guo, A.; Xu, C.; Yu, Q. 2021: Drought of early time in growing season decreases community aboveground biomass, but increases belowground biomass in a desert steppe. Bmc Ecology and Evolution 21(1): 106
Gomes, L.E.d.O.; da Silva, E.C. 2020: Drought periods driving bioinvasion on hard substrates at a tropical estuary, Eastern Brazil. Marine Pollution Bulletin 160: 111563
Ma, X.; Huete, A.; Cleverly, J.; Eamus, D.; Chevallier, Fédéric.; Joiner, J.; Poulter, B.; Zhang, Y.; Guanter, L.; Meyer, W.; Xie, Z.; Ponce-Campos, G. 2016: Drought rapidly diminishes the large net CO 2 uptake in 2011 over semi-arid Australia. Scientific Reports 6: 37747
Aikens, E.O.; Monteith, K.L.; Merkle, J.A.; Dwinnell, S.P.H.; Fralick, G.L.; Kauffman, M.J. 2020: Drought reshuffles plant phenology and reduces the foraging benefit of green-wave surfing for a migratory ungulate. Global Change Biology 26(8): 4215-4225
Blum, A. 2011: Drought resistance - is it really a complex trait?. Functional Plant Biology: Fpb 38(10): 753-757
Dong, T.; Xi, L.; Xiong, B.; Qiu, X.; Huang, S.; Xu, W.; Wang, J.; Wang, B.; Yao, Y.; Duan, C.; Tang, X.; Sun, G.; Wang, X.; Deng, H.; Wang, Z. 2021: Drought resistance in Harumi tangor seedlings grafted onto different rootstocks. Functional Plant Biology: Fpb 48(5): 529-541
Liu, Y.; He, Z.; Xie, Y.; Su, L.; Zhang, R.; Wang, H.; Li, C.; Long, S. 2021: Drought resistance mechanisms of Phedimus aizoon L. Scientific Reports 11(1): 13600
Nardini, A.; Pitt, F. 1999: Drought resistance of Quercus pubescens as a function of root hydraulic conductance, xylem embolism and hydraulic architecture. New Phytologist 143(3): 485-493
Smeekens, S. 2017: Drought resistance: Spraying for yield. Nature Plants 3: 17023
De Souza, B.C.; Carvalho, E.C.D.; Oliveira, R.S.; de Araujo, F.S.; de Lima, A.é L.A.; Rodal, M.J.N. 2020: Drought response strategies of deciduous and evergreen woody species in a seasonally dry neotropical forest. Oecologia 194(1-2): 221-236
Meza, I.; Eyshi Rezaei, E.; Siebert, S.; Ghazaryan, G.; Nouri, H.; Dubovyk, O.; Gerdener, H.; Herbert, C.; Kusche, J.ür.; Popat, E.; Rhyner, J.; Jordaan, A.; Walz, Y.; Hagenlocher, M. 2021: Drought risk for agricultural systems in South Africa: Drivers, spatial patterns, and implications for drought risk management. Science of the Total Environment 799: 149505
Gatti, L.V.; Gloor, M.; Miller, J.B.; Doughty, C.E.; Malhi, Y.; Domingues, L.G.; Basso, L.S.; Martinewski, A.; Correia, C.S.C.; Borges, V.F.; Freitas, S.; Braz, R.; Anderson, L.O.; Rocha, H.; Grace, J.; Phillips, O.L.; Lloyd, J. 2014: Drought sensitivity of Amazonian carbon balance revealed by atmospheric measurements. Nature 506(7486): 76-80
Engelbrecht, B.M.J.; Comita, L.S.; Condit, R.; Kursar, T.A.; Tyree, M.T.; Turner, B.L.; Hubbell, S.P. 2007: Drought sensitivity shapes species distribution patterns in tropical forests. Nature 447(7140): 80-82
Bian, F.; Wang, Y.; Duan, B.; Wu, Z.; Zhang, Y.; Bi, Y.; Wang, A.; Zhong, H.; Du, X. 2021: Drought stress introduces growth, physiological traits and ecological stoichiometry changes in two contrasting Cunninghamia lanceolata cultivars planted in continuous-plantation soils. Bmc Plant Biology 21(1): 379
Zhuang, J.; Wang, Y.; Chi, Y.; Zhou, L.; Chen, J.; Zhou, W.; Song, J.; Zhao, N.; Ding, J. 2020: Drought stress strengthens the link between chlorophyll fluorescence parameters and photosynthetic traits. Peerj 8: E10046
Kaur, E.; Bhardwaj, R.D.; Kaur, S.; Grewal, S.K. 2021: Drought stress-induced changes in redox metabolism of barley (Hordeum vulgare L.). Biologia Futura 72(3): 347-358
Razi, K.; Muneer, S. 2021: Drought stress-induced physiological mechanisms, signaling pathways and molecular response of chloroplasts in common vegetable crops. Critical Reviews in Biotechnology 2021: 1-40
Vikram, P.; Swamy, B.P.Mallikarjuna.; Dixit, S.; Singh, R.; Singh, B.P.; Miro, B.; Kohli, A.; Henry, A.; Singh, N.K.; Kumar, A. 2015: Drought susceptibility of modern rice varieties: an effect of linkage of drought tolerance with undesirable traits. Scientific Reports 5: 14799
Melandri, G.; AbdElgawad, H.; Floková, K.ýn.; Jamar, D.C.; Asard, H.; Beemster, G.T.S.; Ruyter-Spira, C.; Bouwmeester, H.J. 2021: Drought tolerance in selected aerobic and upland rice varieties is driven by different metabolic and antioxidative responses. Planta 254(1): 13
Sahana, V.; Mondal, A.; Sreekumar, P. 2021: Drought vulnerability and risk assessment in India: Sensitivity analysis and comparison of aggregation techniques. Journal of Environmental Management 299: 113689
Tian, J.; Pang, Y.; Zhao, Z. 2021: Drought, Salinity, and Low Nitrogen Differentially Affect the Growth and Nitrogen Metabolism of Sophora japonica (L.) in a Semi-Hydroponic Phenotyping Platform. Frontiers in Plant Science 12: 715456
Gebre, B.; Ayenew, H.Y.; Biadgilign, S. 2021: Drought, hunger and coping mechanisms among rural household in Southeast Ethiopia. Heliyon 7(3): E06355
Geppert, C.; Contri, C.; De Boni, L.; Corcos, D.; Marini, L. 2021: Drought, nitrogen deposition and arthropod herbivory modify plant establishment dynamics after soil disturbance. Science of the Total Environment 796: 148956
Castorina, G.; Domergue, Fédéric.; Chiara, M.; Zilio, M.; Persico, M.; Ricciardi, V.; Horner, D.Stephen.; Consonni, G. 2020: Drought-Responsive ZmFDL1/MYB94 Regulates Cuticle Biosynthesis and Cuticle-Dependent Leaf Permeability. Plant Physiology 184(1): 266-282
Pontes-Lopes, A.; Silva, C.V.J.; Barlow, J.; Rincón, L.M.; Campanharo, W.A.; Nunes, C.ás.A.; de Almeida, C.T.; Silva Júnior, C.H.L.; Cassol, H.L.G.; Dalagnol, R.; Stark, S.C.; Graça, P.M.L.A.; Aragão, L.E.O.C. 2021: Drought-driven wildfire impacts on structure and dynamics in a wet Central Amazonian forest. PROCEEDINGS. Biological Sciences 288(1951): 20210094
Rolly, N.K.; Imran, Q.M.; Shahid, M.; Imran, M.; Khan, M.; Lee, S.-U.; Hussain, A.; Lee, I.-J.; Yun, B.-W. 2020: Drought-induced AtbZIP62 transcription factor regulates drought stress response in Arabidopsis. Plant Physiology and Biochemistry: Ppb 156: 384-395
Smith, C.F.; Schuett, G.W.; Reiserer, R.S.; Dana, C.E.; Collyer, M.L.; Davis, M.A. 2019: Drought-induced Suppression of Female Fecundity in a Capital Breeder. Scientific Reports 9(1): 15499
Ng, C.K.; Carr, K.; McAinsh, M.R.; Powell, B.; Hetherington, A.M. 2001: Drought-induced guard cell signal transduction involves sphingosine-1-phosphate. Nature 410(6828): 596-599
Here, A.-M.; Voltas, J.; L Pez, B.C.; Mart Nez-Vilalta, J. 2014: Drought-induced mortality selectively affects Scots pine trees that show limited intrinsic water-use efficiency responsiveness to raising atmospheric CO2. Functional Plant Biology: Fpb 41(3): 244-256
Maitra Majee, S.; Sharma, E.; Singh, B.; Khurana, J.P. 2020: Drought-induced protein (Di19-3) plays a role in auxin signaling by interacting with IAA14 in Arabidopsis. Plant Direct 4(6): E00234
Kuppler, J.; Wieland, J.; Junker, R.R.; Ayasse, M. 2021: Drought-induced reduction in flower size and abundance correlates with reduced flower visits by bumble bees. Aob Plants 13(1): Plab 001
Mikac, S.; Žmegač, A.; Trlin, D.; Paulić, V.; Oršanić, M.; Anić, I. 2018: Drought-induced shift in tree response to climate in floodplain forests of Southeastern Europe. Scientific Reports 8(1): 16495
Ryu, M.; Mishra, R.Chandra.; Jeon, J.; Lee, S.Keun.; Bae, H. 2018: Drought-induced susceptibility for Cenangium ferruginosum leads to progression of Cenangium-dieback disease in Pinus koraiensis. Scientific Reports 8(1): 16368
Dai, J.; Liu, H.; Wang, Y.; Guo, Q.; Hu, T.; Quine, T.; Green, S.; Hartmann, H.; Xu, C.; Liu, X.; Jiang, Z. 2020: Drought-modulated allometric patterns of trees in semi-arid forests. Communications Biology 3(1): 405
Charnley, G.E.C.; Kelman, I.; Murray, K.A. 2021: Drought-related cholera outbreaks in Africa and the implications for climate change: a narrative review. Pathogens and Global Health 2021: 1-10
Tollefson, J. 2011: Drought-tolerant maize gets US debut. Nature 469(7329): 144
Zhang, Q.; Shi, R.; Singh, V.P.; Xu, C.-Y.; Yu, H.; Fan, K.; Wu, Z. 2022: Droughts across China: Drought factors, prediction and impacts. Science of the Total Environment 803: 150018
Zhang, X.; Obringer, R.; Wei, C.; Chen, N.; Niyogi, D. 2017: Droughts in India from 1981 to 2013 and Implications to Wheat Production. Scientific Reports 7: 44552
Schiermeier, Q. 2018: Droughts, heatwaves and floods: How to tell when climate change is to blame. Nature 560(7716): 20-22
Guzman, A.; Weed, K.R. 2021: Drowning Outside the Insurance Pool. Ama Journal of Ethics 23(6): E499-E500
Szpilman, D.; Palacios Aguilar, J.; Barcala-Furelos, R.; Baker, S.; Dunne, C.; Peden, A.E.; Brander, R.; Claesson, A.; Avramidis, S.; Leavy, J.; Luckhaus, J.L.; Manino, L.A.; Marques, O.; Nyitrai, N.J.; Pascual-Gomez, L.-M.; Springer, L.; Stanley, T.J.; Venema, A.M.; Queiroga, A.C. 2021: Drowning and aquatic injuries dictionary. Resuscitation Plus 5: 100072
Gabrielli, A.; Layon, A.J. 1997: Drowning and near drowning. Journal of the Florida Medical Association 84(7): 452-457
Mathur, G.P.; Mathur, S. 1986: Drowning and near-drowning. Indian Pediatrics 23 Suppl: 189-194
Kot, P.A. 1974: Drowning and near-drowning. American Family Physician 10(1): 72-76
Ryan, C.A.; Dowling, G. 1993: Drowning deaths in people with epilepsy. Cmaj: Canadian Medical Association Journal 148(5): 781-784
Fessell, D.; Lexa, F.J. 2020: Drowning in E-Mail. Journal of the American College of Radiology: Jacr 2020
Clemens, T.; Oporia, F.; Parker, E.M.; Yellman, M.A.; Ballesteros, M.F.; Kobusingye, O. 2022: Drowning in Uganda: examining data from administrative sources. Injury Prevention: Journal of the International Society for Child and Adolescent Injury Prevention 28(1): 9-15
Ryan, K.M.; Dugas, J.; Pina, T.; Maksimenko, Y.; Liu, J. 2020: Drowning injuries in the United States: Patient characteristics, mortality risk, and associated primary diagnoses. Injury 51(11): 2560-2564
Lawson, B.; Duff, J.Paul.; Beckmann, K.M.; Chantrey, J.; Peck, K.M.; Irvine, R.M.; Robinson, R.A.; Cunningham, A.A. 2015: Drowning is an apparent and unexpected recurrent cause of mass mortality of Common starlings (Sturnus vulgaris). Scientific Reports 5: 17020
Martin, R.; Bruxner, G.; Ng, G.; Brewster, C.; Kothari, A. 2020: Drowning our sorrows: clinical and ethical considerations of termination in alcohol-affected pregnancy. Bmc Pregnancy and Childbirth 20(1): 356
Wheatley, D. 1972: Drowsiness and antidepressant drugs in mild depressive illness. British Journal of Psychiatry: the Journal of Mental Science 120(558): 507-509
Stawarczyk, D.; François, C.ém.; Wertz, J.ér.ôm.; D'Argembeau, A. 2020: Drowsiness or mind-wandering? Fluctuations in ocular parameters during attentional lapses. Biological Psychology 156: 107950
Dela Peña, I.; Shen, G.; Shi, W.-X. 2021: Droxidopa alters dopamine neuron and prefrontal cortex activity and improves attention-deficit/hyperactivity disorder-like behaviors in rats. European Journal of Pharmacology 892: 173826
Hauser, R.A.; Heritier, S.; Rowse, G.J.; Hewitt, L.Arthur.; Isaacson, S.H. 2016: Droxidopa and Reduced Falls in a Trial of Parkinson Disease Patients With Neurogenic Orthostatic Hypotension. Clinical Neuropharmacology 39(5): 220-226
Luo, X.; Cai, S.; Li, Y.; Li, G.; Cao, Y.; Ai, C.; Gao, Y.; Li, T. 2020: Drp-1 as Potential Therapeutic Target for Lipopolysaccharide-Induced Vascular Hyperpermeability. Oxidative Medicine and Cellular Longevity 2020: 5820245
Adachi, Y.; Kato, T.; Yamada, T.; Murata, D.; Arai, K.; Stahelin, R.V.; Chan, D.C.; Iijima, M.; Sesaki, H. 2020: Drp1 Tubulates the ER in a GTPase-Independent Manner. Molecular Cell 80(4): 621-632.E6
Zhang, S.; Che, L.; He, C.; Huang, J.; Guo, N.; Shi, J.; Lin, Y.; Lin, Z. 2019: Drp1 and RB interaction to mediate mitochondria-dependent necroptosis induced by cadmium in hepatocytes. Cell Death and Disease 10(7): 523
Rappold, P.M.; Cui, M.; Grima, J.C.; Fan, R.Z.; de Mesy-Bentley, K.L.; Chen, L.; Zhuang, X.; Bowers, W.J.; Tieu, K. 2014: Drp1 inhibition attenuates neurotoxicity and dopamine release deficits in vivo. Nature Communications 5: 5244
Dulac, M.; Leduc-Gaudet, J.-P.; Reynaud, O.; Ayoub, M.-B.; Guérin, A.; Finkelchtein, M.; Hussain, S.N.; Gouspillou, G. 2020: Drp1 knockdown induces severe muscle atrophy and remodelling, mitochondrial dysfunction, autophagy impairment and denervation. Journal of Physiology 598(17): 3691-3710
Peña-Blanco, A.; Haschka, M.D.; Jenner, A.; Zuleger, T.; Proikas-Cezanne, T.; Villunger, A.; García-Sáez, A.J. 2020: Drp1 modulates mitochondrial stress responses to mitotic arrest. Cell Death and Differentiation 27(9): 2620-2634
Giovarelli, M.; Zecchini, S.; Martini, E.; Garrè, M.; Barozzi, S.; Ripolone, M.; Napoli, L.; Coazzoli, M.; Vantaggiato, C.; Roux-Biejat, P.; Cervia, D.; Moscheni, C.; Perrotta, C.; Parazzoli, D.; Clementi, E.; De Palma, C. 2020: Drp1 overexpression induces desmin disassembling and drives kinesin-1 activation promoting mitochondrial trafficking in skeletal muscle. Cell Death and Differentiation 27(8): 2383-2401
Chang, C-Rung.; Blackstone, C. 2007: Drp1 phosphorylation and mitochondrial regulation. Embo Reports 8(12): 1088-9; Author Reply 1089-90
Duan, C.; Kuang, L.; Xiang, X.; Zhang, J.; Zhu, Y.; Wu, Y.; Yan, Q.; Liu, L.; Li, T. 2020: Drp1 regulates mitochondrial dysfunction and dysregulated metabolism in ischemic injury via Clec16a-, BAX-, and GSH- pathways. Cell Death and Disease 11(4): 251
Ye, S.; Yang, P.; Cheng, K.; Zhou, T.; Wang, Y.; Hou, Z.; Jiang, Y.; Ren, L. 2016: Drp1-Dependent Mitochondrial Fission Mediates Toxicity of Positively Charged Graphene in Microglia. Acs Biomaterials Science and Engineering 2(5): 722-733
Johnson, J.; Mercado-Ayón, E.; Clark, E.; Lynch, D.; Lin, H. 2021: Drp1-dependent peptide reverse mitochondrial fragmentation, a homeostatic response in Friedreich ataxia. Pharmacology Research and Perspectives 9(3): E00755
Xie, L.; Shi, F.; Li, Y.; Li, W.; Yu, X.; Zhao, L.; Zhou, M.; Hu, J.; Luo, X.; Tang, M.; Fan, J.; Zhou, J.; Gao, Q.; Wu, W.; Zhang, X.; Liao, W.; Bode, A.M.; Cao, Y. 2020: Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance. Signal Transduction and Targeted Therapy 5(1): 56
Xie, L.; Shi, F.; Li, Y.; Li, W.; Yu, X.; Zhao, L.; Zhou, M.; Hu, J.; Luo, X.; Tang, M.; Fan, J.; Zhou, J.; Gao, Q.; Wu, W.; Zhang, X.; Liao, W.; Bode, A.M.; Cao, Y. 2020: Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance. Signal Transduction and Targeted Therapy 5: 56
Jin, C.; Zhong, Y.; Han, J.; Zhu, J.; Liu, Q.; Sun, D.; Xia, X.; Peng, X. 2020: Drp1-mediated mitochondrial fission induced autophagy attenuates cell apoptosis caused by 3-chlorpropane-1,2-diol in HEK293 cells. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 145: 111740
Wang, Y.; Lu, M.; Xiong, L.; Fan, J.; Zhou, Y.; Li, H.; Peng, X.; Zhong, Z.; Wang, Y.; Huang, F.; Chen, W.; Yu, X.; Mao, H. 2020: Drp1-mediated mitochondrial fission promotes renal fibroblast activation and fibrogenesis. Cell Death and Disease 11(1): 29
Seay, M.D.; Digre, K.B.; Rucker, J.C.; Leigh, R.J.; Zee, D. 2020: Drs. Richard John Leigh and David Zee. Journal of Neuro-Ophthalmology: the Official Journal of the North American Neuro-Ophthalmology Society 40(3): E17-E26
Yu, L.; Fan, G. 2021: DrsNet: Dual-resolution Semantic Segmentation with Rare Class-Oriented Superpixel Prior. Multimedia Tools and Applications 80(2): 1687-1706
Banach, M.; Penson, P.E. 2021: Drucebo effect - the challenge we should all definitely face!. Archives of Medical Science: Ams 17(2): 542-543
Srinivasan, C.S.; Zanello, G.; Nkegbe, P.; Cherukuri, R.; Picchioni, F.; Gowdru, N.; Webb, P. 2019: Drudgery reduction, physical activity and energy requirements in rural livelihoods. Economics and Human Biology 37: 100846
Zhai, Y.; Wang, J.; Qiu, L. 2021: Drug -driven self-assembly of pH-sensitive nano-vesicles with high loading capacity and anti-tumor efficacy. Biomaterials Science 9(9): 3348-3361
Khazaee-Pool, M.; Naghibi, S.A.; Pashaei, T.; Chaleshgar-Kordasiabi, M.; Daneshnia, M.; Ponnet, K. 2021: Drug Abstinence Self-Efficacy Scale (DASES): psychometric properties of the Farsi version. Substance Abuse Treatment Prevention and Policy 16(1): 1
Chopra, R.N. 1935: Drug Addiction in India and its Treatment. Indian Medical Gazette 70(3): 121-131
Wright, R.E. 1935: Drug Addiction in India and its Treatment. Indian Medical Gazette 70(8): 479
Wright, R.E. 1936: Drug Addiction in India and its Treatment. Indian Medical Gazette 71(7): 435
Koob, G.F. 2021: Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development. Pharmacological Reviews 73(1): 163-201
Huang, L.; Wang, D.; Zhang, C. 2021: Drug Affinity Responsive Target Stability (DARTS ) Assay to Detect Interaction Between a Purified Protein and a Small Molecule. Methods in Molecular Biology 2213: 175-182
Rodriguez-Furlan, C.; Zhang, C.; Raikhel, N.; Hicks, G.R. 2017: Drug Affinity Responsive Target Stability (DARTS) to Resolve Protein-Small Molecule Interaction in Arabidopsis. Current Protocols in Plant Biology 2(4): 370-378
Cravidi, C.; Caimmi, S.; De Filippo, M.; Martelli, A.; Caffarelli, C.; Miraglia Del Giudice, M.; Calvani, M.; Tosca, M.Angela.; Cardinale, F.; Marseglia, G.Luigi.; Manti, S.; Chiappini, E.; Caimmi, D. 2020: Drug Allergy in children: focus on beta-lactams and NSAIDs. Acta Bio-Medica: Atenei Parmensis 91(11-S): E2020008
Wouters, H.; Hilmer, S.N.; Twisk, J.; Teichert, M.; Van Der Meer, H.G.; Van Hout, H.P.J.; Taxis, K. 2020: Drug Burden Index and Cognitive and Physical Function in Aged Care Residents: A Longitudinal Study. Journal of the American Medical Directors Association 21(8): 1086-1092.E1
Black, S.; Lerman, J.; Banks, S.E.; Noghrehkar, D.; Curia, L.; Mai, C.L.; Schwengel, D.; Nelson, C.K.; Foster, J.M.T.; Breneman, S.; Arheart, K.L. 2019: Drug Calculation Errors in Anesthesiology Residents and Faculty: An Analysis of Contributing Factors. Anesthesia and Analgesia 128(6): 1292-1299
Conner, B. 2021: Drug Calculations in Veterinary Medical Education-Where Are We?. Journal of Veterinary Medical Education 48(3): 252-255
Betzler, F.; Helbig, J.; Viohl, L.; Ernst, F.; Roediger, L.; Gutwinski, S.; Ströhle, A.; Köhler, S. 2021: Drug Checking and its Potential Impact on Substance use. European Addiction Research 27(1): 25-32
Fregonese, M.; Albino, A.; Covino, C.; Gili, A.; Bacci, M.; Nicoletti, A.; Gambelunghe, C. 2021: Drug Checking as Strategy for Harm Reduction in Recreational Contests: Evaluation of two Different Drug Analysis Methodologies. Frontiers in Psychiatry 12: 596895
Fong, K.Y.; Zhao, J.J.; Tan, E.; Syn, N.L.; Sultana, R.; Zhuang, K.D.; Chua, J.M.E.; Patel, A.; Irani, F.G.; Tay, K.H.; Tan, B.S.; Too, C.W. 2021: Drug Coated Balloons for Dysfunctional Haemodialysis Venous Access: a Patient Level Meta-Analysis of Randomised Controlled Trials. European Journal of Vascular and Endovascular Surgery: the Official Journal of the European Society for Vascular Surgery 62(4): 610-621
Uprety, D. 2017: Drug Combinations with Transplantation for Myeloma. New England Journal of Medicine 377(1): 92
Attal, M.; Richardson, P.G.; Moreau, P. 2017: Drug Combinations with Transplantation for Myeloma. New England Journal of Medicine 377(1): 93-94
Baer, D. 2017: Drug Combinations with Transplantation for Myeloma. New England Journal of Medicine 377(1): 92-93
Iglesias-Sancho, M.; Llambí Mateos, F.; Salleras-Redonnet, M. 2020: Drug Compounding for Diseases of the Oral Mucosa. Actas Dermo-Sifiliograficas 111(10): 822-828
Rauhut, A.S.; Warnick, J.A. 2020: Drug Conditioning and Sensitization in Mice: Importance of Early Voluntary Exercise. Neuroscience 442: 114-123
Docherty, M.; Mulvey, E.; Beardslee, J.; Sweeten, G.; Pardini, D. 2020: Drug Dealing and Gun Carrying go Hand in Hand: Examining how Juvenile Offenders' Gun Carrying Changes Before and After Drug Dealing Spells across 84 Months. Journal of Quantitative Criminology 36(4): 993-1015
Makvandi, P.; Josic, U.; Delfi, M.; Pinelli, F.; Jahed, V.; Kaya, E.; Ashrafizadeh, M.; Zarepour, A.; Rossi, F.; Zarrabi, A.; Agarwal, T.; Zare, E.N.; Ghomi, M.; Kumar Maiti, T.; Breschi, L.; Tay, F.R. 2021: Drug Delivery (Nano)Platforms for Oral and Dental Applications: Tissue Regeneration, Infection Control, and Cancer Management. Advanced Science 8(8): 2004014
Ebrahimi, S.; Vatani, P.; Amani, A.; Shamloo, A. 2021: Drug delivery performance of nanocarriers based on adhesion and interaction for abdominal aortic aneurysm treatment. International Journal of Pharmaceutics 594: 120153
Jaimalai, T.; Meeroekyai, S.; Suree, N.; Prangkio, P. 2020: Drug Delivery System Targeting CD4+ T Cells for HIV-1 Latency Reactivation Towards the Viral Eradication. Journal of Pharmaceutical Sciences 109(10): 3013-3020
Ishima, Y.; Maruyama, T.; Otagiri, M.; Ishida, T. 2020: Drug Delivery System for Refractory Cancer Therapy via an Endogenous Albumin Transport System. Chemical and Pharmaceutical Bulletin 68(7): 583-588
Zhao, R.; Lu, Z.; Yang, J.; Zhang, L.; Li, Y.; Zhang, X. 2020: Drug Delivery System in the Treatment of Diabetes Mellitus. Frontiers in Bioengineering and Biotechnology 8: 880
Metaxa, A.-F.; Vrontaki, E.; Efthimiadou, E.K.; Mavromoustakos, T. 2021: Drug Delivery Systems Based on Modified Polysaccharides: Synthesis and Characterization. Methods in Molecular Biology 2207: 151-161
Caimano, M.; Lospinoso Severini, L.; Loricchio, E.; Infante, P.; Di Marcotullio, L. 2021: Drug Delivery Systems for Hedgehog Inhibitors in the Treatment of SHH-Medulloblastoma. Frontiers in Chemistry 9: 688108
Aranda-Lara, L.; García, B.E.O.; Isaac-Olivé, K.; Ferro-Flores, G.; Meléndez-Alafort, L.; Morales-Avila, E. 2021: Drug Delivery Systems-Based Dendrimers and Polymer Micelles for Nuclear Diagnosis and Therapy. Macromolecular Bioscience 21(3): E2000362
Iatrou, H.; Fragouli, P.G.; Stavroulaki, D.; Athanasiou, B. 2021: Drug Delivery Through Multifunctional Polypeptidic Hydrogels. Methods in Molecular Biology 2207: 127-137
Samal, S.; Dash, P.; Dash, M. 2021: Drug Delivery to the Bone Microenvironment Mediated by Exosomes: An Axiom or Enigma. International Journal of Nanomedicine 16: 3509-3540
Chroni, A.; Chrysostomou, V.; Skandalis, A.; Pispas, S. 2021: Drug Delivery: Hydrophobic Drug Encapsulation into Amphiphilic Block Copolymer Micelles. Methods in Molecular Biology 2207: 71-83
Flemming, A. 2014: Drug Delivery: Non-invasive drug depot refill. Nature Reviews. Drug Discovery 13(11): 810-811
Blumenthal, K.G.; Castells, M.; Banerji, A. 2021: Drug desensitization in the coronavirus disease 2019 pandemic era: Local success to widespread potential. Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 126(6): 739-741
Kowalczyk, M.; Golonko, A.; Świsłocka, R.; Kalinowska, M.; Parcheta, M.; Swiergiel, A.; Lewandowski, W.ło. 2021: Drug Design Strategies for the Treatment of Viral Disease. Plant Phenolic Compounds and their Derivatives. Frontiers in Pharmacology 12: 709104
McMillin, G.A. 2018: Drug Detection in Urine for Evaluating Exposure-No Limits!. Journal of Applied Laboratory Medicine 2(4): 648-652
Buckley, L.A.; Bebenek, I.; Cornwell, P.D.; Hodowanec, A.; Jensen, E.C.; Murphy, C.; Ghantous, H.N. 2020: Drug Development 101: a Primer. International Journal of Toxicology 39(5): 379-396
Bao, J.; Liu, B.; Wu, C. 2020: Drug Development and Treatment of Autophagy in other Diseases. Advances in Experimental Medicine and Biology 1207: 689-697
Cummings, J. 2021: Drug Development for Psychotropic, Cognitive-Enhancing, and Disease-Modifying Treatments for Alzheimer's Disease. Journal of Neuropsychiatry and Clinical Neurosciences 33(1): 3-13
Rathner, A.; Rathner, P.; Friedrich, A.; Wießner, M.; Kitzler, C.M.; Schernthaner, J.; Karl, T.; Krauß, J.; Lottspeich, F.; Mewes, W.; Hintner, H.; Bauer, J.W.; Breitenbach, M.; Müller, N.; Breitenbach-Koller, H.; von Hagen, J.ör. 2021: Drug Development for Target Ribosomal Protein rpL35/uL29 for Repair of LAMB3R635X in Rare Skin Disease Epidermolysis Bullosa. Skin Pharmacology and Physiology 34(4): 167-182
Garcia-Alvarez, A.; Hernando Cubero, J.; Capdevila, J. 2021: Drug Development in Neuroendocrine Tumors: what Is on the Horizon?. Current Treatment Options in Oncology 22(5): 43
Borys, N.; Dewhirst, M.W. 2021: Drug development of lyso-thermosensitive liposomal doxorubicin: Combining hyperthermia and thermosensitive drug delivery. Advanced Drug Delivery Reviews 178: 113985
Abualia, M.; Amarin, J.Z.; Zayed, A.A. 2019: Drug Effects on the Thyroid. New England Journal of Medicine 381(20): 1979-1980
Angus, L.; Peeters, R.P.; van der Veldt, A.A.M. 2019: Drug Effects on the Thyroid. New England Journal of Medicine 381(20
Converse, P.J.; Almeida, D.V.; Nuermberger, E.L. 2022: Drug Efficacy Testing in the Mouse Footpad Model of Buruli Ulcer. Methods in Molecular Biology 2387: 195-207
Lee, Y.-J.; Kook, H.; Ko, Y.-G.; Yu, C.W.; Joo, H.J.; Ahn, C.-M.; Choi, D. 2021: Drug Eluting Stent vs. Drug Coated Balloon for Native Femoropopliteal Artery Disease: a two Centre Experience. European Journal of Vascular and Endovascular Surgery: the Official Journal of the European Society for Vascular Surgery 61(2): 287-295
Maning, J.; Blumer, V.; Chaparro, S. 2020: Drug Eluting Stents versus Bare Metal Stents for Cardiac Allograft Vasculopathy: A Systematic Review and Meta-Analysis. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 39(4s): S231
Stowers, J.H. 1911: Drug Eruptions: Their Nature and Varieties. Hospital 49(1277): 433-436
Burn, J.H. 1949: Drug Excretion in Milk. Monitor de la Farmacia y de la Terapeutica 55(1460): 127-130
Alrasheed, M.; Hincapie, A.L.; Guo, J.J. 2021: Drug Expenditure, Price, and Utilization in the U.S. Medicaid: a Trend Analysis for SSRi and SNRi Antidepressants from 1991 to 2018. Journal of Mental Health Policy and Economics 24(1): 3-11
Maddock, K.; Connor, K. 2020: Drug Fever: a Patient Case Scenario and Review of the Evidence. AACN Advanced Critical Care 31(3): 233-238
Fang, L.; Shi, G.H.; Richard, C.A.Èl.; Dong, X.; Thomas, J.C.; Victor, M.C.; Wang, T.; Shinkle, S.; Zhao, C. 2020: Drug Formulation Impact on Prefilled Syringe Functionality and Autoinjector Performance. Pda Journal of Pharmaceutical Science and Technology 74(6): 674-687
Schwartz, H.R.; Richards, R.; Fontana, R.E.; Joyce, A.J.; Honeywell, M.E.; Lee, M.J. 2020: Drug GRADE: An Integrated Analysis of Population Growth and Cell Death Reveals Drug-Specific and Cancer Subtype-Specific Response Profiles. Cell Reports 31(12): 107800
Prinz, H. 1912: Drug Idolatry in Dental Medicine. Dental Register 66(1): 30-39
Soumelidou, E.; Golič Grdadolnik, S.; Mavromoustakos, T. 2021: Drug Incorporation in the Drug Delivery System of Micelles. Methods in Molecular Biology 2207: 99-108
Norman, B.H. 2020: Drug Induced Liver Injury (DILI). Mechanisms and Medicinal Chemistry Avoidance/Mitigation Strategies. Journal of Medicinal Chemistry 63(20): 11397-11419
Gabora, K.; Piciu, A.; Piciu, D. 2021: Drug Induced Liver Injury to Immune Checkpoint Inhibitors Detected by F18-Fluorodeoxyglucose PET/CT. Journal of Gastrointestinal and Liver Diseases: Jgld 30(2): 191
Sekino, H. 2021: Drug Information Provided to Patients and Public-Present Regulatory Status and Future Prospects. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 141(3): 381-385
Patil, A.N.; Kumar, M.P.; Yadav, R.; Kosey, S.; Behl, T.; Kumaravel, J. 2021: Drug Information Services in Low-Resource Setting: a Responsibility of Pharmacists or Pharmacologists or Both the Professions Conjointly. Journal of Pharmacy and Bioallied Sciences 13(2): 283-290
Marberger, M. 2006: Drug Insight: 5alpha-reductase inhibitors for the treatment of benign prostatic hyperplasia. Nature Clinical Practice. Urology 3(9): 495-503
Folprecht, G.; Köhne, C-Henning. 2005: Drug Insight: Metastatic colorectal cancer--oral fluoropyrimidines and new perspectives in the adjuvant setting. Nature Clinical Practice. Oncology 2(11): 578-587
Ruderman, E.M.; Pope, R.M. 2006: Drug Insight: abatacept for the treatment of rheumatoid arthritis. Nature Clinical Practice. Rheumatology 2(12): 654-660
van de Beek, D.; Weisfelt, M.; de Gans, J.; Tunkel, A.R.; Wijdicks, E.F.M. 2006: Drug Insight: adjunctive therapies in adults with bacterial meningitis. Nature Clinical Practice. Neurology 2(9): 504-516
Lévy, S. 2006: Drug Insight: angiotensin-converting-enzyme inhibitors and atrial fibrillation--indications and contraindications. Nature Clinical Practice. Cardiovascular Medicine 3(4): 220-225
Pandolfo, M. 2008: Drug Insight: antioxidant therapy in inherited ataxias. Nature Clinical Practice. Neurology 4(2): 86-96
Bray, G.A. 2005: Drug Insight: appetite suppressants. Nature Clinical Practice. Gastroenterology and Hepatology 2(2): 89-95
Chancellor, M.B.; Fowler, C.J.; Apostolidis, A.; de Groat, W.C.; Smith, C.P.; Somogyi, G.T.; Aoki, K.Roger. 2008: Drug Insight: biological effects of botulinum toxin A in the lower urinary tract. Nature Clinical Practice. Urology 5(6): 319-328
Bernier, J. 2008: Drug Insight: cetuximab in the treatment of recurrent and metastatic squamous cell carcinoma of the head and neck. Nature Clinical Practice. Oncology 5(12): 705-713
Geusens, P.P.; Roux, C.H.; Reid, D.M.; Lems, W.F.; Adami, S.; Adachi, J.D.; Sambrook, P.N.; Saag, K.G.; Lane, N.E.; Hochberg, M.C. 2008: Drug Insight: choosing a drug treatment strategy for women with osteoporosis-an evidence--based clinical perspective. Nature Clinical Practice. Rheumatology 4(5): 240-248
Engel, Jörg.B.; Schally, A.V. 2007: Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone. Nature Clinical Practice. Endocrinology and Metabolism 3(2): 157-167
Gillmore, J.D.; Hawkins, P.N. 2006: Drug Insight: emerging therapies for amyloidosis. Nature Clinical Practice. Nephrology 2(5): 263-270
Humbert, M.; Simonneau, Gérald. 2005: Drug Insight: endothelin-receptor antagonists for pulmonary arterial hypertension in systemic rheumatic diseases. Nature Clinical Practice. Rheumatology 1(2): 93-101
McManus, F.; McInnes, G.T.; Connell, J.M.C. 2008: Drug Insight: eplerenone, a mineralocorticoid-receptor antagonist. Nature Clinical Practice. Endocrinology and Metabolism 4(1): 44-52
Sleijfer, S.; Wiemer, E.; Verweij, J. 2008: Drug Insight: gastrointestinal stromal tumors (GIST)--the solid tumor model for cancer-specific treatment. Nature Clinical Practice. Oncology 5(2): 102-111
Khan, O.; La Thangue, N.B. 2008: Drug Insight: histone deacetylase inhibitor-based therapies for cutaneous T-cell lymphomas. Nature Clinical Practice. Oncology 5(12): 714-726
Potenza, M.N.; Voon, V.; Weintraub, D. 2007: Drug Insight: impulse control disorders and dopamine therapies in Parkinson's disease. Nature Clinical Practice. Neurology 3(12): 664-672
Marrie, R.Ann.; Rudick, R.A. 2006: Drug Insight: interferon treatment in multiple sclerosis. Nature Clinical Practice. Neurology 2(1): 34-44
Cameron, D.A.; Stein, S. 2008: Drug Insight: intracellular inhibitors of HER2--clinical development of lapatinib in breast cancer. Nature Clinical Practice. Oncology 5(9): 512-520
Gervois, P.; Fruchart, J-Charles.; Staels, B. 2007: Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors. Nature Clinical Practice. Endocrinology and Metabolism 3(2): 145-156
Colosimo, C.; Fabbrini, G.; Berardelli, A. 2006: Drug Insight: new drugs in development for Parkinson's disease. Nature Clinical Practice. Neurology 2(11): 600-610
Briganti, A.; Salonia, A.; Gallina, A.; Saccà, A.; Montorsi, P.; Rigatti, P.; Montorsi, F. 2005: Drug Insight: oral phosphodiesterase type 5 inhibitors for erectile dysfunction. Nature Clinical Practice. Urology 2(5): 239-247
Mano, M.; Humblet, Y. 2008: Drug Insight: panitumumab, a human EGFR-targeted monoclonal antibody with promising clinical activity in colorectal cancer. Nature Clinical Practice. Oncology 5(7): 415-425
de Boer, N.K.H.; van Bodegraven, A.A.; Jharap, B.; de Graaf, P.; Mulder, C.J.J. 2007: Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD. Nature Clinical Practice. Gastroenterology and Hepatology 4(12): 686-694
Goffin, V.; Touraine, P.; Culler, M.D.; Kelly, P.A. 2006: Drug Insight: prolactin-receptor antagonists, a novel approach to treatment of unresolved systemic and local hyperprolactinemia?. Nature Clinical Practice. Endocrinology and Metabolism 2(10): 571-581
Shahapuni, I.; Monge, M.; Oprisiu, R.; Mazouz, H.; Westeel, P-François.; Morinière, P.; Massy, Z.; Choukroun, G.; Fournier, A. 2006: Drug Insight: renal indications of calcimimetics. Nature Clinical Practice. Nephrology 2(6): 316-325
van der Heijden, J.W.; Dijkmans, B.A.C.; Scheper, R.J.; Jansen, G. 2007: Drug Insight: resistance to methotrexate and other disease-modifying antirheumatic drugs--from bench to bedside. Nature Clinical Practice. Rheumatology 3(1): 26-34
Sacco, R.L.; Liao, J.K. 2005: Drug Insight: statins and stroke. Nature Clinical Practice. Cardiovascular Medicine 2(11): 576-584
Fitch, M.T.; van de Beek, D. 2008: Drug Insight: steroids in CNS infectious diseases--new indications for an old therapy. Nature Clinical Practice. Neurology 4(2): 97-104
Mason, W.P.; Cairncross, J.Gregory. 2005: Drug Insight: temozolomide as a treatment for malignant glioma--impact of a recent trial. Nature Clinical Practice. Neurology 1(2): 88-95
Brennan, A.M.; Mantzoros, C.S. 2006: Drug Insight: the role of leptin in human physiology and pathophysiology--emerging clinical applications. Nature Clinical Practice. Endocrinology and Metabolism 2(6): 318-327
Gold, R.; Stangel, M.; Dalakas, M.C. 2007: Drug Insight: the use of intravenous immunoglobulin in neurology--therapeutic considerations and practical issues. Nature Clinical Practice. Neurology 3(1): 36-44
Pandi-Perumal, S.R.; Srinivasan, V.; Poeggeler, B.; Hardeland, Rüdiger.; Cardinali, D.P. 2007: Drug Insight: the use of melatonergic agonists for the treatment of insomnia-focus on ramelteon. Nature Clinical Practice. Neurology 3(4): 221-228
Weber, M.S.; Prod'homme, T.; Steinman, L.; Zamvil, S.S. 2005: Drug Insight: using statins to treat neuroinflammatory disease. Nature Clinical Practice. Neurology 1(2): 106-112
Sechi, A.; di Altobrando, A.; Cerciello, E.; Maietti, E.; Patrizi, A.; Savoia, F. 2021: Drug Intake and Actinic Keratosis: a Case-Control Study. Dermatology Practical and Conceptual 11(2): E2021031
Abubucker, S.; Reti, I.M.; Miller, C.; Schiavi, A. 2020: Drug Interaction with Remifentanil in a Transgender man Receiving Exogenous Testosterone and Electroconvulsive Therapy. Journal of Ect 36(4): E48-E49
Hofmann, T.; Hachenberg, T. 2020: Drug Interactions in Emergency Medicine. Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie: Ains 55(5): 314-322
Mohebbi, N.; Talebi, A.; Moghadamnia, M.; Nazari Taloki, Z.; Shakiba, A. 2020: Drug Interactions of Psychiatric and COVID-19 Medications. Basic and Clinical Neuroscience 11(2): 185-200
Fravel, M.A.; Ernst, M. 2021: Drug Interactions with Antihypertensives. Current Hypertension Reports 23(3): 14
Cirrincione, L.R.; Senneker, T.; Scarsi, K.; Tseng, A. 2020: Drug Interactions with Gender-Affirming Hormone Therapy: Focus on Antiretrovirals and Direct Acting Antivirals. Expert Opinion on Drug Metabolism and Toxicology 16(7): 565-582
Coccè, V.; Farronato, D.; Brini, A.Teresa.; Masia, C.; Giannì, A.Bruno.; Piovani, G.; Sisto, F.; Alessandri, G.; Angiero, F.; Pessina, A. 2017: Drug Loaded Gingival Mesenchymal Stromal Cells (GinPa-MSCs) Inhibit In Vitro Proliferation of Oral Squamous Cell Carcinoma. Scientific Reports 7(1): 9376
Liu, M.; Dasgupta, A.; Koczera, P.; Schipper, S.; Rommel, D.; Shi, Y.; Kiessling, F.; Lammers, T. 2020: Drug Loading in Poly(butyl cyanoacrylate)-Based Polymeric Microbubbles. Molecular Pharmaceutics 17(8): 2840-2848
Dvořák, Z.ěk.; Sokol, H.; Mani, S. 2020: Drug Mimicry: Promiscuous Receptors PXR and AhR, and Microbial Metabolite Interactions in the Intestine. Trends in Pharmacological Sciences 41(12): 900-908
Anand, A.; Hosanagar, A. 2021: Drug Misuse in the Veterinary Setting: an Under-recognized Avenue. Current Psychiatry Reports 23(2): 3
Xin, X.; Du, X.; Xiao, Q.; Azevedo, H.S.; He, W.; Yin, L. 2019: Drug Nanorod-Mediated Intracellular Delivery of microRNA-101 for Self-sensitization via Autophagy Inhibition. Nano-MicroLetters 11(1): 82
Appa, A.; Rodda, L.N.; Cawley, C.; Zevin, B.; Coffin, P.O.; Gandhi, M.; Imbert, E. 2021: Drug Overdose Deaths Before and After Shelter-in-Place Orders During the COVID-19 Pandemic in San Francisco. JAMA Network Open 4(5): E2110452
Zhang, Q.; Zhang, L.; Li, Y.; Ye, M. 2021: Drug Packaging Management Based on the Effect of Medical Images on the Intracellular Polysaccharide Synthesis and Antivertigo Activity of Phalaenopsis. Journal of Healthcare Engineering 2021: 3793610
Lynn, E.; Doyle, A.; Keane, M.; Bennett, K.; Cousins, G.ái. 2020: Drug Poisoning Deaths Among Women: a Scoping Review. Journal of Studies on Alcohol and Drugs 81(5): 543-555
Al-Rashdi, M.S.; Abdulaziz, B.; Al Balushi, K.A. 2020: Drug Prescribing Practices in Dental Care Patients at a Dental and Maxillofacial Surgery Clinic in Oman. Oman Medical Journal 35(6): E191
Gowers, S.; Claxton, M.; Rowlands, L.; Inbasagaran, A.; Wood, D.; Yi, I.; Hugo, P.; Clark-Stone, S.; Bryant-Waugh, R.; Nicholls, D.; Ayton, A. 2010: Drug Prescribing in Child and Adolescent Eating Disorder Services. Child and Adolescent Mental Health 15(1): 18-22
Russo, P.; Marcellusi, A.; Zanuzzi, M.; Carletto, A.; Fratto, M.E.; Favato, G.; Staniscia, T.; Romano, F. 2021: Drug Prices and Value of Oncology Drugs in Italy. Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research 24(9): 1273-1278
Rome, B.N.; Feldman, W.B.; Kesselheim, A.S. 2020: Drug Prices, Rebates, and Discounts. JAMA 324(4): 399
Anderson-Cook, A.; Noda, A. 2020: Drug Prices, Rebates, and Discounts. JAMA 324(4): 398-399
Lexchin, J. 2021: Drug Promotion in India Since 2000: Problems Remain. International Journal of Health Services: Planning Administration Evaluation 51(3): 392-403
Bumbacea, R.S.; Ali, S.; Ogneva, D.O.; Motei, C.; Rusu, C.; Spiru, L. 2021: Drug Provocation Testing in the Diagnosis of Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE) Induced by Clarithromycin. Maedica 16(2): 297-301
García-Boyano, M.; Gómez-Traseira, C.; Umpiérrez, A.M.ía.; Quirce, S.; Boyano-Martínez, T. 2020: Drug Provocation Tests for Assessing Antibiotic Hypersensitivity: Is Shorter Also Better?. Pediatric Infectious Disease Journal 39(9): 835-839
Birmingham, K. 2002: Drug R&D costs queried. Nature Medicine 8(2): 93
Shalom, G.; Khoury, R.; Horev, A. 2020: Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Associated with Mycoplasma pneumoniae Infection. Case Reports in Dermatology 12(3): 225-230
O'Malley, P.A. 2021: Drug Recalls and Significance for Safe Clinical Nurse Specialist Prescribing. Clinical Nurse Specialist Cns 35(6): 288-290
Meek, A.; Weaver, D.F. 2022: Drug-Receptor Interactions: it is a Numbers Game. Canadian Journal of Neurological Sciences. le Journal Canadien des Sciences Neurologiques 49(4): 589-590
Qian, J.; Berkland, C. 2021: Drug Release Kinetics from Nondegradable Hydrophobic Polymers can be Modulated and Predicted by the Glass Transition Temperature. Advanced Healthcare Materials 10(12): E2100015
You, C.; Tseng, L.-F.; Pappas, A.; Concagh, D.; Kuang, Y. 2022: Drug Release and Pharmacokinetic Evaluation of Novel Implantable Mometasone Furoate Matrices in Rabbit Maxillary Sinuses. American Journal of Rhinology and Allergy 36(2): 198-206
Wang, X.; Burgess, D.J. 2021: Drug release from in situ forming implants and advances in release testing. Advanced Drug Delivery Reviews 178: 113912
Choi, H.; Schulte, A.; Müller, M.; Park, M.; Jo, S.; Schönherr, H. 2021: Drug Release from Thermo-Responsive Polymer Brush Coatings to Control Bacterial Colonization and Biofilm Growth on Titanium Implants. Advanced Healthcare Materials 10(11): E2100069
Partridge, M.A.; Karayusuf, E.K.; Shyu, G.; Georgaros, C.; Torri, A.; Sumner, G. 2020: Drug Removal Strategies in Competitive Ligand Binding Neutralizing Antibody (NAb) Assays: Highly Drug-Tolerant Methods and Interpreting Immunogenicity Data. Aaps Journal 22(5): 112
Senbabaoglu, F.; Aksu, A.C.; Cingoz, A.; Seker-Polat, F.; Borklu-Yucel, E.; Solaroglu, İh.; Bagci-Onder, T. 2020: Drug Repositioning Screen on a new Primary Cell Line Identifies Potent Therapeutics for Glioblastoma. Frontiers in Neuroscience 14: 578316
Yoon, S.; Kim, H.S. 2021: Drug Repositioning with an Anticancer Effect: Contributions to Reduced Cancer Incidence in Susceptible Individuals. In Vivo 35(6): 3039-3044
Benavides-Cordoba, V. 2020: Drug Repositioning for COVID-19. Colombia Medica 51(2): E4279
Beklen, H.; Gulfidan, G.; Arga, K.Y.; Mardinoglu, A.; Turanli, B. 2020: Drug Repositioning for P-Glycoprotein Mediated Co-Expression Networks in Colorectal Cancer. Frontiers in Oncology 10: 1273
Kifle, Z.D.; Ayele, A.G.; Enyew, E.F. 2021: Drug Repurposing Approach, Potential Drugs, and Novel Drug Targets for COVID-19 Treatment. Journal of Environmental and Public Health 2021: 6631721
Siswanto, S.; Yamamoto, H.; Furuta, H.; Kobayashi, M.; Nagashima, T.; Kayanuma, G.; Nagayasu, K.; Imai, Y.; Kaneko, S. 2021: Drug Repurposing Prediction and Validation from Clinical Big Data for the Effective Treatment of Interstitial Lung Disease. Frontiers in Pharmacology 12: 635293
Chen, C.Z.; Shinn, P.; Itkin, Z.; Eastman, R.T.; Bostwick, R.; Rasmussen, L.; Huang, R.; Shen, M.; Hu, X.; Wilson, K.M.; Brooks, B.; Guo, H.; Zhao, T.; Klump-Thomas, C.; Simeonov, A.; Michael, S.G.; Lo, D.C.; Hall, M.D.; Zheng, W. 2020: Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2. Biorxiv: the Preprint Server for Biology 2020
Chen, C.Z.; Shinn, P.; Itkin, Z.; Eastman, R.T.; Bostwick, R.; Rasmussen, L.; Huang, R.; Shen, M.; Hu, X.; Wilson, K.M.; Brooks, B.M.; Guo, H.; Zhao, T.; Klump-Thomas, C.; Simeonov, A.; Michael, S.G.; Lo, D.C.; Hall, M.D.; Zheng, W. 2020: Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2. Frontiers in Pharmacology 11: 592737
Sahoo, B.M.; Ravi Kumar, B.V.V.; Sruti, J.; Mahapatra, M.K.; Banik, B.K.; Borah, P. 2021: Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection. Frontiers in Molecular Biosciences 8: 628144
Abbasi, J. 2020: Drug Repurposing Study Pinpoints Potential COVID-19 Antivirals. JAMA 324(10): 928
Pinzi, L.; Tinivella, A.; Caporuscio, F.; Rastelli, G. 2021: Drug Repurposing and Polypharmacology to Fight SARS-CoV-2 Through Inhibition of the Main Protease. Frontiers in Pharmacology 12: 636989
Soleimani Zakeri, N.S.; Pashazadeh, S.; MotieGhader, H. 2021: Drug Repurposing for Alzheimer's Disease Based on Protein-Protein Interaction Network. Biomed Research International 2021: 1280237
Zhang, R.; Hristovski, D.; Schutte, D.; Kastrin, A.; Fiszman, M.; Kilicoglu, H. 2021: Drug repurposing for COVID-19 via knowledge graph completion. Journal of Biomedical Informatics 115: 103696
Ino, H.; Nakazawa, E.; Akabayashi, A. 2021: Drug Repurposing for COVID-19: Ethical Considerations and Roadmaps. Cambridge Quarterly of Healthcare Ethics: Cq: the International Journal of Healthcare Ethics Committees 30(1): 51-58
Tsakaneli, A.; Williams, O. 2021: Drug Repurposing for Targeting Acute Leukemia with KMT2A (MLL)-Gene Rearrangements. Frontiers in Pharmacology 12: 741413
Yan, V.K.C.; Li, X.; Ye, X.; Ou, M.; Luo, R.; Zhang, Q.; Tang, B.; Cowling, B.J.; Hung, I.; Siu, C.W.; Wong, I.C.K.; Cheng, R.C.K.; Chan, E.W. 2021: Drug Repurposing for the Treatment of COVID-19: a Knowledge Graph Approach. Advanced Therapeutics 4(7): 2100055
Hammoud, H.; Saker, Z.; Harati, H.; Fares, Y.; Bahmad, H.F.; Nabha, S. 2020: Drug Repurposing in Medulloblastoma: Challenges and Recommendations. Current Treatment Options in Oncology 22(1): 6
Shakkour, Z.; Habashy, K.J.; Berro, M.; Takkoush, S.; Abdelhady, S.; Koleilat, N.; Eid, A.H.; Zibara, K.; Obeid, M.; Shear, D.; Mondello, S.; Wang, K.K.; Kobeissy, F. 2021: Drug Repurposing in Neurological Disorders: Implications for Neurotherapy in Traumatic Brain Injury. Neuroscientist: a Review Journal Bringing Neurobiology Neurology and Psychiatry 27(6): 620-649
Ghiam, M.K.; Patel, S.D.; Hoffer, A.; Selman, W.R.; Hoffer, B.J.; Hoffer, M.E. 2021: Drug Repurposing in the Treatment of Traumatic Brain Injury. Frontiers in Neuroscience 15: 635483
Li, Z.; He, P.; Long, Y.; Yuan, G.; Shen, W.; Chen, Z.; Zhang, B.; Wang, Y.; Yue, D.; Seidl, C.; Zhang, X. 2021: Drug Repurposing of Pantoprazole and Vitamin C Targeting Tumor Microenvironment Conditions Improves Anticancer Effect in Metastatic Castration-Resistant Prostate Cancer. Frontiers in Oncology 11: 660320
Shirley, D.-A.; Sharma, I.; Warren, C.A.; Moonah, S. 2021: Drug Repurposing of the Alcohol Abuse Medication Disulfiram as an Anti-Parasitic Agent. Frontiers in Cellular and Infection Microbiology 11: 633194
De Felice, A.; Aureli, S.; Limongelli, V. 2021: Drug Repurposing on G Protein-Coupled Receptors Using a Computational Profiling Approach. Frontiers in Molecular Biosciences 8: 673053
Fiscon, G.; Conte, F.; Amadio, S.; Volonté, C.; Paci, P. 2021: Drug Repurposing: a Network-based Approach to Amyotrophic Lateral Sclerosis. Neurotherapeutics: the Journal of the American Society for Experimental Neurotherapeutics 18(3): 1678-1691
Kort, E.; Jovinge, S. 2021: Drug Repurposing: Claiming the Full Benefit from Drug Development. Current Cardiology Reports 23(6): 62
Ghosh, D.; Panja, A.; Saha, D.; Banerjee, U.; Datta, A.K.; Basu, A. 2021: Drug Repurposing: Hydroxyurea Therapy Improves the Transfusion-Free Interval in HbE/Beta-Thalassemia-Major Patients with the Xmni Polymorphism. Genetic Testing and Molecular Biomarkers 25(8): 563-570
She, P.; Wang, Y.; Li, Y.; Zhou, L.; Li, S.; Zeng, X.; Liu, Y.; Xu, L.; Wu, Y. 2021: Drug Repurposing: in vitro and in vivo Antimicrobial and Antibiofilm Effects of Bithionol Against Enterococcus faecalis and Enterococcus faecium. Frontiers in Microbiology 12: 579806
Ayalew, S.; Wegayehu, T.; Taye, H.; Wassie, L.; Girma, S.; Berg, S.; Mihret, A. 2021: Drug Resistance Conferring Mutation and Genetic Diversity of Mycobacterium tuberculosis Isolates in Tuberculosis Lymphadenitis Patients; Ethiopia. Infection and Drug Resistance 14: 575-584
Bedru, H.; Fikru, M.; Niguse, W.; Jemal, A.; Getinet, G.; Gobena, A.; Hailu, A.; Peter, S. 2021: Drug Resistance Pattern of M. tuberculosis Complex in Oromia Region of Ethiopia. Infection and Drug Resistance 14: 1679-1689
Löscher, W.; Potschka, H.; Sisodiya, S.M.; Vezzani, A. 2020: Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and new Innovative Treatment Options. Pharmacological Reviews 72(3): 606-638
Olivier, C.; Oliver, L.; Lalier, L.; Vallette, F.ço.M. 2020: Drug Resistance in Glioblastoma: the two Faces of Oxidative Stress. Frontiers in Molecular Biosciences 7: 620677
Almas, I.; Afzal, S.; Imtiaz, H.; Shaheen, M.A.; Daud, M.; Saghir, A.; Amin, I.; Shahid, M.; Idrees, M. 2020: Drug Resistance in Hepatitis C Virus: Future Prospects and Strategies to Combat it. Critical Reviews in Eukaryotic Gene Expression 30(4): 323-336
Lee, K.-C.; Yen, C.-K.; Chen, C.-N.; Chang, S.-F.; Lu, Y.-C.; Huang, W.-S. 2021: Drug Resistance of CPT-11 in Human DLD-1 Colorectal Cancer Cells through MutS Homolog 2 Upregulation. International Journal of Medical Sciences 18(5): 1269-1276
Yin, Y.Q.; Lu, J.; Zhou, Y.; Shi, L.E.; Yuan, D.F.; Chen, J.S.; Xuan, Y.; Hu, H.Y.; Zhang, Z.; Xu, X.Q.; Fu, G.F.; Wang, B. 2021: Drug Resistance to HIV-1 Integrase Inhibitors among Treatment-naive Patients in Jiangsu, China. Biomedical and Environmental Sciences: Bes 34(5): 400-403
Panda, P.K.; Agstam, S.; Mokta, J.; Sharma, A.; Sharma, Y.P. 2020: Drug Resistant Seizure Disorder in Young Patient. Journal of the Association of Physicians of India 68(12): 74
Zhang, J.; Shen, Z.; Song, Z.; Luan, J.; Li, Y.; Zhao, T. 2020: Drug Response Associated with and Prognostic lnc RNAs Mediated by DNA Methylation and Transcription Factors in Colon Cancer. Frontiers in Genetics 11: 554833
McInnes, G.; Altman, R.B. 2021: Drug Response Pharmacogenetics for 200,000 UK Biobank Participants. Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing 26: 184-195
Stanfield, Z.; Coşkun, M.; Koyutürk, M. 2017: Drug Response Prediction as a Link Prediction Problem. Scientific Reports 7: 40321
Zhou, J.; Li, M.; Wang, X.; He, Y.; Xia, Y.; Sweeney, J.A.; Kopp, R.F.; Liu, C.; Chen, C. 2021: Drug Response-Related DNA Methylation Changes in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder. Frontiers in Neuroscience 15: 674273
Furlan, G.; Caduff-Janosa, P.; Sottosanti, L.; Cappello, E.; Valdiserra, G.; Tuccori, M. 2020: Drug Safety in Geriatric Patients: Current Status and Proposed way Forward. Drug Safety 43(9): 853-866
Liao, Y.-H.; Chen, L.-Y.; Liao, K.-M.; Chen, C.-Y. 2020: Drug Safety of Benzodiazepines in Asian Patients with Chronic Obstructive Pulmonary Disease. Frontiers in Pharmacology 11: 592910
Menduti, G.; Rasà, D.M.; Stanga, S.; Boido, M. 2020: Drug Screening and Drug Repositioning as Promising Therapeutic Approaches for Spinal Muscular Atrophy Treatment. Frontiers in Pharmacology 11: 592234
Akay, M.; Hite, J.; Avci, N.Gul.; Fan, Y.; Akay, Y.; Lu, G.; Zhu, J-Jiguang. 2018: Drug Screening of Human GBM Spheroids in Brain Cancer Chip. Scientific Reports 8(1): 15423
Dai, Y.-H.; Chen, G.-Y.; Tang, C.-H.; Huang, W.-C.; Yang, J.-C.; Wu, Y.-C. 2021: Drug Screening of Potential Multiple Target Inhibitors for Estrogen Receptor-α-positive Breast Cancer. In Vivo 35(2): 761-777
Duan, X.; Chen, H.; Fan, L.; Kong, J. 2016: Drug Self-Assembled Delivery System with Dual Responsiveness for Cancer Chemotherapy. Acs Biomaterials Science and Engineering 2(12): 2347-2354
Mason, A.B.; Dartois, V.ér. 2021: Drug Sensitivity Testing of Mycobacterium tuberculosis Growing in a Hollow Fiber Bioreactor. Methods in Molecular Biology 2314: 715-731
Moss, J.D.; Schwenk, H.T.; Chen, M.; Gaskari, S. 2021: Drug Shortage and Critical Medication Inventory Management at a Children's Hospital During the COVID-19 Pandemic. Journal of Pediatric Pharmacology and Therapeutics: Jppt: the Official Journal of Ppag 26(1): 21-25
Shukar, S.; Zahoor, F.; Hayat, K.; Saeed, A.; Gillani, A.H.; Omer, S.; Hu, S.; Babar, Z.-U.-D.; Fang, Y.; Yang, C. 2021: Drug Shortage: Causes, Impact, and Mitigation Strategies. Frontiers in Pharmacology 12: 693426
Calleja, K. 2020: Drug Shortages and Group Purchasing Organizations. JAMA 324(8): 808-809
Shin, E.; Lee, Y.Chul.; Kim, S.Ri.; Kim, S.Ha.; Park, J. 2015: Drug Signature-based Finding of Additional Clinical Use of LC28-0126 for Neutrophilic Bronchial Asthma. Scientific Reports 5: 17784
van den Reek, J.M.P.A.; Kievit, W.; Gniadecki, R.; Goeman, J.J.; Zweegers, J.; van de Kerkhof, P.C.M.; Seyger, M.M.B.; de Jong, E.M.G.J. 2015: Drug Survival Studies in Dermatology:Principles, Purposes, and Pitfalls. Journal of Investigative Dermatology 135(7): 1-5
Yu, C.-L.; Yang, C.-H.; Chi, C.-C. 2020: Drug Survival of Biologics in Treating Ankylosing Spondylitis: a Systematic Review and Meta-analysis of Real-World Evidence. Biodrugs: Clinical Immunotherapeutics Biopharmaceuticals and Gene Therapy 34(5): 669-679
Lockshin, B.; Cronin, A.; Harrison, R.W.; McLean, R.R.; Anatale-Tardiff, L.; Burge, R.; Zhu, B.; Malatestinic, W.N.; Atiya, B.; Murage, M.J.; Gallo, G.; Strober, B.; Van Voorhees, A. 2021: Drug survival of ixekizumab, TNF inhibitors, and other IL-17 inhibitors in real-world patients with psoriasis: the Corrona Psoriasis Registry. Dermatologic Therapy 34(2): E14808
Gibson, S.E.R.; Harrison, J.; Cox, J.A.G. 2021: Drug Susceptibility Screening Using in Vitro Models of Hypoxic Non-Replicating Persistent Mycobacteria. Methods in Molecular Biology 2314: 247-260
Ettari, R.; Previti, S.; Di Chio, C.; Maiorana, S.; Allegra, A.; Schirmeister, T.; Zappalà, M. 2020: Drug Synergism: Studies of Combination of RK-52 and Curcumin against Rhodesain of Trypanosoma brucei rhodesiense. Acs Medicinal Chemistry Letters 11(5): 806-810
Chiurillo, M.A.; Jensen, B.C.; Docampo, R. 2021: Drug Target Validation of the Protein Kinase AEK1, Essential for Proliferation, Host Cell Invasion, and Intracellular Replication of the Human Pathogen Trypanosoma cruzi. Microbiology Spectrum 9(2): E0073821
Shafer, W.M. 2020: Drug Targeting a Gonococcal Virulence Factor Exploits Host Antimicrobial Peptides in Clearance of Infection. Journal of Infectious Diseases 222(10): 1585-1586
Ferraro, F.; Cabrera, M.A.; Álvarez, G.án.I.; Corvo, I. 2020: Drug Targets: Screening for Small Molecules that Inhibit Fasciola hepatica Enzymes. Methods in Molecular Biology 2137: 221-231
Motrapu, M.; Świderska, M.K.; Mesas, I.; Marschner, J.A.; Lei, Y.; Martinez Valenzuela, L.; Fu, J.; Lee, K.; Angelotti, M.L.; Antonelli, G.; Romagnani, P.; Anders, H.-J.; Anguiano, L. 2020: Drug Testing for Residual Progression of Diabetic Kidney Disease in Mice Beyond Therapy with Metformin, Ramipril, and Empagliflozin. Journal of the American Society of Nephrology: Jasn 31(8): 1729-1745
Tefera, G.M.; Zeleke, A.Z.; Jima, Y.M.; Kebede, T.M. 2020: Drug Therapy Problems and the Role of Clinical Pharmacist in Surgery Ward: Prospective Observational and Interventional Study. Drug Healthcare and Patient Safety 12: 71-83
Ruedy, J. 1965: Drug Therapy for Acute Pyelonephritis. Canadian Medical Association Journal 92(24): 1278
Lewin, P.K. 1964: Drug Therapy in Dysmenorrhea. Canadian Medical Association Journal 91(10): 569
Boucher, R.C. 1992: Drug Therapy in the 1990s : what can we Expect for Cystic Fibrosis?. Drugs 43(4): 431-439
Anderson, P.O. 2020: Drug Therapy of Genetic Diseases During Breastfeeding. Breastfeeding Medicine: the Official Journal of the Academy of Breastfeeding Medicine 15(7): 426-428
Olsen, T.W.; Dyer, R.B.; Mano, F.; Boatright, J.H.; Chrenek, M.A.; Paley, D.; Wabner, K.; Schmit, J.; Chae, J.B.; Sellers, J.T.; Singh, R.J.; Wiedmann, T.S. 2020: Drug Tissue Distribution of TUDCA from a Biodegradable Suprachoroidal Implant versus Intravitreal or Systemic Delivery in the Pig Model. Translational Vision Science and Technology 9(6): 11
Kharlamova, N.; Hermanrud, C.; Dunn, N.; Ryner, M.; Hambardzumyan, K.; Vivar Pomiano, N.; Marits, P.; Gjertsson, I.; Saevarsdottir, S.; Pullerits, R.; Fogdell-Hahn, A. 2020: Drug Tolerant Anti-drug Antibody Assay for Infliximab Treatment in Clinical Practice Identifies Positive Cases Earlier. Frontiers in Immunology 11: 1365
Nakazono, Y.; Arakawa, H.; Nishino, M.; Yamaki, I.; Oba, T.; Tomotoshi, K.; Kakinuma, C.; Ogihara, T.; Tamai, I. 2021: Drug Transcellular Transport Assay Using a High Porosity Honeycomb Film. Biological and Pharmaceutical Bulletin 44(5): 635-641
Seelinger, G.ün.; Mannel, M. 2007: Drug Treatment in Juvenile Depression - Is St. John's Wort a Safe and Effective Alternative?. Child and Adolescent Mental Health 12(3): 143-149
Held, F.; Klein, A.-K.; Berthele, A. 2021: Drug Treatment of Neuromyelitis Optica Spectrum Disorders: out with the Old, in with the New?. Immunotargets and Therapy 10: 87-101
Alghoul, M.S.; Vaca, E.E.; Mioton, L.M.; Zins, J.E. 2020: Letter to the Editor: The Functional Anatomy of the Deep Facial Fat Compartments: A Detailed Imaging-Based Investigation. Plastic and Reconstructive Surgery 2020
Anderson, P.O. 2020: Drug Treatment of Raynaud's Phenomenon of the Nipple. Breastfeeding Medicine: the Official Journal of the Academy of Breastfeeding Medicine 15(11): 686-688
Mandge, V.; Husain, A.M. 2020: Drug Trials in Status Epilepticus: Current Evidence and Future Concepts. Journal of Clinical Neurophysiology: Official Publication of the American Electroencephalographic Society 37(5): 434-445
Fekadu, G.; Bekele, F.; Bekele, K.; Hanbisa, S.; Belay, G.; Maqbool, M. 2020: Drug use Evaluation of Beta-Blockers in Medical Wards of Nedjo General Hospital, Western Ethiopia. Cardiovascular Therapeutics 2020: 2509875
Obeid, W.M.N.; Abdoon, I.H.; Osman, B.; Osman, W.J.A.; Suliman, H.M.; Mohamed, E.M.; Mothana, R.A.A. 2021: Drug use evaluation of cefepime at Khartoum North Teaching Hospital in Sudan. International Journal of Clinical Practice 75(4): E13882
Adinolfi, A.C.; Bezerra, A.éi.G.; Curado, D.F.án.; de Souza, A.A.L.; Galduróz, J.é C.F. 2022: Drug use Frequency Variation and Mental Health During the COVID-19 Pandemic: an Online Survey. International Journal of Mental Health and Addiction 20(5): 2755-2769
Kalichman, S.C.; Kalichman, M.O.; Banas, E.; Hill, M.; Katner, H. 2021: Drug Use and Life Chaos as Potential Factors Contributing to HIV Viral Load among People with Lower Health Literacy. Substance use and Misuse 2021: 1-9
Patel, R.; Redmond, N.M.; Kesten, J.M.; Linton, M.-J.; Horwood, J.; Wilcox, D.; Munafo, J.; Coast, J.; Macleod, J.; Jeal, N. 2020: Drug use in Street Sex wor Kers (DUSSK) study: results of a mixed methods feasibility study of a complex intervention to reduce illicit drug use in drug dependent female sex workers. Bmj Open 10(12): E036491
Zin, C.S.; Taufek, N.H.; Bux, S.H. 2020: Drug Utilization and Drug Pricing in the Private Primary Healthcare System in Malaysia: An Employer Price Control Mechanism. Frontiers in Public Health 8: 551328
Cabezón, E.; Arechaga, I. 2020: Drug Weaponry to Fight Against SARS-CoV-2. Frontiers in Molecular Biosciences 7: 204
Sica, D.A. 1999: Drug absorption in congestive heart failure: impact on management. Progress in Cardiovascular Nursing 14(2): 72-74
Budha, N.R.; Frymoyer, A.; Smelick, G.S.; Jin, J.Y.; Yago, M.R.; Dresser, M.J.; Holden, S.N.; Benet, L.Z.; Ware, J.A. 2012: Drug absorption interactions between oral targeted anticancer agents and PPIs: is pH-dependent solubility the Achilles heel of targeted therapy?. Clinical Pharmacology and Therapeutics 92(2): 203-213
Amble, F.R. 1990: Drug abuse by adolescents. Texas Medicine 86(11): 58-63
Matsumura, Y. 1998: Drug abuse in Japan. Nihon Arukoru Yakubutsu Igakkai Zasshi 33(5): 597-602
Allen, V.R. 1969: Drug abuse in adolescence. Pediatrics 44(6): 1038-1039
Reyes, B.V. 1983: Drug abuse in the Philippines. Seishin Shinkeigaku Zasshi 85(8): 473-477
Cahal, D.A. 1970: Drug abuse in the United Kingdom. Applied Therapeutics 12(9): 16; 21-23
Rigatelli, G.; De Santis, G.; Zuin, M. 2021: Drug abuse, hypothermia, or acute myocardial infarction?. European Heart Journal. Case Reports 5(10): Ytab 309
Bousquet, J. 1995: Drug accidents of immunological origin. Physiopathology. La Revue du Praticien 45(9): 1145-1148
Webster, D.J.; Flook, D.; Jenkins, J.; Hutchings, A.; Routledge, P.A. 1989: Drug acetylation in breast cancer. British Journal of Cancer 60(2): 236-237
Bueding, E. 1949: Drug action and enzymes. Alumni Bulletin. Western Reserve University. School of Medicine 13(5): 83-86
Benzi, G.; Arrigoni, E.; Pastoris, O.; Villa, R.F.; Dossena, M.; Agnoli, A.; Giuffrida, A.M. 1982: Drug action on the metabolic changes induced by acute hypoxia on synaptosomes from the cerebral cortex. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 2(2): 229-239
Yang, H.; Li, J.; Zheng, Y.; Zhou, L.; Tong, S.; Zhao, B.; Cai, W. 2016: Drug activity screening based on microsomes-hydrogel system in predicting metabolism induced antitumor effect of oroxylin A. Scientific Reports 6: 21604
Llorca, P.M.; Scotto, J.C. 1995: Drug addiction and AIDS. La Revue du Praticien 45(11): 1371-1374
Gentilini, M.; Duneton, P. 1993: Drug addiction and AIDS. Bulletin de l'Academie Nationale de Medecine 177(8): 1353-1369
Carratala, R.E. 1946: Drug addiction and crime. Criminalia 12: 2-12
Faucett, R.L. 1957: Drug addiction and other considerations in the management of pain with narcotic drugs. American Practitioner and Digest of Treatment 8(8): 1230-1231
Bongain, A.; Huss, M.; Gillet, J.Y. 1992: Drug addiction and pregnancy. La Revue du Praticien 42(8): 1004-1009
Fauchère, P.A. 1983: Drug addiction and the general hospital. KRANKENPFLEGE. Soins Infirmiers 76(9): 27-28
Swetlow, G.I. 1948: Drug addiction and the law. BULLETIN. Medical Society of the County of Kings 27(3): 86-92
Kalivas, P.W.; O'Brien, C. 2008: Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 33(1): 166-180
McGinn, M.A.; Pantazis, C.B.; Tunstall, B.J.; Marchette, R.C.N.; Carlson, E.R.; Said, N.; Koob, G.F.; Vendruscolo, L.F. 2021: Drug addiction co-morbidity with alcohol: Neurobiological insights. International Review of Neurobiology 157: 409-472
Palenzona, C. 1984: Drug addiction in Europe. Minerva Medica 75(7): 338-342
Zimmering, P.; Toolan, J. 1952: Drug addiction in adolescents. Journal of Nervous and Mental Disease 116(3): 262-265
Zimmering, P.; Toolan, J.M. 1952: Drug addiction in adolescents. A.M.A. Archives of Neurology and Psychiatry 67(4): 556-558
Ewald, K. 1948: Drug addiction in applicable criminal law; a forensic-psychiatric contribution. Der Nervenarzt 19(6): 265-267
Yang, Z.; Ye, J.; Li, C.; Zhou, D.; Shen, Q.; Wu, J.; Cao, L.; Wang, T.; Cui, D.; He, S.; Qi, G.; He, L.; Liu, Y. 2013: Drug addiction is associated with leukocyte telomere length. Scientific Reports 3: 1542
Self, D.W. 1995: Drug addiction. Cocaine abuse takes a shot. Nature 378(6558): 666-667
Harrison, C. 2010: Drug addiction: Blocking cocaine-seeking behaviour. Nature Reviews. Drug Discovery 9(10): 764-765
Tyndale, R. 2008: Drug addiction: a critical problem calling for novel solutions. Clinical Pharmacology and Therapeutics 83(4): 503-506
Liu, J-Feng.; Li, J-Xu. 2018: Drug addiction: a curable mental disorder?. Acta Pharmacologica Sinica 39(12): 1823-1829
Robbins, T.W.; Everitt, B.J. 1999: Drug addiction: bad habits add up. Nature 398(6728): 567-570
Cheron, J.; Kerchove d'Exaerde, A.de. 2021: Drug addiction: from bench to bedside. Translational Psychiatry 11(1): 424
Volkow, N.D.; Li, T-Kai. 2004: Drug addiction: the neurobiology of behaviour gone awry. Nature Reviews. Neuroscience 5(12): 963-970
Pouletty, P. 2002: Drug addictions: towards socially accepted and medically treatable diseases. Nature Reviews. Drug Discovery 1(9): 731-736
Reh, T. 1945: Drug addicts and their surveillance. Gesundheit 25: 4-13
Ciura, K.; Ulenberg, S.; Kapica, H.; Kawczak, P.; Belka, M.; Bączek, T. 2020: Drug affinity to human serum albumin prediction by retention of cetyltrimethylammonium bromide pseudostationary phase in micellar electrokinetic chromatography and chemically advanced template search descriptors. Journal of Pharmaceutical and Biomedical Analysis 188: 113423
Wadman, M. 2005: Drug agency accused of political bias. Nature 437(7056): 179
Castells, M.C. 2020: Drug allergy labeling and delabeling in the coronavirus disease 2019 era: what is important and what do we need to know. Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 124(6): 523-525
Chan, B.; Freeman, M.; Ayers, C.; Korthuis, P.; Paynter, R.; Kondo, K.; Kansagara, D. 2021: Drug and Alcohol Dependence response to KK-21-1460 "Considering rationales for use in defining subgroups for the treatment of stimulant use disorder". Drug and Alcohol Dependence 221: 108571
Bechara, R.; Feray, A.; Pallardy, M. 2021: Drug and Chemical Allergy: a Role for a Specific Naive T-Cell Repertoire?. Frontiers in Immunology 12: 653102
Proschmann, U.; Haase, R.; Inojosa, H.; Akgün, K.; Ziemssen, T. 2021: Drug and Neurofilament Levels in Serum and Breastmilk of Women with Multiple Sclerosis Exposed to Natalizumab During Pregnancy and Lactation. Frontiers in Immunology 12: 715195
Mynott, R.L.; Wallington-Beddoe, C.T. 2021: Drug and Solute Transporters in Mediating Resistance to Novel Therapeutics in Multiple Myeloma. Acs Pharmacology and Translational Science 4(3): 1050-1065
Peraza, N.; Bello, M.S.; Schiff, S.J.; Cho, J.; Zhang, Y.; Callahan, C.; Tackett, A.; Leventhal, A.M. 2021: Drug and alcohol dependence acute effects of pod-style e-cigarettes in vaping-naïve smokers. Drug and Alcohol Dependence 228: 109083
Young, K.N.; Yeates, E.O.; Grigorian, A.; Schellenberg, M.; Owattanapanich, N.; Barmparas, G.; Margulies, D.; Juillard, C.; Garber, K.; Cryer, H.; Tillou, A.; Burruss, S.; Penaloza-Villalobos, L.; Lin, A.; Figueras, R.Arthur.; Brenner, M.; Firek, C.; Costantini, T.; Santorelli, J.; Curry, T.; Wintz, D.; Biffl, W.L.; Schaffer, K.B.; Duncan, T.K.; Barbaro, C.; Diaz, G.; Johnson, A.; Chinn, J.; Naaseh, A.; Leung, A.; Grabar, C.; Nahmias, J. 2021: Drug and alcohol positivity of traumatically injured patients related to COVID-19 stay-at-home orders. American Journal of Drug and Alcohol Abuse 2021: 1-7
Kmietowicz, Z. 2021: Drug and alcohol services for young people cut by £26m in six years. Bmj 372: N817
Crane, H.M.; Nance, R.M.; Whitney, B.M.; Ruderman, S.; Tsui, J.I.; Chander, G.; McCaul, M.E.; Lau, B.; Mayer, K.H.; Batey, D.Scott.; Safren, S.A.; Moore, R.D.; Eron, J.J.; Napravnik, S.; Mathews, W.Chris.; Fredericksen, R.J.; Hahn, A.W.; Mugavero, M.J.; Lober, W.B.; Saag, M.S.; Kitahata, M.M.; Delaney, J.A.C. 2021: Drug and alcohol use among people living with HIV in care in the United States by geographic region. Aids Care 2021: 1-8
Dozois, A.; Nkondora, P.; Noste, E.; Mfinanga, J.A.; Sawe, H.R.; Runyon, M.S. 2021: Drug and alcohol use in Tanzanian road traffic collision drivers. African Journal of Emergency Medicine: Revue Africaine de la Medecine d'Urgence 11(4): 390-395
Wadman, M. 1996: Drug and cigarette company donations favour Republicans. Nature 383(6595): 5
Harnisch, L.; Matthews, I.; Chard, J.; Karlsson, M.O. 2013: Drug and disease model resources: a consortium to create standards and tools to enhance model-based drug development. Cpt: Pharmacometrics and Systems Pharmacology 2: E34
Stathias, V.; Jermakowicz, A.M.; Maloof, M.E.; Forlin, M.; Walters, W.; Suter, R.K.; Durante, M.A.; Williams, S.L.; Harbour, J.William.; Volmar, C-Henry.; Lyons, N.J.; Wahlestedt, C.; Graham, R.M.; Ivan, M.E.; Komotar, R.J.; Sarkaria, J.N.; Subramanian, A.; Golub, T.R.; Schürer, S.C.; Ayad, N.G. 2018: Drug and disease signature integration identifies synergistic combinations in glioblastoma. Nature Communications 9(1): 5315
Pardridge, W.M. 2002: Drug and gene targeting to the brain with molecular Trojan horses. Nature Reviews. Drug Discovery 1(2): 131-139
Livingston, A.N.; Mattingly, T.J. 2021: Drug and medical device product failures and the stability of the pharmaceutical supply chain. Journal of the American Pharmacists Association: Japha 61(1): E119-E122
Staniszewska, M.; Iking, J.; Lückerath, K.; Hadaschik, B.; Herrmann, K.; Ferdinandus, J.; Fendler, W.P. 2021: Drug and molecular radiotherapy combinations for metastatic castration resistant prostate cancer. Nuclear Medicine and Biology 96-97: 101-111
Ludwig, A.; Monico, L.B.; Gryczynski, J.; Lertch, E.; Schwartz, R.P.; Fishman, M.; Dionne, R.; Mitchell, S.G. 2021: Drug and sexual HIV-risk behaviors among adolescents and young adults with opioid use disorder. Journal of Substance Abuse Treatment 130: 108477
McCLUSKEY, C.M. 1959: Drug and solution control. Hospital Management 87(4): 100 Passim
Nigam, S.K.; Bush, K.T.; Bhatnagar, V. 2007: Drug and toxicant handling by the OAT organic anion transporters in the kidney and other tissues. Nature Clinical Practice. Nephrology 3(8): 443-448
Matheny, J.; Smith, B.; Courtney, B.; Mair, M. 2009: Drug and vaccine development for infectious diseases: the value of priority review vouchers. Clinical Pharmacology and Therapeutics 85(6): 571-572
Richards, R.; Schwartz, H.R.; Honeywell, M.E.; Stewart, M.S.; Cruz-Gordillo, P.; Joyce, A.J.; Landry, B.D.; Lee, M.J. 2020: Drug antagonism and single-agent dominance result from differences in death kinetics. Nature Chemical Biology 16(7): 791-800
Delaye, M.; Rodrigues, M. 2020: Drug approval : entrectinib and larotrectinib - cancers with NTRK fusion. Bulletin du Cancer 107(11): 1085-1086
Frantz, S. 2006: Drug approval triggers debate on future direction for cancer treatments. Nature Reviews. Drug Discovery 5(2): 91
Buderi, R. 1990: Drug approval: product licensing by phone. Nature 343(6255): 196
Vlatakis, G.; Andersson, L.I.; Müller, R.; Mosbach, K. 1993: Drug assay using antibody mimics made by molecular imprinting. Nature 361(6413): 645-647
Ledford, H. 2012: Drug bests cystic-fibrosis mutation. Nature 482(7384): 145
Saegusa, A. 1998: Drug bill cuts force firms overseas. Nature Biotechnology 16(6): 506-507
Komatsu, T.S.; Okimoto, N.; Koyama, Y.M.; Hirano, Y.; Morimoto, G.; Ohno, Y.; Taiji, M. 2020: Drug binding dynamics of the dimeric SARS-CoV-2 main protease, determined by molecular dynamics simulation. Scientific Reports 10(1): 16986
Mitcheson, J.S. 2003: Drug binding to HERG channels: evidence for a 'non-aromatic' binding site for fluvoxamine. British Journal of Pharmacology 139(5): 883-884
Catta-Preta, C.M.C.; Mottram, J.C. 2018: Drug candidate and target for leishmaniasis. Nature 560(7717): 171-172
Ledford, H. 2012: Drug candidates derailed in case of mistaken identity. Nature 483(7391): 519
Gever, L.N. 1982: Drug challenge: drug combinations. Nursing 12(2): 106
Tobias, S.; Shapiro, A.M.; Grant, C.J.; Patel, P.; Lysyshyn, M.; Ti, L. 2021: Drug checking identifies counterfeit alprazolam tablets. Drug and Alcohol Dependence 218: 108300
Oliveira, M.A.; Lino-Alvarado, A.E.; Moriya, H.T.; Vitorasso, R.L. 2021: Drug class effects on respiratory mechanics in animal models: access and applications. Experimental Biology and Medicine 246(9): 1094-1103
Weinberger, M.M. 1992: Drug clearance in patients with cystic fibrosis. Clinical Pharmacology and Therapeutics 52(1): 106-107
Rathore, S.; Tehrani, S.; Prvulovic, D.; Araya, M.; Lefèvre, T.; Banning, A.P.; Burzotta, F.; Rigatelli, G.; Gutierrez-Chico, J.Luis.; Bonaventura, K.; Chevalier, B.; Kinoshita, Y.; Sikic, J.; Alfonso, F.; Louvard, Y.; Stankovic, G. 2020: Drug coated balloons and their role in bifurcation coronary angioplasty: appraisal of the current evidence and future directions. Expert Review of Medical Devices 17(10): 1021-1033
Corballis, N.H.; Paddock, S.; Gunawardena, T.; Merinopoulos, I.; Vassiliou, V.S.; Eccleshall, S.C. 2021: Drug coated balloons for coronary artery bifurcation lesions: a systematic review and focused meta-analysis. Plos one 16(7): E0251986
Correia, A.S.é; Gärtner, F.át.; Vale, N. 2021: Drug combination and repurposing for cancer therapy: the example of breast cancer. Heliyon 7(1): E05948
Di Chio, C.; Previti, S.; De Luca, F.; Allegra, A.; Zappalà, M.; Ettari, R. 2021: Drug combination studies of PS-1 and quercetin against rhodesain of Trypanosoma brucei rhodesiense. Natural Product Research 2021: 1-5
Ahmed, H.; Curtis, C.R.; Tur-Gracia, S.; Olatunji, T.O.; Carter, K.C.; Williams, R.A.M. 2020: Drug combinations as effective anti-leishmanials against drug resistant Leishmania mexicana. Rsc Medicinal Chemistry 11(8): 905-912
Tyers, M.; Wright, G.D. 2019: Drug combinations: a strategy to extend the life of antibiotics in the 21st century. Nature Reviews. Microbiology 17(3): 141-155
Sinha, G. 2006: Drug companies accused of stalling tailored therapies. Nature Medicine 12(9): 983
Rimmer, A. 2021: Drug companies are fined more than £260m for overcharging NHS for hydrocortisone pills. Bmj 374: N1809
May, M. 2011: Drug companies hope to breathe life into asthma pipeline. Nature Medicine 17(6): 642-643
Dolgin, E. 2012: Drug companies look to biomarkers to salvage cancer target. Nature Medicine 18(9): 1312-1313
Clarke, T. 2003: Drug companies snub antibiotics as pipeline threatens to run dry. Nature 425(6955): 225
Casassus, B. 2021: Drug company Servier is found guilty of manslaughter and aggravated deceit over Mediator diabetes drug. Bmj 372: N873
Wadman, M. 1999: Drug company backs Africa's war on AIDS. Nature 399(6732): 96
Munafo, A.; Christen, Y.; Nussberger, J.; Shum, L.Y.; Borland, R.M.; Lee, R.J.; Waeber, B.; Biollaz, J.; Brunner, H.R. 1992: Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist. Clinical Pharmacology and Therapeutics 51(5): 513-521
Johnson, L.R.; Weaver, P.G.; Forsythe, L.E.; Thomasy, S.M.; Knych, H.K. 2021: Drug content on receipt and over time for compounded formulations of famciclovir. Journal of Feline Medicine and Surgery 23(6): 519-525
Borkowski, B. 1970: Drug control in Poland. Pharmazeutische Praxis 8: 187-191
Cimons, M. 2003: Drug costs threaten patent protection. Nature Medicine 9(1): 9
Guillot, B. 2020: Drug course: from evaluation to price. Annales de Dermatologie et de Venereologie 147(12s): A29-A30
Kapourani, A.; Tzakri, T.; Valkanioti, V.; Kontogiannopoulos, K.N.; Barmpalexis, P. 2021: Drug crystal growth in ternary amorphous solid dispersions: Effect of surfactants and polymeric matrix-carriers. International Journal of Pharmaceutics: X 3: 100086
Mahase, E. 2020: Drug deaths: England and Wales see highest number since records began. Bmj 371: M3988
Shio, M.Temi.; Paquet, M.; Martel, C.; Bosschaerts, T.; Stienstra, S.; Olivier, M.; Fortin, A. 2014: Drug delivery by tattooing to treat cutaneous leishmaniasis. Scientific Reports 4: 4156
Cai, S.S.; Li, T.; Akinade, T.; Zhu, Y.; Leong, K.W. 2021: Drug delivery carriers with therapeutic functions. Advanced Drug Delivery Reviews 176: 113884
Corbett, J.M.; Hawthorne, I.; Coulter, I.S.; English, K. 2021: Drug delivery formulation impacts cyclosporine efficacy in a humanised mouse model of acute graft versus host disease. Transplant Immunology 65: 101373
Arruebo, M.; Vilaboa, N.; Santamaria, J. 2010: Drug delivery from internally implanted biomedical devices used in traumatology and in orthopedic surgery. Expert Opinion on Drug Delivery 7(5): 589-603
Dhanasingh, A.; Hochmair, I. 2021: Drug delivery in cochlear implantation. Acta Oto-Laryngologica 141(Sup1): 135-156
Colella, F.; Garcia, J.ão.P.; Sorbona, M.; Lolli, A.; Antunes, B.; D'Atri, D.; Barré, F.P.Y.; Oieni, J.; Vainieri, M.L.; Zerrillo, L.; Capar, S.; Häckel, S.; Cai, Y.; Creemers, L.B. 2020: Drug delivery in intervertebral disc degeneration and osteoarthritis: Selecting the optimal platform for the delivery of disease-modifying agents. Journal of Controlled Release: Official Journal of the Controlled Release Society 328: 985-999
Smith, B.; Uhl, K. 2009: Drug delivery in the twenty-first century: a new paradigm. Clinical Pharmacology and Therapeutics 85(5): 451-455
Edelman, E.R.; Lovich, M. 1998: Drug delivery models transported to a new level. Nature Biotechnology 16(2): 136-137
Alazzawi, H.F.; Salih, I.K.; Albayati, T.M. 2021: Drug delivery of amoxicillin molecule as a suggested treatment for covid-19 implementing functionalized mesoporous SBA-15 with aminopropyl groups. Drug Delivery 28(1): 856-864
Grice, P.T.; Liu, J.; Gabrielson, A.T.; Pearce, I.; Bivalacqua, T.J.; Modgil, V. 2020: Drug delivery options and therapeutic advances in the management of erectile dysfunction. Expert Opinion on Drug Delivery 17(9): 1259-1268
Narayanamurthy, R.; Yang, J.-L.J.; Yager, J.Y.; Unsworth, L.D. 2021: Drug delivery platforms for neonatal brain injury. Journal of Controlled Release: Official Journal of the Controlled Release Society 330: 765-787
Prow, T.W.; Mandinova, A. 2020: Drug delivery progress in benign and malignant lesions of aging skin. Advanced Drug Delivery Reviews 153: 1
Patel, S.K.; Valicherla, G.R.; Micklo, A.C.; Rohan, L.C. 2021: Drug delivery strategies for management of women's health issues in the upper genital tract. Advanced Drug Delivery Reviews 177: 113955
Lai, V.; Neshat, S.Y.; Rakoski, A.; Pitingolo, J.; Doloff, J.C. 2021: Drug delivery strategies in maximizing anti-angiogenesis and anti-tumor immunity. Advanced Drug Delivery Reviews 179: 113920
Brain, D.; Plant-Hately, A.; Heaton, B.; Arshad, U.; David, C.; Hedrich, C.; Owen, A.; Liptrott, N.J. 2021: Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19. Advanced Drug Delivery Reviews 178: 113848
Malacarne, M.C.; Banfi, S.; Rugiero, M.; Caruso, E. 2021: Drug delivery systems for the photodynamic application of two photosensitizers belonging to the porphyrin family. Photochemical and Photobiological Sciences: Official Journal of the European Photochemistry Association and the European Society for Photobiology 20(8): 1011-1025
Mukhtar, M.; Ali, H.; Ahmed, N.; Munir, R.; Talib, S.; Khan, A.S.; Ambrus, R. 2020: Drug delivery to macrophages: a review of nano-therapeutics targeted approach for inflammatory disorders and cancer. Expert Opinion on Drug Delivery 17(9): 1239-1257
Kumar, A.S.; Kamalasanan, K. 2021: Drug delivery to optimize angiogenesis imbalance in keloid: a review. Journal of Controlled Release: Official Journal of the Controlled Release Society 329: 1066-1076
Moradi Kashkooli, F.; Soltani, M.; Hamedi, M.-H. 2020: Drug delivery to solid tumors with heterogeneous microvascular networks: Novel insights from image-based numerical modeling. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 151: 105399
Mofidfar, M.; Abdi, B.; Ahadian, S.; Mostafavi, E.; Desai, T.A.; Abbasi, F.; Sun, Y.; Manche, E.E.; Ta, C.N.; Flowers, C.W. 2021: Drug delivery to the anterior segment of the eye: a review of current and future treatment strategies. International Journal of Pharmaceutics 607: 120924
Hartwig, O.; Shetab Boushehri, M.A.; Shalaby, K.S.; Loretz, B.; Lamprecht, A.; Lehr, C.-M. 2021: Drug delivery to the inflamed intestinal mucosa - targeting technologies and human cell culture models for better therapies of IBD. Advanced Drug Delivery Reviews 175: 113828
Edwards, R.H. 2001: Drug delivery via the blood-brain barrier. Nature Neuroscience 4(3): 221-222
Nguyen, D.N.; Chen, S.C-Y.; Lu, J.; Goldberg, M.; Kim, P.; Sprague, A.; Novobrantseva, T.; Sherman, J.; Shulga-Morskaya, S.; de Fougerolles, A.; Chen, J.; Langer, R.; Anderson, D.G. 2009: Drug delivery-mediated control of RNA immunostimulation. Molecular Therapy: the Journal of the American Society of Gene Therapy 17(9): 1555-1562
Ashford, M. 2020: Drug delivery-the increasing momentum. Drug Delivery and Translational Research 10(6): 1888-1894
Siegel, R.A. 1998: Drug delivery. A lesson from secretory granules. Nature 394(6692): 427-428
Bradley, C.A. 2018: Drug delivery: DNA nanorobots - seek and destroy. Nature Reviews. Cancer 18(4): 208
Bradley, C.A. 2018: Drug delivery: DNA nanorobots - seek and destroy. Nature Reviews. Drug Discovery 17(4): 242
Flight, M.Hoyos. 2012: Drug delivery: Encapsulation improves therapeutic stem cell action. Nature Reviews. Drug Discovery 11(2): 106
Boso, D.P.; Di Mascolo, D.; Santagiuliana, R.; Decuzzi, P.; Schrefler, B.A. 2020: Drug delivery: Experiments, mathematical modelling and machine learning. Computers in Biology and Medicine 123: 103820
Villanueva, M.Teresa. 2015: Drug delivery: Get in there!. Nature Reviews. Cancer 15(6): 317
Dawson, K.A.; Yan, Y. 2016: Drug delivery: Leukocyte-like carriers. Nature Materials 15(9): 935-936
Cully, M. 2015: Drug delivery: Long live the peptides. Nature Reviews. Drug Discovery 14(11): 750
Flemming, A. 2010: Drug delivery: Nanobioconjugate shrinks brain tumours. Nature Reviews. Drug Discovery 9(12): 917
Kingwell, K. 2016: Drug delivery: New targets for drug delivery across the BBB. Nature Reviews. Drug Discovery 15(2): 84-85
Campolongo, M.J.; Luo, D. 2009: Drug delivery: Old polymer learns new tracts. Nature Materials 8(6): 447-448
Prausnitz, M.R. 2015: Drug delivery: Puncturing cells en masse. Nature Materials 14(5): 470-471
Curry, F-Roy.E. 2016: Drug delivery: Redefining tumour vascular barriers. Nature Nanotechnology 11(6): 494-496
Crunkhorn, S. 2016: Drug delivery: Star-shaped pill sustains drug release. Nature Reviews. Drug Discovery 16(1): 16-17
Butcher, N.J.; Mortimer, G.M.; Minchin, R.F. 2016: Drug delivery: Unravelling the stealth effect. Nature Nanotechnology 11(4): 310-311
Hoag, H. 2014: Drug delivery: brain food. Nature 510(7506): S6-S7
de la Zerda, A.; Gambhir, S.S. 2007: Drug delivery: keeping tabs on nanocarriers. Nature Nanotechnology 2(12): 745-746
West, J.L. 2003: Drug delivery: pulsed polymers. Nature Materials 2(11): 709-710
Couvreur, P. 2014: Drug delivery: replenishing reservoirs in vivo. Nature Nanotechnology 9(11): 874-875
Putnam, D. 2008: Drug delivery: the heart of the matter. Nature Materials 7(11): 836-837
Quesnel, L.B.; York, P.; Skinner, V.M. 1971: Drug dependence and phenotypic masking in E. coli. Nature 233(5315): 121-122
Ozaki, S. 2012: Drug dependence syndrome as a side effect of medical drug use. Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 6): 597-600
Acuda, S.W. 1988: Drug dependence: health and socio-economic consequences. Kenya Nursing Journal 16(2): 11-23
Eddy, N.B.; Halbach, H.; Isbell, H.; Seevers, M.H. 1966: Drug dependence: its significance and characteristics. Psychopharmacology Bulletin 3(3): 1-12
Guedes, I.A.; Costa, L.S.C.; Dos Santos, K.B.; Karl, A.L.M.; Rocha, Gório.K.; Teixeira, I.M.; Galheigo, M.M.; Medeiros, V.; Krempser, E.; Custódio, Fábio.L.; Barbosa, H.J.C.; Nicolás, M.F.; Dardenne, L.E. 2021: Drug design and repurposing with DockThor-VS web server focusing on SARS-CoV-2 therapeutic targets and their non-synonym variants. Scientific Reports 11(1): 5543
Tou, W.Ieong.; Chang, S-Sen.; Lee, C-Chun.; Chen, C.Yu-Chian. 2013: Drug design for neuropathic pain regulation from traditional Chinese medicine. Scientific Reports 3: 844
Lee, C-Jin.; Liang, X.; Wu, Q.; Najeeb, J.; Zhao, J.; Gopalaswamy, R.; Titecat, M.; Sebbane, F.; Lemaitre, N.; Toone, E.J.; Zhou, P. 2016: Drug design from the cryptic inhibitor envelope. Nature Communications 7: 10638
Da Silva, A.P.; Chiari, L.P.A.; Guimaraes, A.R.; Honorio, K.M.; da Silva, A.ér.B.F. 2021: Drug design of new 5-HT6R antagonists aided by artificial neural networks. Journal of Molecular Graphics and Modelling 104: 107844
Taylor, G. 1993: Drug design. A rational attack on influenza. Nature 363(6428): 401-402
Brady, L.; Dodson, G. 1994: Drug design. Reflections on a peptide. Nature 368(6473): 692-693
Mann, J. 1995: Drug design. Rules for the manipulation of polyketides. Nature 375(6532): 533-534
Crunkhorn, S. 2016: Drug design: Cannabinoid receptor structure revealed. Nature Reviews. Drug Discovery 15(12): 822
Eisenstein, M. 2018: Drug designers embrace cryo-EM. Nature Biotechnology 36(7): 557-558
Rutter, D.V. 1998: Drug designers in anaesthesia. Anaesthesia 53(4): 405
Batool, A.; Bibi, N.; Amin, F.; Kamal, M.A. 2021: Drug designing against NSP15 of SARS-COV2 via high throughput computational screening and structural dynamics approach. European Journal of Pharmacology 892: 173779
Coumbis, R.J.; Albano, E.H.; Lyons, M. 1970: Drug detection in urines of commercial blood bank donors. JAMA 214(3): 596
Belsey, M.J. 2007: Drug developer strategies to boost competitiveness. Nature Reviews. Drug Discovery 6(4): 265-266
Chi, K.Rae. 2016: Drug developers delve into the cell's trash-disposal machinery. Nature Reviews. Drug Discovery 15(5): 295-297
Willyard, C. 2011: Drug developers explore vitamin D benefits without the vitamin. Nature Medicine 17(1): 9
Sheridan, C. 2016: Drug developers refocus efforts on RAS. Nature Biotechnology 34(3): 217-218
Sheridan, C. 2019: Drug developers switch gears to inhibit STING. Nature Biotechnology 37(3): 199-201
Hohl, R.J. 2014: Drug development (and academic medicine): charting the course forward. Clinical Pharmacology and Therapeutics 96(5): 519-522
Rubin, E.H.; Gilliland, D.Gary. 2012: Drug development and clinical trials--the path to an approved cancer drug. Nature Reviews. Clinical Oncology 9(4): 215-222
Woosley, R.L.; Cossman, J. 2007: Drug development and the FDA's Critical Path Initiative. Clinical Pharmacology and Therapeutics 81(1): 129-133
Bertsch, T.G.; Denton, T.T.; Perea, N.M.; Ahmed, A.; McKeirnan, K.C. 2021: Drug development and the process of transitioning to team-based learning in a qualitative way. Currents in Pharmacy Teaching and Learning 13(6): 723-728
McCracken, J.T.; Anagnostou, E.; Arango, C.; Dawson, G.; Farchione, T.; Mantua, V.; McPartland, J.; Murphy, D.; Pandina, G.; Veenstra-VanderWeele, J. 2021: Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions. European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology 48: 3-31
Pangalos, M.N.; Schechter, L.E.; Hurko, O. 2007: Drug development for CNS disorders: strategies for balancing risk and reducing attrition. Nature Reviews. Drug Discovery 6(7): 521-532
Reynolds, K.S. 2009: Drug development for emerging infections. Clinical Pharmacology and Therapeutics 86(3): 225-229
Berry-Kravis, E.M.; Lindemann, L.; Jønch, A.E.; Apostol, G.; Bear, M.F.; Carpenter, R.L.; Crawley, J.N.; Curie, A.; Des Portes, V.; Hossain, F.; Gasparini, F.; Gomez-Mancilla, B.; Hessl, D.; Loth, E.; Scharf, S.H.; Wang, P.P.; Von Raison, F.; Hagerman, R.; Spooren, W.; Jacquemont, Sébastien. 2018: Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome. Nature Reviews. Drug Discovery 17(4): 280-299
Varela-Nieto, I.; Murillo-Cuesta, S.; Calvino, M.; Cediel, R.; Lassaletta, L. 2020: Drug development for noise-induced hearing loss. Expert Opinion on Drug Discovery 15(12): 1457-1471
Teo, M.Yuen.; O'Shaughnessy, M.J.; McBride, S.M.; Vargas, H.A.; Scher, H.I. 2018: Drug development for noncastrate prostate cancer in a changed therapeutic landscape. Nature Reviews. Clinical Oncology 15(3): 168-182
Teo, M.Yuen.; O'Shaughnessy, M.J.; McBride, S.M.; Vargas, H.A.; Scher, H.I. 2018: Drug development for noncastrate prostate cancer in a changed therapeutic landscape. Nature Reviews. Clinical Oncology 15(3): 150
Jiang, K. 2013: Drug development for progeria yields insights into normal aging. Nature Medicine 19(5): 515
Molinski, T.F.; Dalisay, D.S.; Lievens, S.L.; Saludes, J.P. 2009: Drug development from marine natural products. Nature Reviews. Drug Discovery 8(1): 69-85
Arango, C. 2021: Drug development in ASD, an ISCTM-ECNP joint adventure. European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology 48: 1-2
Woodcock, J. 2014: Drug development in serious diseases: the new "breakthrough therapy" designation. Clinical Pharmacology and Therapeutics 95(5): 483-485
Luo, Z-Wei.; Ovcjak, A.; Wong, R.; Yang, B-Xue.; Feng, Z-Ping.; Sun, H-Shuo. 2020: Drug development in targeting ion channels for brain edema. Acta Pharmacologica Sinica 41(10): 1272-1288
Dugger, S.A.; Platt, A.; Goldstein, D.B. 2018: Drug development in the era of precision medicine. Nature Reviews. Drug Discovery 17(3): 183-196
Fitzgerald, G. 2010: Drug development needs a new brand of science. Nature 468(7326): 869
Comoglio, P.M.; Giordano, S.; Trusolino, L. 2008: Drug development of MET inhibitors: targeting oncogene addiction and expedience. Nature Reviews. Drug Discovery 7(6): 504-516
Do, A.; Ilagan-Ying, Y.C.; Mehal, W.Z.; Lim, J.K. 2020: Drug development of nonalcoholic fatty liver disease: challenges in research, regulatory pathways, and study endpoints. Expert Opinion on Drug Discovery 2020: 1-10
Lalonde, R.L.; Wagner, J.A. 2009: Drug development perspective on pharmacokinetic studies of new drugs in patients with renal impairment. Clinical Pharmacology and Therapeutics 86(5): 557-561
Baras, A.I.; Baras, A.S.; Schulman, K.A. 2012: Drug development risk and the cost of capital. Nature Reviews. Drug Discovery 11(5): 347-348
Holt, P.G.; Sly, P.D.; Martinez, F.D.; Weiss, S.T.; Björkstén, B.; von Mutius, E.; Wahn, U. 2004: Drug development strategies for asthma: in search of a new paradigm. Nature Immunology 5(7): 695-698
Ito, T.; May, W.S. 1996: Drug development train gathering steam. Nature Medicine 2(4): 403-404
Gershon, D. 1992: Drug development. Orphan drug windfalls?. Nature 355(6359): 381
Maxmen, A. 2013: Drug development: A combined effort. Nature 502(7470): S4-S6
Morgan, B. 2016: Drug development: A healthy pipeline. Nature 533(7603): S116-S117
Zhang, W.; Sidhu, S.S. 2018: Drug development: Allosteric inhibitors hit USP7 hard. Nature Chemical Biology 14(2): 110-111
Cully, M. 2013: Drug development: Chemical brace. Nature 503(7475): S10-S12
Chakma, J. 2013: Drug development: Educate physicians about investor types. Nature 494(7437): 314
Eisenstein, M. 2012: Drug development: Holding out for reinforcements. Nature 484(7395): S16-S18
Cully, M. 2014: Drug development: Illuminated targets. Nature 511(7508): S12-S13
Bishai, W.R. 2017: Drug development: Locking down metabolism. Nature Chemical Biology 13(9): 925-926
Hubbell, J.A. 2010: Drug development: Longer-lived proteins. Nature 467(7319): 1051-1052
Scudellari, M. 2015: Drug development: Mix and match. Nature 521(7551): S12-S14
Begley, C.Glenn.; Ellis, L.M. 2012: Drug development: Raise standards for preclinical cancer research. Nature 483(7391): 531-533
Weintraub, K. 2013: Drug development: Releasing the brakes. Nature 504(7480): S6-S8
Paulson, T. 2014: Drug development: Searching for patterns. Nature 507(7490): S10-S11
Katsnelson, A. 2014: Drug development: The modelling challenge. Nature 508(7494): S8-S9
Owens, B. 2015: Drug development: The treasure chest. Nature 525(7570): S6-S8
DeWeerdt, S. 2016: Drug development: Through the barrier. Nature 537(7621): S154-S157
May, M. 2014: Drug development: Time for teamwork. Nature 509(7498): S4-S5
Hoag, H. 2014: Drug development: a chance of survival. Nature 515(7527): S118-S120
Humphries, C. 2014: Drug development: a complicated path. Nature 515(7526): S4-S5
Katsnelson, A. 2013: Drug development: target practice. Nature 498(7455): S8-S9
Scudellari, M. 2014: Drug development: try and try again. Nature 516(7529): S4-S6
Zini, J.; Kekkonen, J.; Kaikkonen, V.A.; Laaksonen, T.; Keränen, P.; Talala, T.; Mäkynen, A.J.; Yliperttula, M.; Nissinen, I. 2021: Drug diffusivities in nanofibrillar cellulose hydrogel by combined time-resolved Raman and fluorescence spectroscopy. Journal of Controlled Release: Official Journal of the Controlled Release Society 334: 367-375
Belleudi, V.; Poggi, F.R.; Perna, S.; Naldi, L.; Bortolus, R.; Rosa, A.C.; Kirchmayer, U.; Davoli, M.; Addis, A. 2020: Drug discontinuation in pregnant women with psoriasis: the PSO-MOTHER cohort study. Pharmacoepidemiology and Drug Safety 29(8): 904-912
Bakke, O.M.; Wardell, W.M.; Lasagna, L. 1984: Drug discontinuations in the United Kingdom and the United States, 1964 to 1983: issues of safety. Clinical Pharmacology and Therapeutics 35(5): 559-567
Clearfield, H.R. 1982: Drug dissolution of gallstones. Medical Trial Technique Quarterly 29(2): 209-213
Flaherty, S.M.; Russell, I.J.; Lukashkin, A.N. 2021: Drug distribution along the cochlea is strongly enhanced by low-frequency round window micro vibrations. Drug Delivery 28(1): 1312-1320
Khare, A.K. 1998: Drug donations to developing countries. Africa Health 21(1): 8-9
Smith, N.A. 2021: Drug dosage in patients with obesity: Investigation of lean body mass. Anaesthesia and Intensive Care 49(6): 486-488
Ochs, H.R. 1981: Drug dosage in the aged. Die Medizinische Welt 32(7): 225-228
Abduljalil, K.; Badhan, R.K.S. 2020: Drug dosing during pregnancy-opportunities for physiologically based pharmacokinetic models. Journal of Pharmacokinetics and Pharmacodynamics 47(4): 319-340
Wells, M.; Goldstein, L. 2020: Drug dosing errors in simulated paediatric emergencies - Comprehensive dosing guides outperform length-based tapes with precalculated drug doses. African Journal of Emergency Medicine: Revue Africaine de la Medecine d'Urgence 10(2): 74-80
Coats, A.J.S. 2019: Drug dosing for heart failure: does sex or size matter?. Nature Reviews. Cardiology 16(12): 705-706
Sprangers, B.; Sandhu, G.; Rosner, M.H.; Tesarova, P.; Stadler, W.M.; Malyszko, J. 2021: Drug dosing in cancer patients with decreased kidney function: a practical approach. Cancer Treatment Reviews 93: 102139
Brater, D.C. 2009: Drug dosing in patients with impaired renal function. Clinical Pharmacology and Therapeutics 86(5): 483-489
Erstad, B.L.; Barletta, J.F. 2020: Drug dosing in the critically ill obese patient-a focus on sedation, analgesia, and delirium. Critical Care 24(1): 315
Erstad, B.L.; Barletta, J.F. 2021: Drug dosing in the critically ill obese patient: a focus on medications for hemodynamic support and prophylaxis. Critical Care 25(1): 77
Duke, E.J.; Glassman, E. 1968: Drug effects in Drosophila: streptomycin sensitive strains and fluorouracil resistant strains. Nature 220(5167): 588-589
Guidi, A.; Petrella, G.; Fustaino, V.; Saccoccia, F.; Lentini, S.; Gimmelli, R.; Di Pietro, G.; Bresciani, A.; Cicero, D.O.; Ruberti, G. 2020: Drug effects on metabolic profiles of Schistosoma mansoni adult male parasites detected by 1H-NMR spectroscopy. Plos Neglected Tropical Diseases 14(10): E0008767
Xia, X. 2020: Drug efficacy and toxicity prediction: an innovative application of transcriptomic data. Cell Biology and Toxicology 36(6): 591-602
Changal, K.H.; Mir, T.; Khan, S.; Nazir, S.; Elzanatey, A.; Meenakshisundaram, C.; Mubbasher, S.; Sheikh, M.A. 2021: Drug-Eluting Stents Versus Bare-Metal Stents in Large Coronary Artery Revascularization: Systematic Review and Meta-Analysis. Cardiovascular Revascularization Medicine: Including Molecular Interventions 23: 42-49
Ludwig, C.; Goh, V.; Rajkumar, J.; Au, J.; Tsoukas, M. 2020: Drug eruptions associated with tumor therapy: Great imitators. Clinics in Dermatology 38(2): 208-215
Shin, H.T.; Chang, M.W. 2001: Drug eruptions in children. Current Problems in Pediatrics 31(7): 207-234
Chu, C.-Y. 2020: Drug eruptions: Great imitators. Clinics in Dermatology 38(2): 193-207
O'connor Donelan, T.D. 1954: Drug eruptions: old and new. Journal of the Irish Medical Association 35(206): 229-230
Drummond, M. 1954: Drug eruptions: old and new. Journal of the Irish Medical Association 35(206): 230-231
Li, X.; Li, Y.; Guo, S.; Liu, W. 2020: Drug evaluation and pharmaceutical care in a critically ill COVID-19 patient. International Journal of Clinical Pharmacology and Therapeutics 58(10): 568-574
López-Briz, E.; Fraga-Fuentes, M.ª D.; Clopés-Estela, A.; Ortega-Eslava, A.; Alegre-Del Rey, E.J.ús. 2020: Drug evaluation is also a clinical activity. Farmacia Hospitalaria: Organo Oficial de Expresion Cientifica de la Sociedad Espanola de Farmacia Hospitalaria 45(1): 45-47
Gründemann, D.; Gorboulev, V.; Gambaryan, S.; Veyhl, M.; Koepsell, H. 1994: Drug excretion mediated by a new prototype of polyspecific transporter. Nature 372(6506): 549-552
More, B. 2018: Drug executives should take a Hippocratic oath. Nature 555(7698): 561
More, B. 2018: Drug executives should take a Hippocratic oath. Nature 555(7698): 561
Yao, X-Qiu.; Kenzaki, H.; Murakami, S.; Takada, S. 2010: Drug export and allosteric coupling in a multidrug transporter revealed by molecular simulations. Nature Communications 1: 117
Such-Díaz, A.; Díaz-Marín, C.; Sánchez-Pérez, R.; Iglesias-Peinado, I. 2020: Drug exposure associated with exacerbation of symptoms in patients with myasthenia gravis. Revista de Neurologia 71(4): 143-150
Iacobelli, S.; Lorrain, S.; Gouyon, B.éa.; Gambacorta, S.; Laforgia, N.; Gouyon, J.-B.; Bonsante, F. 2020: Drug exposure for PDA closure in France: a prospective, cohort-based, analysis. European Journal of Clinical Pharmacology 76(12): 1765-1772
Gerber, D.E.; Putnam, W.C. 2021: Drug exposure: still relevant after all these years. Oncotarget 12(8): 721-722
Zhang, X.; Zhao, M.; Zheng, C. 2021: Drug fever induced by carboplatin-based regimens: Higher incidence in a women's hospital. Taiwanese Journal of Obstetrics and Gynecology 60(5): 882-887
Butler, D. 2012: Drug firm to share raw trial data. Nature 490(7420): 322
Towie, N. 2005: Drug firms donate compounds for anti-HIV gel. Nature 438(7064): 6-7
Wang, P.-H. 2020: Drug for heart is applicable to liver: Is it possible?. Journal of the Chinese Medical Association: Jcma 83(12): 1057-1058
Wadman, M. 2005: Drug giants fail to name compounds in trial database. Nature 435(7042): 548
Firestone, R.A. 2006: Drug giants hamstrung by timid middle management. Nature 441(7091): 282
Ledford, H. 2010: Drug giants turn their backs on RNA interference. Nature 468(7323): 487
Kiiski, I.; Ollikainen, E.; Artes, S.; Järvinen, P.äi.; Jokinen, V.; Sikanen, T. 2021: Drug glucuronidation assays on human liver microsomes immobilized on microfluidic flow-through reactors. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 158: 105677
Villani, A.; Costa, C.; Fabbrocini, G.; Scalvenzi, M. 2020: Drug holiday regimen for vismodegib treatment in patients with multiple primary basal cell carcinomas. Dermatologic Therapy 33(4): E13707
Eisenstein, M. 2021: Drug hunters uncloak the non-coding 'hidden' genome. Nature Biotechnology 39(10): 1169-1171
Scheckel, C.J.; Vincent Rajkumar, S. 2021: Drug importation: limitations of current proposals and opportunities for improvement. Blood Cancer Journal 11(7): 132
Bayer, R. 1953: Drug induced acceleration of the opening of the isthmic cervical segment in labor. Zentralblatt für Gynakologie 75(37): 1444-1456
Black, M. 1983: Drug induced liver disease. Postgraduate Medical Journal 59(Suppl 4): 116-122
Zuberi, S.J. 1981: Drug induced liver disease. JPMA. Journal of the Pakistan Medical Association 31(2): 32-33
Pannier, R. 1983: Drug induced lung disease. European Journal of Respiratory Diseases. Suppl 126: 151-156
Abu-El-Haija, M.; Hornung, L.; Lin, T.K.; Nathan, J.D.; Thompson, T.; Vitale, D.S.; Nasr, A.; Husain, S.Z.; Denson, L. 2020: Drug induced pancreatitis is the leading known cause of first attack acute pancreatitis in children. Pancreatology: Official Journal of the International Association of Pancreatology . 20(6): 1103-1108
Takimoto, R.; Takamori, K. 2004: Drug induced toxic epidermal necrolysis. Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 5): 515-518
Schweiger, J.; Phillips, K.; Patel, A.; Echols, C. 2022: Drug induced very severe hypertriglyceridemia in a pediatric stem cell transplant recipient. Pediatric Blood and Cancer 69(2): E29379
Oligino, T.; Poliani, P.L.; Wang, Y.; Tsai, S.Y.; O'Malley, B.W.; Fink, D.J.; Glorioso, J.C. 1998: Drug inducible transgene expression in brain using a herpes simplex virus vector. Gene Therapy 5(4): 491-496
Rogers, P.G. 1987: Drug information for patients. Lancet 1(8536): 810-811
Giovanazzi, A.; Miselli, M.; Poggiolini, D. 1988: Drug information for patients. Lancet 1(8581): 362
Hill, J. 1980: Drug information for patients. Canadian Medical Association Journal 122(4): 395 399
Macleod, S.M. 1980: Drug information for patients. Canadian Medical Association Journal 122(4): 399
Maywald, U.; Schindler, C.; Bux, Y.; Kirch, W. 2005: Drug information for patients -- unmet needs, evaluation and influence on the compliance. Deutsche Medizinische Wochenschrift 130(24): 1485-1490
Lumholtz, I.B. 1979: Drug information: agents for the treatment of gynecologic diseases. Hormone substitution in the climacteric. Sygeplejersken 79(36): 17
Lumholtz, I.B. 1979: Drug information: agents for the treatment of gynecologic diseases. Hormone substitution in the climacteric. Sygeplejersken 79(38): 10
Karimi, S.E.; Zanjari, N.; SoleimanvandiAzar, N.; Ahounbar, E.; Mohammadi Gharehghani, M.A.; Ahmadi, S. 2021: Drug injection and associated factors among the elderly living with HIV/AIDS in Tehran, Iran. Medical Journal of the Islamic Republic of Iran 35: 55
Skomsvoll, J.F.; Wallenius, M.; Koksvik, H.S.; Rødevand, E.; Salvesen, K.A.; Spigset, O.; Kvien, T.K. 2007: Drug insight: Anti-tumor necrosis factor therapy for inflammatory arthropathies during reproduction, pregnancy and lactation. Nature Clinical Practice. Rheumatology 3(3): 156-164
Chapurlat, R.D.; Delmas, P.D. 2006: Drug insight: Bisphosphonates for postmenopausal osteoporosis. Nature Clinical Practice. Endocrinology and Metabolism 2(4): 211-9; Quiz Following 238
Colao, A.; Di Sarno, A.; Guerra, E.; De Leo, M.; Mentone, A.; Lombardi, G. 2006: Drug insight: Cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women. Nature Clinical Practice. Endocrinology and Metabolism 2(4): 200-210
Keith, W.Nicol.; Bilsland, A.; Hardie, M.; Evans, T.R.Jeffry. 2004: Drug insight: Cancer cell immortality-telomerase as a target for novel cancer gene therapies. Nature Clinical Practice. Oncology 1(2): 88-96
Gurbel, P.A.; Tantry, U.S. 2006: Drug insight: Clopidogrel nonresponsiveness. Nature Clinical Practice. Cardiovascular Medicine 3(7): 387-395
Olanow, C.Warren.; Obeso, Jé.A.; Stocchi, F. 2006: Drug insight: Continuous dopaminergic stimulation in the treatment of Parkinson's disease. Nature Clinical Practice. Neurology 2(7): 382-392
Mulder, J.E.; Kolatkar, N.S.; LeBoff, M.S. 2006: Drug insight: Existing and emerging therapies for osteoporosis. Nature Clinical Practice. Endocrinology and Metabolism 2(12): 670-680
Kelly, W.Kevin.; Marks, P.A. 2005: Drug insight: Histone deacetylase inhibitors--development of the new targeted anticancer agent suberoylanilide hydroxamic acid. Nature Clinical Practice. Oncology 2(3): 150-157
Borer, J.S. 2004: Drug insight: If inhibitors as specific heart-rate-reducing agents. Nature Clinical Practice. Cardiovascular Medicine 1(2): 103-109
Steffens, S.; Mach, Fçois. 2006: Drug insight: Immunomodulatory effects of statins--potential benefits for renal patients?. Nature Clinical Practice. Nephrology 2(7): 378-387
Beuers, U. 2006: Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nature Clinical Practice. Gastroenterology and Hepatology 3(6): 318-328
Oo, T.H.; Hesketh, P.J. 2005: Drug insight: New antiemetics in the management of chemotherapy-induced nausea and vomiting. Nature Clinical Practice. Oncology 2(4): 196-201
Cernea, S.; Herold, K.C. 2006: Drug insight: New immunomodulatory therapies in type 1 diabetes. Nature Clinical Practice. Endocrinology and Metabolism 2(2): 89-98
Fung, S.K.; Lok, A.S.F. 2004: Drug insight: Nucleoside and nucleotide analog inhibitors for hepatitis B. Nature Clinical Practice. Gastroenterology and Hepatology 1(2): 90-97
Katznelson, L. 2006: Drug insight: Primary medical therapy of acromegaly. Nature Clinical Practice. Endocrinology and Metabolism 2(2): 109-17; Quiz Following 117
Amory, J.K.; Page, S.T.; Bremner, W.J. 2006: Drug insight: Recent advances in male hormonal contraception. Nature Clinical Practice. Endocrinology and Metabolism 2(1): 32-41
Santoro, M.; Carlomagno, F. 2006: Drug insight: Small-molecule inhibitors of protein kinases in the treatment of thyroid cancer. Nature Clinical Practice. Endocrinology and Metabolism 2(1): 42-52
Raffel, O.Christopher.; White, H.D. 2006: Drug insight: Statin use in the elderly. Nature Clinical Practice. Cardiovascular Medicine 3(6): 318-328
Bhasin, S.; Calof, O.M.; Storer, T.W.; Lee, M.L.; Mazer, N.A.; Jasuja, R.; Montori, V.M.; Gao, W.; Dalton, J.T. 2006: Drug insight: Testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging. Nature Clinical Practice. Endocrinology and Metabolism 2(3): 146-159
Kojima, M.; Kangawa, K. 2006: Drug insight: The functions of ghrelin and its potential as a multitherapeutic hormone. Nature Clinical Practice. Endocrinology and Metabolism 2(2): 80-88
Mackler, N.J.; Pienta, K.J. 2005: Drug insight: Use of docetaxel in prostate and urothelial cancers. Nature Clinical Practice. Urology 2(2): 92
Schneider, B.P.; Sledge, G.W. 2007: Drug insight: VEGF as a therapeutic target for breast cancer. Nature Clinical Practice. Oncology 4(3): 181-189
Larkin, J.M.G.; Chowdhury, S.; Gore, M.E. 2007: Drug insight: advances in renal cell carcinoma and the role of targeted therapies. Nature Clinical Practice. Oncology 4(8): 470-479
Fosang, A.J.; Little, C.B. 2008: Drug insight: aggrecanases as therapeutic targets for osteoarthritis. Nature Clinical Practice. Rheumatology 4(8): 420-427
Kalidindi, S.R.; Tang, W.H.Wilson.; Francis, G.S. 2007: Drug insight: aldosterone-receptor antagonists in heart failure--the journey continues. Nature Clinical Practice. Cardiovascular Medicine 4(7): 368-378
Nielsen, O.H.; Munck, L.K. 2007: Drug insight: aminosalicylates for the treatment of IBD. Nature Clinical Practice. Gastroenterology and Hepatology 4(3): 160-170
Hering, D.; Piper, C.; Horstkotte, D. 2005: Drug insight: an overview of current anticoagulation therapy after heart valve replacement. Nature Clinical Practice. Cardiovascular Medicine 2(8): 415-422
Chang, J.T.; Lichtenstein, G.R. 2006: Drug insight: antagonists of tumor-necrosis factor-alpha in the treatment of inflammatory bowel disease. Nature Clinical Practice. Gastroenterology and Hepatology 3(4): 220-228
Langford, C.A. 2008: Drug insight: anti-tumor necrosis factor therapies for the vasculitic diseases. Nature Clinical Practice. Rheumatology 4(7): 364-370
Henderson, C.; Davis, J.C. 2006: Drug insight: anti-tumor-necrosis-factor therapy for ankylosing spondylitis. Nature Clinical Practice. Rheumatology 2(4): 211-218
Reinacher-Schick, A.; Pohl, M.; Schmiegel, W. 2008: Drug insight: antiangiogenic therapies for gastrointestinal cancers--focus on monoclonal antibodies. Nature Clinical Practice. Gastroenterology and Hepatology 5(5): 250-267
Helft, Gérard.; Gilard, M.; Le Feuvre, C.; Zaman, A.G. 2006: Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation. Nature Clinical Practice. Cardiovascular Medicine 3(12): 673-680
Patrono, C.; Rocca, B. 2007: Drug insight: aspirin resistance--fact or fashion?. Nature Clinical Practice. Cardiovascular Medicine 4(1): 42-50
Maree, A.O.; Cox, D.; Fitzgerald, D.J. 2007: Drug insight: aspirin resistance-fact or fashion?. Nature Clinical Practice. Cardiovascular Medicine 4(3): E1; Author Reply E2
Rothman, M.T. 2005: Drug insight: bleeding after percutaneous coronary intervention-risks, measures and impact of anticoagulant treatment options. Nature Clinical Practice. Cardiovascular Medicine 2(9): 465-474
Reed, J.C. 2006: Drug insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms. Nature Clinical Practice. Oncology 3(7): 388-398
Spektor, G.; Fuster, V. 2005: Drug insight: cyclo-oxygenase 2 inhibitors and cardiovascular risk--where are we now?. Nature Clinical Practice. Cardiovascular Medicine 2(6): 290-300
Hinz, B.; Renner, B.; Brune, K. 2007: Drug insight: cyclo-oxygenase-2 inhibitors--a critical appraisal. Nature Clinical Practice. Rheumatology 3(10): 552-60; Quiz 1 P Following 589
Rigby, W.F.C. 2007: Drug insight: different mechanisms of action of tumor necrosis factor antagonists-passive-aggressive behavior?. Nature Clinical Practice. Rheumatology 3(4): 227-233
Heneka, M.T.; Landreth, G.E.; Hüll, M. 2007: Drug insight: effects mediated by peroxisome proliferator-activated receptor-gamma in CNS disorders. Nature Clinical Practice. Neurology 3(9): 496-504
Faderl, S.; Kantarjian, H.M. 2005: Drug insight: emerging new drugs in the treatment of myelodysplastic syndromes. Nature Clinical Practice. Oncology 2(7): 348-355
Loriot, Y.; Perlemuter, G.; Malka, D.; Penault-Llorca, Fédérique.; Penault-Lorca, Fédérique.; Boige, Vérie.; Deutsch, E.; Massard, C.; Armand, J.Pierre.; Soria, J-Charles. 2008: Drug insight: gastrointestinal and hepatic adverse effects of molecular-targeted agents in cancer therapy. Nature Clinical Practice. Oncology 5(5): 268-278
Dunaif, A. 2008: Drug insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome--a reappraisal. Nature Clinical Practice. Endocrinology and Metabolism 4(5): 272-283
Samaniego, M.; Becker, B.N.; Djamali, A. 2006: Drug insight: maintenance immunosuppression in kidney transplant recipients. Nature Clinical Practice. Nephrology 2(12): 688-699
Fantini, M.C.; Becker, C.; Kiesslich, R.; Neurath, M.F. 2006: Drug insight: novel small molecules and drugs for immunosuppression. Nature Clinical Practice. Gastroenterology and Hepatology 3(11): 633-644
Salama, A.D.; Pusey, C.D. 2006: Drug insight: rituximab in renal disease and transplantation. Nature Clinical Practice. Nephrology 2(4): 221-230
Taplin, M-Ellen. 2007: Drug insight: role of the androgen receptor in the development and progression of prostate cancer. Nature Clinical Practice. Oncology 4(4): 236-244
McMaster, A.; Ray, D.W. 2008: Drug insight: selective agonists and antagonists of the glucocorticoid receptor. Nature Clinical Practice. Endocrinology and Metabolism 4(2): 91-101
Bhuket, T.P.; Higgins, P.D.R. 2006: Drug insight: statins and gastrointestinal cancer. Nature Clinical Practice. Gastroenterology and Hepatology 3(10): 552-562
Lipinski, M.J.; Abbate, A.; Fuster, V.; Vetrovec, G.W. 2007: Drug insight: statins for nonischemic heart failure--evidence and potential mechanisms. Nature Clinical Practice. Cardiovascular Medicine 4(4): 196-205
Srinivas-Shankar, U.; Wu, F.C.W. 2006: Drug insight: testosterone preparations. Nature Clinical Practice. Urology 3(12): 653-665
Kumar, S.; Anderson, K.C. 2005: Drug insight: thalidomide as a treatment for multiple myeloma. Nature Clinical Practice. Oncology 2(5): 262-270
Taylor, R.P.; Lindorfer, M.A. 2007: Drug insight: the mechanism of action of rituximab in autoimmune disease--the immune complex decoy hypothesis. Nature Clinical Practice. Rheumatology 3(2): 86-95
Wong, F. 2007: Drug insight: the role of albumin in the management of chronic liver disease. Nature Clinical Practice. Gastroenterology and Hepatology 4(1): 43-51
Gotto, A.M.; Farmer, J.A. 2006: Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol. Nature Clinical Practice. Cardiovascular Medicine 3(12): 664-672
Panchapakesan, U.; Chen, X-Ming.; Pollock, C.A. 2005: Drug insight: thiazolidinediones and diabetic nephropathy--relevance to renoprotection. Nature Clinical Practice. Nephrology 1(1): 33-43
Sanossian, N.; Ovbiagele, B. 2008: Drug insight: translating evidence on statin therapy into clinical benefits. Nature Clinical Practice. Neurology 4(1): 43-49
Moss, M.L.; Sklair-Tavron, L.; Nudelman, R. 2008: Drug insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis. Nature Clinical Practice. Rheumatology 4(6): 300-309
Hohlfeld, R.; Wekerle, H. 2005: Drug insight: using monoclonal antibodies to treat multiple sclerosis. Nature Clinical Practice. Neurology 1(1): 34-44
Cooney, M.M.; van Heeckeren, W.; Bhakta, S.; Ortiz, J.; Remick, S.C. 2006: Drug insight: vascular disrupting agents and angiogenesis--novel approaches for drug delivery. Nature Clinical Practice. Oncology 3(12): 682-692
Brown, A.J.; Slatopolsky, E. 2007: Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease. Nature Clinical Practice. Endocrinology and Metabolism 3(2): 134-144
Sanzenbacher, G.T.; Wettstein, G. 2020: Drug insurance and the strategic behavior of drug manufacturers: Evergreening and generic entry after Medicare Part D. Journal of Health Economics 72: 102332
Jonkman, S.; Pelloux, Y.; Everitt, B.J. 2012: Drug intake is sufficient, but conditioning is not necessary for the emergence of compulsive cocaine seeking after extended self-administration. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 37(7): 1612-1619
Mori, T.; Aisa, Y.; Kato, J.; Nakamura, Y.; Ikeda, Y.; Okamoto, S. 2009: Drug interaction between voriconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplantation 44(6): 371-374
Mori, T.; Kato, J.; Yamane, A.; Ono, Y.; Shimizu, T.; Okamoto, S. 2011: Drug interaction between voriconazole and tacrolimus in allogeneic hematopoietic SCT recipients. Bone Marrow Transplantation 46(3): 450-451
Bilek, O.; Holanek, M.; Jurica, J.; Stepankova, S.; Vasina, J.; Selingerova, I.; Poprach, A.; Borilova, S.; Kazda, T.; Kiss, I.; Zdrazilova-Dubska, L. 2021: Drug interaction profile of TKi alectinib allows effective and safe treatment of ALK+ lung cancer in the kidney transplant recipient. International Immunopharmacology 99: 108012
Huang, S-M.; Temple, R.; Throckmorton, D.C.; Lesko, L.J. 2007: Drug interaction studies: study design, data analysis, and implications for dosing and labeling. Clinical Pharmacology and Therapeutics 81(2): 298-304
Yuk, J.H.; Williams, T.W. 1991: Drug interaction with quinolone antibiotics in intensive care unit patients. Archives of Internal Medicine 151(3): 619
Yeh, P.J.; Hegreness, M.J.; Aiden, A.Presser.; Kishony, R. 2009: Drug interactions and the evolution of antibiotic resistance. Nature Reviews. Microbiology 7(6): 460-466
Orme, M.L.; Back, D.J. 1986: Drug interactions between oral contraceptive steroids and antibiotics. British Dental Journal 160(5): 169-170
Oswald, S.; Nassif, A.; Modess, C.; Keiser, M.; Ulrich, A.; Runge, D.; Hanke, U.; Lütjohann, D.; Engel, A.; Weitschies, W.; Siegmund, W. 2011: Drug interactions between the immunosuppressant tacrolimus and the cholesterol absorption inhibitor ezetimibe in healthy volunteers. Clinical Pharmacology and Therapeutics 89(4): 524-528
Djuricich, P.; Vázquez, E. 2009: Drug interactions chart. An abbreviated, at-a-glance guide to HIV drug interactions. Positively Aware: the Monthly Journal of the Test Positive Aware Network 20(2): 56-58
Rogero-Blanco, Eísa.; Del-Cura-González, I.; Aza-Pascual-Salcedo, M.; García de Blas González, F.; Terrón-Rodas, C.; Chimeno-Sánchez, S.; García-Domingo, E.; López-Rodríguez, J.A. 2021: Drug interactions detected by a computer-assisted prescription system in primary care patients in Spain: MULTIPAP study. European Journal of General Practice 27(1): 90-96
Forgerini, M.; Schiavo, G.; Lucchetta, R.C.; Mastroianni, P.íc.d.C. 2021: Drug interactions for elderly people with mental and behavioral disorders: a systematic scoping review. Archives of Gerontology and Geriatrics 93: 104283
Castro-Moraga, M.ía.E.; Campos L, A.; Figueroa V, C.; Yizmeyián M, A.í; Piñera M, C. 2021: Drug interactions in HIV-infected children undergoing treatment with antiretrovirals. Andes Pediatrica: Revista Chilena de Pediatria 92(3): 446-454
Ghoneim, M.M. 1971: Drug interactions in anesthesia. Journal of the Iowa Medical Society 61(5): 294 Passim
Chadha, M. 2005: Drug interactions in anesthesia. Middle East Journal of Anaesthesiology 18(3): 457-475
Wulf, H. 1991: Drug interactions in bupivacaine-induced cardiotoxicity. Regional Anesthesia 16(2): 116-117
Scripture, C.D.; Figg, W.D. 2006: Drug interactions in cancer therapy. Nature Reviews. Cancer 6(7): 546-558
Torres, J.H.; Bons, P.; Bayssière, J.; Blayac, J.P.; Boucard, R. 1990: Drug interactions in dentistry. Actualites Odonto-Stomatologiques 44(171): 407-413
Caldarone, C.V. 1974: Drug interactions in dentistry. Journal of the Rhode Island State Dental Society 7(1): 3-4
Dawoud, B.E.S.; Roberts, A.; Yates, J.M. 2014: Drug interactions in general dental practice--considerations for the dental practitioner. British Dental Journal 216(1): 15-23
Callahan, A.M.; Fava, M.; Rosenbaum, J.F. 1993: Drug interactions in psychopharmacology. Psychiatric Clinics of North America 16(3): 647-671
Kuprash, L.P.; Zaika, M.U. 1985: Drug interactions in the elderly. Meditsinskaia Sestra 44(10): 26-29
Fabre, J.; Dayer, P.; Leemann, T. 1985: Drug interactions in the elderly. Therapeutische Umschau. Revue Therapeutique 42(12): 831-836
Leather, H.L. 2004: Drug interactions in the hematopoietic stem cell transplant (HSCT) recipient: what every transplanter needs to know. Bone Marrow Transplantation 33(2): 137-152
Mullin, J.M.; Schrogie, J.J. 2013: Drug interactions produced by proton pump inhibitors: not simply a pH effect. Clinical Pharmacology and Therapeutics 93(2): 150
Fletcher, C.V. 2010: Drug interactions should be evaluated in patients. Clinical Pharmacology and Therapeutics 88(5): 585-587
Fancher, K.M.; Pappacena, J.J. 2020: Drug interactions with Bruton's tyrosine kinase inhibitors: clinical implications and management. Cancer ChemoTherapy and Pharmacology 86(4): 507-515
Cromdos, S. 1981: Drug interactions with cimetidine. Australian Nurses' Journal. Royal Australian Nursing Federation 11(2): 34; 40
Schwinghammer, T.L. 1981: Drug interactions with cimetidine. American Journal of Hospital Pharmacy 38(12): 1976-1978
Hall, D.; Kraus, F.; Rudolph, W. 1993: Drug interactions with digitalis glycosides. Herz 18(2): 124-134
Kowalsky, S.F. 1990: Drug interactions with fluconazole. PharmacoTherapy 10(6): 170s-173s
Jobski, K.; Hoffmann, F.; Herget-Rosenthal, S.; Dörks, M. 2020: Drug interactions with oral anticoagulants in German nursing home residents: comparison between vitamin K antagonists and non-vitamin K antagonist oral anticoagulants based on two nested case-control studies. Clinical Research in Cardiology: Official Journal of the German Cardiac Society 109(4): 465-475
Back, D.J.; Breckenridge, A.M.; Orme, M.L. 1983: Drug interactions with oral contraceptive steroids. Ippf Medical Bulletin 17(1): 1-2
Ho, V.; Tee, C.; See, K.C. 2020: Drug interactions with potential antivirals used for COVID-19 in older persons. Geriatrics and Gerontology International 20(7): 737-739
Hunninghake, D.B.; Azarnoff, D.L. 1968: Drug interactions with warfarin. Archives of Internal Medicine 121(4): 349-352
Kwan, D.; Bartle, W.R. 1993: Drug interactions with warfarin. Medical Journal of Australia 158(8): 574-575
Neuman, M. 1970: Drug interactions. i. La Presse Medicale 78(44): 1938-1940
Wilson, V. 2017: Drug interactions: Time to put our pens down. British Dental Journal 222(4): 226
Hodge, C.; Marra, F.; Marzolini, C.; Boyle, A.; Gibbons, S.; Siccardi, M.; Burger, D.; Back, D.; Khoo, S. 2020: Drug interactions: a review of the unseen danger of experimental COVID-19 therapies. Journal of Antimicrobial ChemoTherapy 75(12): 3417-3424
Shah, S.; Singh, A. 2020: Drug labeling: the study of compliance of regulatory requirements for prescription drugs in India. Perspectives in Clinical Research 11(4): 164-167
Kesselheim, A.S.; Avorn, J. 2012: Drug labels: a flawed source of data for studying orphan drug approvals. Clinical Pharmacology and Therapeutics 92(6): 694; Author Reply 695
Robey, S.; David, F.S. 2017: Drug launch curves in the modern era. Nature Reviews. Drug Discovery 16(1): 13-14
Fleming, E.; Ma, P. 2002: Drug life-cycle technologies. Nature Reviews. Drug Discovery 1(10): 751-752
Kastens, W. 1960: Drug list for pharmacies. Pharmazeutische Praxis 10: 230-231
Chen, H.; Chi, X.; Li, B.; Zhang, M.; Ma, Y.; Achilefu, S.; Gu, Y. 2014: Drug loaded multilayered gold nanorods for combined photothermal and chemotherapy. Biomaterials Science 2(7): 996-1006
Xi, X.-M.; Xia, S.-J.; Lu, R. 2021: Drug loading techniques for exosome-based drug delivery systems. Die Pharmazie 76(2): 61-67
Šoltys, M.; Zůza, D.; Boleslavská, T.; Machač Akhlasová, S.; Balouch, M.; Kovačík, P.; Beránek, J.; Škalko-Basnet, N.ša.; Flaten, G.ør.E.; Štěpánek, F.še. 2021: Drug loading to mesoporous silica carriers by solvent evaporation: a comparative study of amorphization capacity and release kinetics. International Journal of Pharmaceutics 607: 120982
Francke, N.M.; Bunjes, H. 2021: Drug localization and its effect on the physical stability of poloxamer 188-stabilized colloidal lipid emulsions. International Journal of Pharmaceutics 599: 120394
Mullard, A. 2014: Drug makers and NIH team up to find and validate targets. Nature Reviews. Drug Discovery 13(4): 241-243
Hodgson, J. 2019: Drug makers chase anti-flu pill. Nature Biotechnology 37(6): 576-578
Schmidt, C. 2008: Drug makers chase cancer stem cells. Nature Biotechnology 26(4): 366-367
Sheridan, C. 2015: Drug makers target ubiquitin proteasome pathway anew. Nature Biotechnology 33(11): 1115-1117
Aubin, P.-A.; Rigumye, L.O.ée.; Kosel, M.; Besson, M.; Favrod-Coune, T. 2020: Drug management of behavioral disorders in people with developmental and intellectual disability. Revue Medicale Suisse 16(708): 1786-1789
Tuttle, C.B. 1985: Drug management of pain in cancer patients. Canadian Medical Association Journal 132(2): 121-134
Appel, W.C. 1985: Drug management of pain in cancer patients. Canadian Medical Association Journal 132(8): 899-900
Webb, S. 2010: Drug marketing and the new media. Nature Biotechnology 28(5): 396-398
Cheney, C.A. 2008: Drug menus in protocol applications. A la carte is OK. Lab Animal 37(9): 398-399
Thulin, J.D. 2008: Drug menus in protocol applications. Allow flexibility, with limits. Lab Animal 37(9): 397-398
Strait, K.R. 2008: Drug menus in protocol applications. Formalize SOPs. Lab Animal 37(9): 398
Charo, L.M.; Homer, M.V.; Natarajan, L.; Haunschild, C.; Chung, K.; Mao, J.J.; DeMichele, A.M.; Su, H.Irene. 2020: Drug metabolising enzyme polymorphisms and chemotherapy-related ovarian failure in young breast cancer survivors. Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 2020: 1-6
Zdesenko, G.; Mutapi, F. 2020: Drug metabolism and pharmacokinetics of praziquantel: a review of variable drug exposure during schistosomiasis treatment in human hosts and experimental models. Plos Neglected Tropical Diseases 14(9): E0008649
von Bahr, C.; Groth, C.G.; Jansson, H.; Lundgren, G.; Lind, M.; Glaumann, H. 1980: Drug metabolism in human liver in vitro: establishment of a human liver bank. Clinical Pharmacology and Therapeutics 27(6): 711-725
Richter, E.; Epping, J.; Fuchshofen-Röckel, M.; Heusler, H.; Zilly, W. 1980: Drug metabolism in patients with liver disease. Leber Magen Darm 10(5): 234-240
Khokhar, J.Y.; Tyndale, R.F. 2011: Drug metabolism within the brain changes drug response: selective manipulation of brain CYP2B alters propofol effects. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 36(3): 692-700
Nebert, D.W. 1990: Drug metabolism. Growth signal pathways. Nature 347(6295): 709-710
Krynetski, E.; Evans, W.E. 2003: Drug methylation in cancer therapy: lessons from the TPMT polymorphism. Oncogene 22(47): 7403-7413
Nguipdop-Djomo, P.; Rodrigues, L.C.; Smith, P.G.; Abubakar, I.; Mangtani, P. 2020: Drug misuse, tobacco smoking, alcohol and other social determinants of tuberculosis in UK-born adults in England: a community-based case-control study. Scientific Reports 10(1): 5639
Viny, A.D.; Levine, R.L. 2020: Drug modulation by nuclear condensates. Science 368(6497): 1314-1315
Rüther, E.; Benkert, O.; Eckmann, F.; Eckmann, I.; Grohmann, R.; Helmchen, H.; Hippius, H.; Müller-Oerlinghausen, B.; Poser, W.; Schmidt, L.; Stille, G.; Strauss, A.; Uberla, K. 1980: Drug monitoring in psychiatry. Arzneimittel-Forschung 30(8): 1181-1183
Ge, L.; Yu, J. 2014: Drug monitoring: bright lights yield drug readout. Nature Chemical Biology 10(7): 490-491
Zintchenko, A.; Susha, A.S.; Concia, M.; Feldmann, J.; Wagner, E.; Rogach, A.L.; Ogris, M. 2009: Drug nanocarriers labeled with near-infrared-emitting quantum dots (quantoplexes): imaging fast dynamics of distribution in living animals. Molecular Therapy: the Journal of the American Society of Gene Therapy 17(11): 1849-1856
Rehman, A.; Jafari, S.M.; Tong, Q.; Riaz, T.; Assadpour, E.; Aadil, R.M.; Niazi, S.; Khan, I.M.; Shehzad, Q.; Ali, A.; Khan, S. 2020: Drug nanodelivery systems based on natural polysaccharides against different diseases. Advances in Colloid and Interface Science 284: 102251
Tevaarwerk, J.M. 1993: Drug nomenclature: suggestions for change. Cmaj: Canadian Medical Association Journal 148(5): 714-715
Essayagh, T.; Essayagh, M.; Essayagh, S. 2021: Drug non-adherence in hypertensive patients in Morocco, and its associated risk factors. European Journal of Cardiovascular Nursing 20(4): 324-330
Tideiksaar, R. 1984: Drug noncompliance in the elderly. Hospital Physician 20(3): 92
Iida, K. 1999: Drug of nitrate and nitrite. Nihon Rinsho. Japanese Journal of Clinical Medicine 57 Suppl: 394-396
Gallagher, M.J.; Clearkin, L.G. 2000: Drug or drusen? Central retinal vein occlusion in a young healthy woman with disc drusen. Eye 14: 401-402
Verlinde, C.L.; Dijkstra, B.W. 1995: Drug or tool, design or serendipity?. Nature Structural Biology 2(6): 429-432
Gan, W.Q.; Buxton, J.A.; Palis, H.; Janjua, N.Z.; Scheuermeyer, F.X.; Xavier, C.é G.; Zhao, B.; Desai, R.; Slaunwhite, A.K. 2021: Drug overdose and the risk of cardiovascular diseases: a nested case-control study. Clinical Research in Cardiology: Official Journal of the German Cardiac Society 2021
Cano, M.; Gelpí-Acosta, C. 2021: Drug overdose mortality among stateside Puerto Ricans: Evidence of a health disparity. International Journal on Drug Policy 90: 103079
Storflor, J.Guldteig.; Pettersen, L.Carina.; Slørdal, L.; Spigset, O. 2013: Drug package inserts--varying information for the same medicines. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 133(9): 955-959
Butler, D. 2009: Drug patent plan gets mixed reviews. Nature 457(7233): 1064
Patel, J.P.; Spiller, S.E.; Barker, E.D. 2021: Drug penetration in pediatric brain tumors: Challenges and opportunities. Pediatric Blood and Cancer 68(6): E28983
Minchinton, A.I.; Tannock, I.F. 2006: Drug penetration in solid tumours. Nature Reviews. Cancer 6(8): 583-592
Fang, M.; Richardson, B.; Cameron, C.M.; Dazard, J.-E.; Cameron, M.J. 2021: Drug perturbation gene set enrichment analysis (dpGSEA): a new transcriptomic drug screening approach. Bmc Bioinformatics 22(1): 22
DeFrancesco, L. 2019: Drug pipeline 1Q19. Nature Biotechnology 37(6): 579-580
DeFrancesco, L. 2020: Drug pipeline 1Q20. Nature Biotechnology 38(5): 519-520
DeFrancesco, L. 2021: Drug pipeline 1Q21-the old and the new. Nature Biotechnology 39(5): 536-537
DeFrancesco, L. 2017: Drug pipeline 2Q17. Nature Biotechnology 35(8): 703
DeFrancesco, L. 2020: Drug pipeline 2Q20. Nature Biotechnology 38(8): 913-914
DeFrancesco, L. 2021: Drug pipeline 2Q21-accelerated approvals to the fore. Nature Biotechnology 39(8): 904-905
DeFrancesco, L. 2017: Drug pipeline 3Q17. Nature Biotechnology 35(12): 1125
DeFrancesco, L. 2018: Drug pipeline 3Q18. Nature Biotechnology 36(12): 1132
DeFrancesco, L. 2019: Drug pipeline 3Q19. Nature Biotechnology 37(12): 1392-1393
DeFrancesco, L. 2020: Drug pipeline 3Q20. Nature Biotechnology 38(11): 1230-1231
DeFrancesco, L. 2014: Drug pipeline 4Q13. Nature Biotechnology 32(2): 125
DeFrancesco, L. 2020: Drug pipeline 4Q19. Nature Biotechnology 38(2): 124-125
DeFrancesco, L. 2016: Drug pipeline Q4 2015. Nature Biotechnology 34(2): 128
Dolgin, E. 2012: Drug pipeline is flush with new options for chronic constipation. Nature Medicine 18(9): 1308-1309
Mak, C. 2012: Drug pipeline: 1Q12. Nature Biotechnology 30(5): 383
DeFrancesco, L. 2013: Drug pipeline: 1Q13. Nature Biotechnology 31(6): 482
DeFrancesco, L. 2015: Drug pipeline: 1Q15. Nature Biotechnology 33(6): 580
DeFrancesco, L. 2016: Drug pipeline: 1Q16. Nature Biotechnology 34(5): 457
DeFrancesco, L. 2017: Drug pipeline: 1Q17. Nature Biotechnology 35(5): 400
DeFrancesco, L. 2018: Drug pipeline: 1Q18. Nature Biotechnology 36(5): 386
DeFrancesco, L. 2014: Drug pipeline: 2Q14. Nature Biotechnology 32(8): 710
DeFrancesco, L. 2015: Drug pipeline: 2Q15. Nature Biotechnology 33(8): 795
DeFrancesco, L. 2016: Drug pipeline: 2Q16. Nature Biotechnology 34(8): 799
DeFrancesco, L. 2018: Drug pipeline: 2Q18. Nature Biotechnology 36(8): 677
DeFrancesco, L. 2019: Drug pipeline: 2Q19. Nature Biotechnology 37(8): 840-841
DeFrancesco, L. 2015: Drug pipeline: 3Q15. Nature Biotechnology 33(11): 1126
DeFrancesco, L. 2016: Drug pipeline: 3Q16. Nature Biotechnology 34(11): 1089
DeFrancesco, L. 2015: Drug pipeline: 4Q14. Nature Biotechnology 33(2): 124
DeFrancesco, L. 2017: Drug pipeline: 4Q16. Nature Biotechnology 35(2): 107
DeFrancesco, L. 2018: Drug pipeline: 4Q17. Nature Biotechnology 36(2): 130
DeFrancesco, L. 2019: Drug pipeline: 4Q18. Nature Biotechnology 37(3): 206-208
Peng, W. 2011: Drug pipeline: Q111. Nature Biotechnology 29(5): 383
Peng, W. 2010: Drug pipeline: Q210. Nature Biotechnology 28(7): 640
DeFrancesco, L. 2012: Drug pipeline: Q212. Nature Biotechnology 30(9): 817
Peng, W. 2010: Drug pipeline: Q310. Nature Biotechnology 28(10): 998
Peng, W. 2011: Drug pipeline: Q311. Nature Biotechnology 29(10): 859
DeFrancesco, L. 2012: Drug pipeline: Q312. Nature Biotechnology 30(12): 1164
Peng, W. 2011: Drug pipeline: Q410. Nature Biotechnology 29(2): 101
Mak, H.Craig. 2012: Drug pipeline: Q411. Nature Biotechnology 30(1): 15
Todrick, A. 1971: Drug plasma levels and clinical effect. Proceedings of the Royal Society of Medicine 64(3): 290
Shotar, A.M. 2005: Drug poisoning in childhood. Saudi Medical Journal 26(12): 1948-1950
Domingo-Echaburu, S.; Dávalos, L.M.; Orive, G.; Lertxundi, U. 2021: Drug pollution and Sustainable Development Goals. Science of the Total Environment 800: 149412
Sloane, P.; Lekan-Rutledge, D. 1988: Drug prescribing by telephone: a potential cause of polypharmacy in nursing homes. Journal of the American Geriatrics Society 36(6): 574-575
Lamy, P.P. 1981: Drug prescribing for the elderly. Bulletin of the new York Academy of Medicine 57(8): 718-730
Ouslander, J.G. 1981: Drug prescribing for the elderly. Western Journal of Medicine 135(6): 455-462
Cayley, A.C. 1985: Drug prescribing in the elderly. British Journal of Hospital Medicine 34(6): 355-357
Liabeuf, S.; Laville, M. 2021: Drug prescription in patients with chronic kidney disease: a true challenge. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 36(3): 385-386
Emeriau, J.P.; Fourrier, A.; Dartigues, J.F.; Begaud, B. 1998: Drug prescriptions for the elderly. Bulletin de l'Academie Nationale de Medecine 182(7): 1419-1428; Discussion: 1428-1429
Hügel, A.; Hügel, I. 1989: Drug prescriptions in general practice. Zeitschrift für Arztliche Fortbildung 83(22): 1111-1113
Pasina, L.; Novella, A.; Cortesi, L.; Nobili, A.; Tettamanti, M.; Ianes, A. 2020: Drug prescriptions in nursing home residents: an Italian multicenter observational study. European Journal of Clinical Pharmacology 76(7): 1011-1019
Ehsani, J.P.; Michael, J.P.; Duren, M.; Shields, W.C.; Compton, R.P.; Fowler, D.; Smith, G. 2021: Drug presence in driving deaths in Maryland: Comparing trends and prevalence in medical examiner and FARS data. Accident; Analysis and Prevention 154: 106066
Bosch, X. 2001: Drug price deal spells windfall for researchers. Nature 414(6860): 138
Leite, S.N.; Ribeiro, A.A.; Pontes, M.A.; Vargas de Moraes, R. 2020: Drug price transparency initiative: the need for a broader view. Research in Social and Administrative Pharmacy: Rsap 16(9): 1324-1325
Ramsey, S. 2017: Drug pricing should depend on shared values. Nature 552(7685): S78
Ramsey, S. 2017: Drug pricing should depend on shared values. Nature 552(7685): S78
Malas, T.B.; Vlietstra, W.J.; Kudrin, R.; Starikov, S.; Charrout, M.; Roos, M.; Peters, D.J.M.; Kors, J.A.; Vos, R.; 't Hoen, P.A.C.; van Mulligen, E.M.; Hettne, K.M. 2019: Drug prioritization using the semantic properties of a knowledge graph. Scientific Reports 9(1): 6281
Tosh, S. 2021: Drug prohibition and the criminalization of immigrants: the compounding of drug war disparities in the United States deportation regime. International Journal on Drug Policy 87: 102846
Blue, B.A. 1992: Drug promotion and scientific exchange. New England Journal of Medicine 326(2): 133; Author Reply 134
Vogel, R.M. 1992: Drug promotion and scientific exchange. New England Journal of Medicine 326(2): 134
Budiansky, S. 1982: Drug promotion. FDA steps in. Nature 298(5877): 784-785
Vanholder, R.; Van Landschoot, N.; De Smet, R.; Schoots, A.; Ringoir, S. 1988: Drug protein binding in chronic renal failure: evaluation of nine drugs. Kidney International 33(5): 996-1004
Abreu, S.; Castelblanco-Arango, I.Y.; Gómez-Pineda, P.A.; Cardona, R. 2020: Drug provocation tests to identify analgesic alternatives for an infant with Stevens-Johnson syndrome caused by ibuprofen-acetaminophen. Revista Alergia Mexico 67(2): 189-195
Cortes, A.; Park, M.; McCarthy, B.C. 2021: Drug purchase price volatility in an academic medical center. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 78(Suppl_2): S33-S37
MacSweeney, D.; Parr, D. 1970: Drug pushers in the United Kingdom. Nature 228(5270): 422-424
Gerdes, H.; Casado, P.; Dokal, A.; Hijazi, M.; Akhtar, N.; Osuntola, R.; Rajeeve, V.; Fitzgibbon, J.; Travers, J.; Britton, D.; Khorsandi, S.; Cutillas, P.R. 2021: Drug ranking using machine learning systematically predicts the efficacy of anti-cancer drugs. Nature Communications 12(1): 1850
Lobo, I.ês.; Ferreira, M.ár.; Velho, G.ór.; Sanches, M.; Selores, M. 2008: Drug rash with eosinophilia and systemic symptoms (DRESS syndrome). Acta Medica Portuguesa 21(4): 367-372
Gordon, J.S.; Neyman, K.M.; Wells, R.D.; Chen, S.C. 2012: Drug rash with eosinophilia and systemic symptoms (DRESS syndrome). Cutis 89(4): 180-182
López-Anglada, L.; Vázquez, L.; Pérez-Simón, J.A.; Dávila, I.; Santos-Briz, A.; García, L.; Caballero, D. 2011: Drug rash with eosinophilia and systemic symptoms (DRESS) after an unrelated donor BM transplant. Bone Marrow Transplantation 46(11): 1487-1488
Trivedi, A.; Sharma, S.; Govindan, R. 2022: Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome in a paediatric patient taking zonisamide. European Journal of Hospital Pharmacy: Science and Practice 29(4): 231-234
Kerkemeyer, K.L.S.; Lee, S.; Lai, F.Y.X.; Mar, A. 2020: Drug rash with eosinophilia and systemic symptoms syndrome without eosinophilia managed with intravenous immunoglobulin. Internal Medicine Journal 50(9): 1156-1157
Ramirez, G.A.; Della-Torre, E.; Tresoldi, M.; Scarpellini, P.; Ciceri, F.; Dagna, L.; Yacoub, M.-R. 2021: Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 27(8): 1190-1192
Cardones, A.R. 2020: Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. Clinics in Dermatology 38(6): 702-711
Guerrero Gómez, D.A.; París Zorro, S.; Aponte Barrios, W.; Carrillo Bayona, J.A. 2020: Drug reaction with eosinophilia and systemic symptoms (DRESS) with severe and atypical lung involvement. Radiology Case Reports 15(11): 2178-2182
Sandhu, S.; Neema, S.; Vashisht, D.; Venugopal, R.; Sengupta, P.; Radhakrishnan, S. 2021: Drug reaction with eosinophilia and systemic symptoms: a single center descriptive observational study. Dermatologic Therapy 34(1): E14670
Herman, A.; Matthews, M.; Mairlot, M.; Nobile, L.; Fameree, L.; Jacquet, L.-M.; Baeck, M. 2020: Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19. Journal of the European Academy of Dermatology and Venereology: Jeadv 34(12): E768
Menteşoğlu, D.; Doğan Günaydın, S.; Ersoy-Evans, S. 2020: Drug reaction with eosinophilia and systemic symptoms syndrome induced by apixaban. Dermatologic Therapy 33(4): E13719
Wollina, U.; Abdel-Naser, M.B. 2020: Drug reactions affecting hair and nails. Clinics in Dermatology 38(6): 693-701
D'Arcy, P.F. 1987: Drug reactions and interactions. Journal de Pharmacie de Belgique 42(3): 221-224
D'Arcy, P.F. 1987: Drug reactions and interactions. Journal de Pharmacie de Belgique 42(6): 404-408
D'Arcy, P.F. 1988: Drug reactions and interactions. Journal de Pharmacie de Belgique 43(3): 233-236
D'Arcy, P.F. 1987: Drug reactions and interactions. Journal de Pharmacie de Belgique 42(2): 152-159
Renoz, L. 1984: Drug reactions and interactions. Journal de Pharmacie de Belgique 39(1): 63-65
Scrace, B.; Fityan, A.; Bigham, C. 2020: Drug reactions with eosinophilia and systemic symptoms. Bja Education 20(2): 65-71
Byron, J.W. 1973: Drug receptors and the haemopoietic stem cell. Nature: new Biology 241(109): 152-154
Bennett, J. 1980: Drug receptors and their effectors. Nature 285(5762): 192-193
Rang, H.P. 1971: Drug receptors and their function. Nature 231(5298): 91-96
Black, J.W.; Shankley, N.P. 1995: Drug receptors. Inverse agonists exposed. Nature 374(6519): 214-215
Flower, R. 2002: Drug receptors: a long engagement. Nature 415(6872): 587
Kuczynski, E.A.; Sargent, D.J.; Grothey, A.; Kerbel, R.S. 2013: Drug rechallenge and treatment beyond progression--implications for drug resistance. Nature Reviews. Clinical Oncology 10(10): 571-587
Lemprière, S. 2019: Drug reduces excess iron in ultra-rare neurodegenerative disease. Nature Reviews. Neurology 15(9): 492-493
Sanderson, L.; da Silva, M.; Sekhar, G.N.; Brown, R.C.; Burrell-Saward, H.; Fidanboylu, M.; Liu, B.; Dailey, L.A.; Dreiss, C.éc.A.; Lorenz, C.; Christie, M.; Persaud, S.J.; Yardley, V.; Croft, S.L.; Valero, M.; Thomas, S.A. 2021: Drug reformulation for a neglected disease. the NANOHAT project to develop a safer more effective sleeping sickness drug. Plos Neglected Tropical Diseases 15(4): E0009276
Lee, B-Yu.; Clemens, D.L.; Silva, A.; Dillon, B.Jane.; Masleša-Galić, Sša.; Nava, S.; Ding, X.; Ho, C-Ming.; Horwitz, M.A. 2017: Drug regimens identified and optimized by output-driven platform markedly reduce tuberculosis treatment time. Nature Communications 8: 14183
Dickson, D. 1980: Drug regulations: signs change. Nature 285(5765): 430-431
Saiz, L.Carlos.; Alvarez, Jús.; Martínez, H. 2011: Drug regulatory agencies' role in the interaction between clopidogrel and proton pump inhibitors. American Journal of Gastroenterology 106(7): 1369-1370
Aldhous, P. 2005: Drug rehabilitation: cold turkey, Vietnamese style. Nature 433(7026): 568-569
Ruangritchankul, S.; Peel, N.M.; Hanjani, L.S.; Gray, L.C. 2020: Drug related problems in older adults living with dementia. Plos one 15(7): E0236830
Bi, H.; Chen, Z.; Qiu, J. 2021: Drug release and magneto-calorific analysis of magnetic lipid microcapsules for potential cancer therapeutics. Designed Monomers and Polymers 24(1): 156-161
Asare-Addo, K.; Totea, A.-M.; Nokhodchi, A. 2020: Drug release from magnesium aluminium silicate-polyethylene oxide (PEO) nanocomposite matrices: An investigation using the USP IIi apparatus. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 153: 105474
Sagan, J.ří 2020: Drug repositioning - antibiotics as cytostatics. Klinicka Mikrobiologie a Infekcni Lekarstvi 26(4): 138-139
Bibi, N.; Farid, A.; Gul, S.; Ali, J.; Amin, F.; Kalthiya, U.; Hupp, T. 2021: Drug repositioning against COVID-19: a first line treatment. Journal of Biomolecular Structure and Dynamics 2021: 1-15
Ballard, C.; Aarsland, D.; Cummings, J.; O'Brien, J.; Mills, R.; Molinuevo, J.Luis.; Fladby, T.; Williams, G.; Doherty, P.; Corbett, A.; Sultana, J. 2020: Drug repositioning and repurposing for Alzheimer disease. Nature Reviews. Neurology 16(12): 661-673
Khanjani, F.; Jafari, L.; Azadiyan, S.; Roozbehi, S.; Moradian, C.; Zahiri, J.; Hasannia, S.; Sajedi, R.H. 2021: Drug repositioning based on gene expression data for human HER2-positive breast cancer. Archives of Biochemistry and Biophysics 712: 109043
Gao, H.; Ni, Y.; Mo, X.; Li, D.; Teng, S.; Huang, Q.; Huang, S.; Liu, G.; Zhang, S.; Tang, Y.; Lu, L.; Liang, H. 2021: Drug repositioning based on network-specific core genes identifies potential drugs for the treatment of autism spectrum disorder in children. Computational and Structural Biotechnology Journal 19: 3908-3921
Meng, Y.; Jin, M.; Tang, X.; Xu, J. 2021: Drug repositioning based on similarity constrained probabilistic matrix factorization: COVID-19 as a case study. Applied Soft Computing 103: 107135
Deepthi, K.; Jereesh, A.S. 2020: Drug repositioning based on the target micro RNAs using bilateral-inductive matrix completion. Molecular Genetics and Genomics: Mgg 295(5): 1305-1314
Lucchetta, M.; Pellegrini, M. 2021: Drug repositioning by merging active subnetworks validated in cancer and COVID-19. Scientific Reports 11(1): 19839
Alamgir, J.; Yajima, M.; Ergas, R.; Chen, X.; Hill, N.; Munir, N.; Saeed, M.; Gersing, K.; Haendel, M.; Chute, C.G.; Abid, M.R. 2021: Drug repositioning candidates identified using in-silico quasi-quantum molecular simulation demonstrate reduced COVID-19 mortality in 1.5M patient records. Medrxiv: the Preprint Server for Health Sciences 2021
Corbett, A.; Pickett, J.; Burns, A.; Corcoran, J.; Dunnett, S.B.; Edison, P.; Hagan, J.J.; Holmes, C.; Jones, E.; Katona, C.; Kearns, I.; Kehoe, P.; Mudher, A.; Passmore, A.; Shepherd, N.; Walsh, F.; Ballard, C. 2012: Drug repositioning for Alzheimer's disease. Nature Reviews. Drug Discovery 11(11): 833-846
Amemiya, T.; Gromiha, M.Michael.; Horimoto, K.; Fukui, K. 2019: Drug repositioning for dengue haemorrhagic fever by integrating multiple omics analyses. Scientific Reports 9(1): 523
Lüscher Dias, T.; Schuch, V.; Beltrão-Braga, Pícia.Cristina.Baleeiro.; Martins-de-Souza, D.; Brentani, H.Paula.; Franco, Gória.Regina.; Nakaya, H.Imoto. 2020: Drug repositioning for psychiatric and neurological disorders through a network medicine approach. Translational Psychiatry 10(1): 141
Fabbri, C.; Kasper, S.; Zohar, J.; Souery, D.; Montgomery, S.; Albani, D.; Forloni, G.; Ferentinos, P.; Rujescu, D.; Mendlewicz, J.; De Ronchi, D.; Riva, M.Andrea.; Lewis, C.M.; Serretti, A. 2021: Drug repositioning for treatment-resistant depression: Hypotheses from a pharmacogenomic study. ProgressinNeuro-PsychopharmacologyandBiologicalPsychiatry 104: 110050
Nilbert, M.; Mellemkjær, L. 2020: Drug repositioning in cancer: a role for antihistamines in breast cancer?. Acta Oncologica 59(9): 1007-1008
Bouscary, A.; Quessada, C.; René, F.éd.ér.; Spedding, M.; Henriques, A.; Ngo, S.; Loeffler, J.-P. 2020: Drug repositioning in neurodegeneration: An overview of the use of ambroxol in neurodegenerative diseases. European Journal of Pharmacology 884: 173446
Sekiguchi, M.; Sagano, N.; Kawazoe, H.; Hiraga, Y.; Jibiki, A.; Yokoyama, Y.; Suzuki, S.; Nakamura, T. 2021: Drug repositioning of antipsychotic drugs for cisplatin-induced pica behavior in mice. Die Pharmazie 76(10): 484-487
Rauschenbach, L.èl.; Wieland, A.; Reinartz, R.; Kebir, S.; Till, A.; Darkwah Oppong, M.; Dobersalske, C.; Ullrich, V.; Ahmad, A.; Jabbarli, R.; Pierscianek, D.; Fröhlich, H.; Simon, M.; Brüstle, O.; Sure, U.; Glas, M.; Scheffler, B.ör. 2020: Drug repositioning of antiretroviral ritonavir for combinatorial therapy in glioblastoma. European Journal of Cancer 140: 130-139
Parisi, D.; Adasme, M.F.; Sveshnikova, A.; Bolz, S.N.; Moreau, Y.; Schroeder, M. 2020: Drug repositioning or target repositioning: a structural perspective of drug-target-indication relationship for available repurposed drugs. Computational and Structural Biotechnology Journal 18: 1043-1055
Metin, R.; Akten, E.Demet. 2021: Drug repositioning to propose alternative modulators for glucocorticoid receptor through structure-based virtual screening. Journal of Biomolecular Structure and Dynamics 2021: 1-16
Ashburn, T.T.; Thor, K.B. 2004: Drug repositioning: identifying and developing new uses for existing drugs. Nature Reviews. Drug Discovery 3(8): 673-683
Ciliberto, G.; Mancini, R.; Paggi, M.G. 2020: Drug repurposing against COVID-19: focus on anticancer agents. Journal of Experimental and Clinical Cancer Research: Cr 39(1): 86
Kumar, V.; Liu, H.; Wu, C. 2021: Drug repurposing against SARS-CoV-2 receptor binding domain using ensemble-based virtual screening and molecular dynamics simulations. Computers in Biology and Medicine 135: 104634
Arun, K.G.; Sharanya, C.S.; Abhithaj, J.; Francis, D.; Sadasivan, C. 2020: Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target. Journal of Biomolecular Structure and Dynamics 2020: 1-12
Heimfarth, L.; Serafini, M.R.; Martins-Filho, P.R.; Quintans, J.d.S.S.; Quintans-Júnior, L.J.é 2020: Drug repurposing and cytokine management in response to COVID-19: a review. International Immunopharmacology 88: 106947
Nath, J.; Paul, R.; Ghosh, S.K.; Paul, J.; Singha, B.; Debnath, N. 2020: Drug repurposing and relabeling for cancer therapy: Emerging benzimidazole antihelminthics with potent anticancer effects. Life Sciences 258: 118189
Lundström-Stadelmann, B.; Rufener, R.; Hemphill, A. 2020: Drug repurposing applied: Activity of the anti-malarial mefloquine against Echinococcus multilocularis. International Journal for Parasitology. Drugs and Drug Resistance 13: 121-129
Singh, T.U.; Parida, S.; Lingaraju, M.C.; Kesavan, M.; Kumar, D.; Singh, R.K. 2020: Drug repurposing approach to fight COVID-19. Pharmacological Reports: Pr 72(6): 1479-1508
Thirunavukkarasu, M.Kumar.; Karuppasamy, R. 2021: Drug repurposing combined with MM/PBSA based validation strategies towards MEK inhibitors screening. Journal of Biomolecular Structure and Dynamics 2021: 1-12
Williams, G.; Gatt, A.; Clarke, E.; Corcoran, J.; Doherty, P.; Chambers, D.; Ballard, C. 2019: Drug repurposing for Alzheimer's disease based on transcriptional profiling of human iPSC-derived cortical neurons. Translational Psychiatry 9(1): 220
Kumar, N.; Gahlawat, A.; Kumar, R.Naresh.; Singh, Y.Pal.; Modi, G.; Garg, P. 2020: Drug repurposing for Alzheimer's disease: in silico and in vitro investigation of FDA-approved drugs as acetylcholinesterase inhibitors. Journal of Biomolecular Structure and Dynamics 2020: 1-15
Gupta, R.K.; Nwachuku, E.L.; Zusman, B.E.; Jha, R.M.; Puccio, A.M. 2021: Drug repurposing for COVID-19 based on an integrative meta-analysis of SARS-CoV-2 induced gene signature in human airway epithelium. Plos one 16(9): E0257784
Loucera, C.; Esteban-Medina, M.; Rian, K.; Falco, Mías.M.; Dopazo, Jín.; Peña-Chilet, Mía. 2020: Drug repurposing for COVID-19 using machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection. Signal Transduction and Targeted Therapy 5(1): 290
Ng, Y.L.; Salim, C.K.; Chu, J.J.H. 2021: Drug repurposing for COVID-19: Approaches, challenges and promising candidates. Pharmacology and Therapeutics 228: 107930
Trindade, J.D.'A.S.; Freire-de-Lima, C.él.G.; Côrte-Real, S.; Decote-Ricardo, D.; Freire de Lima, M.E. 2021: Drug repurposing for Chagas disease: in vitro assessment of nimesulide against Trypanosoma cruzi and insights on its mechanisms of action. Plos one 16(10): E0258292
Rampioni, G.; Visca, P.; Leoni, L.; Imperi, F. 2017: Drug repurposing for antivirulence therapy against opportunistic bacterial pathogens. Emerging Topics in Life Sciences 1(1): 13-22
Tran, A.A.; Prasad, V. 2020: Drug repurposing for cancer treatments: a well-intentioned, but misguided strategy. LANCET. Oncology 21(9): 1134-1136
Rai, S.; Bhatia, V.; Bhatnagar, S. 2021: Drug repurposing for hyperlipidemia associated disorders: An integrative network biology and machine learning approach. Computational Biology and Chemistry 92: 107505
Behera, S.K.; Mahapatra, N.; Tripathy, C.S.; Pati, S. 2021: Drug repurposing for identification of potential inhibitors against SARS-CoV-2 spike receptor-binding domain: An in silico approach. Indian Journal of Medical Research 153(1; 2: 132-143
Bharadwaj, S.; Dubey, A.; Kamboj, N.Kumar.; Sahoo, A.Kumar.; Kang, S.Gu.; Yadava, U. 2021: Drug repurposing for ligand-induced rearrangement of Sirt2 active site-based inhibitors via molecular modeling and quantum mechanics calculations. Scientific Reports 11(1): 10169
Liu, Y.; Tong, Z.; Shi, J.; Li, R.; Upton, M.; Wang, Z. 2021: Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria. Theranostics 11(10): 4910-4928
Ezebuo, F.C.; Uzochukwu, I.C. 2020: Drug repurposing for schistosomiasis: molecular docking and dynamics investigations. Journal of Biomolecular Structure and Dynamics 2020: 1-15
Batalha, P.N.; Forezi, L.S.M.; Lima, C.G.S.; Pauli, F.P.; Boechat, F.C.S.; de Souza, M.C.íl.B.V.; Cunha, A.C.; Ferreira, V.F.; da Silva, F.d.C. 2021: Drug repurposing for the treatment of COVID-19: Pharmacological aspects and synthetic approaches. Bioorganic Chemistry 106: 104488
Rivero-García, Iés.; Castresana-Aguirre, M.; Guglielmo, L.; Guala, D.; Sonnhammer, E.L.L. 2021: Drug repurposing improves disease targeting 11-fold and can be augmented by network module targeting, applied to COVID-19. Scientific Reports 11(1): 20687
Srivastava, K.; Singh, M.K. 2021: Drug repurposing in COVID-19: a review with past, present and future. Metabolism Open 12: 100121
Mao, Z.; Valluru, M.K.; Ong, A.C.M. 2021: Drug repurposing in autosomal dominant polycystic kidney disease: back to the future with pioglitazone. Clinical Kidney Journal 14(7): 1715-1718
van Driel, B.O.; van der Velden, J. 2020: Drug repurposing in cardiology. Netherlands Heart Journal: Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2020: 1-2
Karatzas, E.; Bourdakou, M.M.; Kolios, G.; Spyrou, G.M. 2017: Drug repurposing in idiopathic pulmonary fibrosis filtered by a bioinformatics-derived composite score. Scientific Reports 7(1): 12569
Bouche, G.; Gedye, C.; Meheus, L.; Pantziarka, P. 2020: Drug repurposing in oncology. LANCET. Oncology 21(12): E542
Frantzi, M.; Latosinska, A.; Mokou, M.; Mischak, H.; Vlahou, A. 2020: Drug repurposing in oncology. LANCET. Oncology 21(12): E543
Bertolini, F.; Sukhatme, V.P.; Bouche, G. 2015: Drug repurposing in oncology--patient and health systems opportunities. Nature Reviews. Clinical Oncology 12(12): 732-742
Vassileva, S.; Mateeva, V.; Drenovska, K. 2021: Drug repurposing of dermatologic medications to treat coronavirus disease 2019: Science or fiction?. Clinics in Dermatology 39(3): 430-445
Mahmoud, D.B.; Shitu, Z.; Mostafa, A. 2020: Drug repurposing of nitazoxanide: can it be an effective therapy for COVID-19?. Journal Genetic Engineering and Biotechnology 18(1): 35
Sun, J.; Yogarajah, T.; Lee, R.Ching.Hua.; Kaur, P.; Inoue, M.; Tan, Y.Wah.; Chu, J.Jang.Hann. 2020: Drug repurposing of pyrimidine analogs as potent antiviral compounds against human enterovirus A71 infection with potential clinical applications. Scientific Reports 10(1): 8159
Pashaei, Y. 2021: Drug repurposing of selective serotonin reuptake inhibitors: could these drugs help fight COVID-19 and save lives?. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 88: 163-172
Drayman, N.; Jones, K.A.; Azizi, S.-A.; Froggatt, H.M.; Tan, K.; Maltseva, N.I.; Chen, S.; Nicolaescu, V.; Dvorkin, S.; Furlong, K.; Kathayat, R.S.; Firpo, M.R.; Mastrodomenico, V.; Bruce, E.A.; Schmidt, M.M.; Jedrzejczak, R.; Muñoz-Alía, M.Á; Schuster, B.; Nair, V.; Botten, J.W.; Brooke, C.B.; Baker, S.C.; Mounce, B.C.; Heaton, N.S.; Dickinson, B.C.; Jaochimiak, A.; Randall, G.; Tay, S.ş 2020: Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 in vitro. Biorxiv: the Preprint Server for Biology 2020
Bakowski, M.A.; Beutler, N.; Wolff, K.C.; Kirkpatrick, M.G.; Chen, E.; Nguyen, T-Trinh.H.; Riva, L.; Shaabani, N.; Parren, M.; Ricketts, J.; Gupta, A.K.; Pan, K.; Kuo, P.; Fuller, M.; Garcia, E.; Teijaro, J.R.; Yang, L.; Sahoo, D.; Chi, V.; Huang, E.; Vargas, N.; Roberts, A.J.; Das, S.; Ghosh, P.; Woods, A.K.; Joseph, S.B.; Hull, M.V.; Schultz, P.G.; Burton, D.R.; Chatterjee, A.K.; McNamara, C.W.; Rogers, T.F. 2021: Drug repurposing screens identify chemical entities for the development of COVID-19 interventions. Nature Communications 12(1): 3309
Dittmar, M.; Lee, J.S.; Whig, K.; Segrist, E.; Li, M.; Kamalia, B.; Castellana, L.; Ayyanathan, K.; Cardenas-Diaz, F.L.; Morrisey, E.E.; Truitt, R.; Yang, W.; Jurado, K.; Samby, K.; Ramage, H.; Schultz, D.C.; Cherry, S. 2021: Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2. Cell Reports 35(1): 108959
Fletcher, E.J.R.; Kaminski, T.; Williams, G.; Duty, S. 2021: Drug repurposing strategies of relevance for Parkinson's disease. Pharmacology Research and Perspectives 9(4): E00841
Koulgi, S.; Jani, V.; Uppuladinne, M.; Sonavane, U.; Nath, A.Kumar.; Darbari, H.; Joshi, R. 2020: Drug repurposing studies targeting SARS-CoV-2: an ensemble docking approach on drug target 3C-like protease (3CL pro ). Journal of Biomolecular Structure and Dynamics 2020: 1-21
Zouboulis, C.C.; Nogueira da Costa, A. 2021: Drug repurposing through drug-gene interaction profiles for hidradenitis suppurativa/acne inversa treatment. Journal of the European Academy of Dermatology and Venereology: Jeadv 35(4): E251-E254
Kingsmore, K.M.; Grammer, A.C.; Lipsky, P.E. 2020: Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases. Nature Reviews. Rheumatology 16(1): 32-52
Mahdian, S.; Ebrahim-Habibi, A.; Zarrabi, M. 2020: Drug repurposing using computational methods to identify therapeutic options for COVID-19. Journal of Diabetes and Metabolic Disorders 19(2): 691-699
Zeng, X.; She, P.; Zhou, L.; Li, S.; Hussain, Z.; Chen, L.; Wu, Y. 2021: Drug repurposing: Antimicrobial and antibiofilm effects of penfluridol against Enterococcus faecalis. Microbiologyopen 10(1): E1148
Crunkhorn, S. 2018: Drug repurposing: Heart failure drug effective in medulloblastoma. Nature Reviews. Drug Discovery 17(12): 864
Sonaye, H.V.; Sheikh, R.Y.; Doifode, C.A. 2021: Drug repurposing: Iron in the fire for older drugs. Biomedicine and PharmacoTherapy 141: 111638
Begley, C.G.; Ashton, M.; Baell, J.; Bettess, M.; Brown, M.P.; Carter, B.; Charman, W.N.; Davis, C.; Fisher, S.; Frazer, I.; Gautam, A.; Jennings, M.P.; Kearney, P.; Keeffe, E.; Kelly, D.; Lopez, A.F.; McGuckin, M.; Parker, M.W.; Rayner, C.; Roberts, B.; Rush, J.S.; Sullivan, M. 2021: Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers. Science Translational Medicine 13(612): Eabd 5524
Pertusati, F.; Pileggi, E.; Richards, J.; Wootton, M.; Van Leemputte, T.; Persoons, L.; De Coster, D.; Villanueva, X.; Daelemans, D.; Steenackers, H.; McGuigan, C.; Serpi, M. 2020: Drug repurposing: phosphate prodrugs of anticancer and antiviral FDA-approved nucleosides as novel antimicrobials. Journal of Antimicrobial ChemoTherapy 75(10): 2864-2878
Pushpakom, S.; Iorio, F.; Eyers, P.A.; Escott, K.Jane.; Hopper, S.; Wells, A.; Doig, A.; Guilliams, T.; Latimer, J.; McNamee, C.; Norris, A.; Sanseau, P.; Cavalla, D.; Pirmohamed, M. 2019: Drug repurposing: progress, challenges and recommendations. Nature Reviews. Drug Discovery 18(1): 41-58
Nam, G.; Suh, J.-M.; Yi, Y.; Lim, M.H. 2021: Drug repurposing: small molecules against Cu(II)-amyloid-β and free radicals. Journal of Inorganic Biochemistry 224: 111592
Sleire, L.; Skeie, B.S.; Netland, I.A.; Førde, H.E.; Dodoo, E.; Selheim, F.; Leiss, L.; Heggdal, J.I.; Pedersen, P-H.; Wang, J.; Enger, P.Ø. 2015: Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc-, leading to glutathione depletion. Oncogene 34(49): 5951-5959
Insel, T.R.; Sahakian, B.J. 2012: Drug research: a plan for mental illness. Nature 483(7389): 269
Kubinyi, H. 2003: Drug research: myths, hype and reality. Nature Reviews. Drug Discovery 2(8): 665-668
Schwab, M.E.; Buchli, A.D. 2012: Drug research: plug the real brain drain. Nature 483(7389): 267-268
Pilcher, H.R. 2003: Drug research: the ups and downs of lithium. Nature 425(6954): 118-120
Gewin, V. 2002: Drug researcher quits controversial cat study. Nature 417(6891): 778
Harrison, C. 2020: Drug researchers pursue new lines of attack against COVID-19. Nature Biotechnology 38(6): 659-662
Hazarika, M.; Prajna, N.V.; Senthilkumari, S. 2021: Drug reservoir function of voriconazole impregnated human amniotic membrane: An in vitro study. Indian Journal of Ophthalmology 69(5): 1068-1072
Sliutz, G.; Karlseder, J.; Tempfer, C.; Orel, L.; Holzer, G.; Simon, M.M. 1996: Drug resistance against gemcitabine and topotecan mediated by constitutive hsp70 overexpression in vitro: implication of quercetin as sensitiser in chemotherapy. British Journal of Cancer 74(2): 172-177
Hay, J.; Kirkness, C.M.; Seal, D.V.; Wright, P. 1994: Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy. Eye 8: 555-563
Li, Y.; Wang, Z.; Ajani, J.A.; Song, S. 2021: Drug resistance and Cancer stem cells. Cell Communication and Signaling: Ccs 19(1): 19
Wang, X.; Zhang, H.; Chen, X. 2019: Drug resistance and combating drug resistance in cancer. Cancer Drug Resistance 2: 141-160
Diriba, G.; Tola, H.H.; Alemu, A.; Yenew, B.; Gamtesa, D.F.; Kebede, A. 2021: Drug resistance and its risk factors among extrapulmonary tuberculosis in Ethiopia: a systematic review and meta-analysis. Plos one 16(10): E0258295
Anderson, E.S.; Lewis, M.J. 1965: Drug resistance and its transfer in Salmonella typhimurium. Nature 206(984): 579-583
Chatterjee, B.R. 1982: Drug resistance and multi-drug therapy in leprosy. Leprosy in India 54(3): 402-411
Arbab, S.; Ullah, H.; Wei, X.; Wang, W.; Ahmad, S.U.; Zhang, J. 2021: Drug resistance and susceptibility testing of Gram negative bacterial isolates from healthy cattle with different β - Lactam resistance Phenotypes from Shandong province China. Brazilian Journal of Biology 83: E247061
Berman, J.; Krysan, D.J. 2020: Drug resistance and tolerance in fungi. Nature Reviews. Microbiology 18(6): 319-331
Wang, Y.; Zhao, S.; Han, L.; Guo, X.; Chen, M.; Ni, Y.; Zhang, Y.; Cui, Z.; He, P. 2014: Drug resistance and virulence of uropathogenic Escherichia coli from Shanghai, China. Journal of Antibiotics 67(12): 799-805
Galmarini, C.M.; Kamath, K.; Vanier-Viornery, A.; Hervieu, V.; Peiller, E.; Falette, N.; Puisieux, A.; Ann Jordan, M.; Dumontet, C. 2003: Drug resistance associated with loss of p53 involves extensive alterations in microtubule composition and dynamics. British Journal of Cancer 88(11): 1793-1799
Radzio-Basu, J.; Council, O.; Cong, M-Er.; Ruone, S.; Newton, A.; Wei, X.; Mitchell, J.; Ellis, S.; Petropoulos, C.J.; Huang, W.; Spreen, W.; Heneine, W.; García-Lerma, J.Gerardo. 2019: Drug resistance emergence in macaques administered cabotegravir long-acting for pre-exposure prophylaxis during acute SHIV infection. Nature Communications 10(1): 2005
Nowacka, M.; Sterzynska, K.; Andrzejewska, M.; Nowicki, M.; Januchowski, R. 2021: Drug resistance evaluation in novel 3D in vitro model. Biomedicine and PharmacoTherapy 138: 111536
Mitsuhashi, S. 1968: Drug resistance factor-R. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 13(7): 643
Filipits, M.; Stranzl, T.; Pohl, G.; Heinzl, H.; Jäger, U.; Geissler, K.; Fonatsch, C.; Haas, O.A.; Lechner, K.; Pirker, R. 2000: Drug resistance factors in acute myeloid leukemia: a comparative analysis. Leukemia 14(1): 68-76
Zhao, J.; Zhang, H.; Lei, T.; Liu, J.; Zhang, S.; Wu, N.; Sun, B.; Wang, M. 2020: Drug resistance gene expression and chemotherapy sensitivity detection in Chinese women with different molecular subtypes of breast cancer. Cancer Biology and Medicine 17(4): 1014-1025
Liu, Q.; Yang, D.; Qiu, B.; Martinez, L.; Ji, Y.; Song, H.; Li, Z.; Wang, J. 2021: Drug resistance gene mutations and treatment outcomes in MDR-TB: a prospective study in Eastern China. Plos Neglected Tropical Diseases 15(1): E0009068
Beghin, J.-C.; Ruelle, J.; Goubau, P.; Van der Linden, D. 2020: Drug resistance in HIV-infected children living in rural South Africa: Implications of an antiretroviral therapy initiated during the first year of life. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 129: 104547
Jain 2000: Drug resistance in Helicobacter pylori infection. Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 19(Suppl 1): S38-S39
Johnson, R.; Streicher, E.M.; Louw, G.E.; Warren, R.M.; van Helden, P.D.; Victor, T.C. 2006: Drug resistance in Mycobacterium tuberculosis. Current Issues in Molecular Biology 8(2): 97-111
Haldar, K.; Bhattacharjee, S.; Safeukui, I. 2018: Drug resistance in Plasmodium. Nature Reviews. Microbiology 16(3): 156-170
Radha, S.; Murugesan, M.; Rupali, P. 2020: Drug resistance in Salmonella Typhi: implications for South Asia and travel. Current Opinion in Infectious Diseases 33(5): 347-354
Löscher, W.; Potschka, H. 2005: Drug resistance in brain diseases and the role of drug efflux transporters. Nature Reviews. Neuroscience 6(8): 591-602
Yagüe, E.; Raguz, S. 2005: Drug resistance in cancer. British Journal of Cancer 93(9): 973-976
Haider, T.; Pandey, V.; Banjare, N.; Gupta, P.N.; Soni, V. 2020: Drug resistance in cancer: mechanisms and tackling strategies. Pharmacological Reports: Pr 72(5): 1125-1151
Luo, M.; Yang, X.; Chen, H.-N.; Nice, E.C.; Huang, C. 2021: Drug resistance in colorectal cancer: An epigenetic overview. Biochimica et Biophysica Acta. Reviews on Cancer 1876(2): 188623
Barney, J.B.; Chandrashekarappa, D.G.; Soncini, S.R.; Schmidt, M.C. 2021: Drug resistance in diploid yeast is acquired through dominant alleles, haploinsufficiency, gene duplication and aneuploidy. Plos Genetics 17(9): E1009800
Czuczwar, P.; Kaczmarczyk, K.; Wierzchowska-Cioch, E.; Łuszczki, J.J.; Czuczwar, Sław.J. 2009: Drug resistance in epilepsy. Przeglad Lekarski 66(11): 963-966
Fairlamb, A.H.; Gow, N.A.R.; Matthews, K.R.; Waters, A.P. 2016: Drug resistance in eukaryotic microorganisms. Nature Microbiology 1(7): 16092
Ghosh, S. 1980: Drug resistance in leprosy. Indian Journal of Dermatology 25(3): 1-4
Matsuoka, M. 2010: Drug resistance in leprosy. Japanese Journal of Infectious Diseases 63(1): 1-7
Shanker, M.; Willcutts, D.; Roth, J.A.; Ramesh, R. 2010: Drug resistance in lung cancer. Lung Cancer 1: 23-36
Wery, M.; Coosemans, M. 1980: Drug resistance in malaria. Annales de la Societe Belge de Medecine Tropicale 60(2): 137-162
Hallinan, T.C. 1959: Drug resistance in malaria. West Indian Medical Journal 8: 132-134
Seruga, B.; Ocana, A.; Tannock, I.F. 2011: Drug resistance in metastatic castration-resistant prostate cancer. Nature Reviews. Clinical Oncology 8(1): 12-23
Sonneveld, P. 1999: Drug resistance in multiple myeloma. Pathologie-Biologie 47(2): 182-187
Pilarski, L.M.; Yatscoff, R.W.; Murphy, G.F.; Belch, A.R. 1998: Drug resistance in multiple myeloma: cyclosporin A analogues and their metabolites as potential chemosensitizers. Leukemia 12(4): 505-509
Weisberg, E.; Sattler, M.; Ray, A.; Griffin, J.D. 2010: Drug resistance in mutant FLT3-positive AML. Oncogene 29(37): 5120-5134